Compositions and methods for controlling plant pests

By expressing polynucleotides and mutant Cry proteins encoding Cry proteins in plants or bacteria, the problem of existing insect pest control agents being limited in scope and resistance to targeted insect lineages is solved, and a variety of important insects are achieved Effective control and environmentally friendly solutions.

CN114026111BActive Publication Date: 2024-11-12SYNGENTA CROP PROTECITON AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202080044490.9
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-06-26
Filing Date
2020-06-10
Publication Date
2024-11-12
Estimated Expiration
2040-06-10

AI Technical Summary

Technical Problem

Existing insect pest control agents have limited lineages to target insect pests, and certain chemical and biological control methods can affect non-target beneficial insects or cause insects to become resistant to control measures, resulting in farmers facing economic and environmental duality. pressure.

Method used

Provides novel polynucleotides and mutant Cry proteins encoding Cry proteins that produce broad spectrum activity and highly toxic insecticidal proteins by expression in plants or bacteria for controlling a variety of economically important insect pests, including Asian corn borers, etc.

Benefits of technology

Effective control of a variety of economically important insect pests is achieved, the impact on non-target organisms is reduced, and the possibility of resistance is reduced, providing an environmentally friendly alternative control method.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003416595550000761
    Figure BDA0003416595550000761
  • Figure BDA0003416595550000791
    Figure BDA0003416595550000791
  • Figure BDA0003416595550000792
    Figure BDA0003416595550000792
Patent Text Reader

Abstract

Disclosed herein are novel insecticidal proteins that are toxic to lepidopteran pests. DNA encoding the insecticidal proteins can be used to transform prokaryotes and eukaryotes to express the insecticidal proteins. The recombinant organisms or compositions containing the recombinant organisms or the insecticidal proteins can be used alone or in combination with appropriate agricultural carriers to control lepidopteran pests in different environments.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Sequence Listing

[0002] An official copy of the sequence listing is submitted electronically as a file named "81291-US-L-ORG-P-1_SeqList_ST25.txt" in ASCII format, generated on June 26, 2019, and having a size of 281 kilobytes, and is submitted concurrently with this specification. The sequence listing contained in this ASCII format file is a part of this specification and is incorporated herein by reference in its entirety. Technical Field

[0003] The present invention relates to pesticidal proteins and nucleic acid molecules encoding them, as well as compositions and methods for controlling plant pests. Background Art

[0004] Bacillus thuringiensis (Bt) is a Gram-positive, spore-forming soil bacterium characterized by its ability to produce crystalline inclusions that are specifically toxic to certain orders and species of plant pests (including insects), but are harmless to plants and other non-target organisms. For this reason, compositions comprising Bacillus thuringiensis strains or their insecticidal proteins can be used as environmentally acceptable insecticides to control agricultural insect pests or insect vectors of various human or animal diseases.

[0005] Crystal (Cry) proteins from Bacillus thuringiensis have potent insecticidal activity primarily against harmful insects of the orders Lepidoptera, Diptera, and Coleoptera. These proteins have also been shown to be active against harmful organisms of the orders Hymenoptera, Homoptera, Trichoderma, Trichophaga, and Tetrapoda, as well as other invertebrate orders such as Nematoda, Platyhelminthes, and Sarcopoda (Feitelson, J., 1993, The Bacillus Thuringiensis family tree, In: Advanced Engineered Pesticides, Marcel Dekker, Inc., New York, NY). These proteins were initially classified as CryI to CryVI based primarily on their insecticidal activity. The main categories are Lepidoptera-specific (I), Lepidoptera- and Diptera-specific (II), Coleoptera-specific (III), Diptera-specific (IV), and nematode-specific (V) and (VI). These proteins are further divided into subfamilies; More highly related proteins within each family are assigned letters of distinction, such as CryIA, CryIB, CryIC, etc. Even more closely related proteins within each distinction are given names, such as CryIC (a), CryIC (b), etc. The terms "Cry toxins" and "δ-endotoxins" are used interchangeably with the term "Cry proteins." The current new nomenclature for Cry proteins and genes is based on amino acid sequence homology rather than insect target specificity (Crickmore et al. (1998) Microbiol. Mol. Biol. Rev. [Microbial Molecular Biology Review] 62: 807-813). In this more acceptable classification, each toxin is assigned a unique name, which incorporates primary rank (Arabic numerals), secondary rank (capital letters), tertiary rank (lowercase letters), and quaternary rank (another Arabic numeral). In the current classification, Roman numerals have been replaced with Arabic numerals in the primary rank. For example, "CryIA(a)" under the old nomenclature is now "Cry1Aa" under the current nomenclature.According to Ibrahim et al. (2010, Bioeng. Bugs, 1:31-50), Cry toxins can still be divided into six major categories based on their insect host specificity and include: Group 1 - Lepidoptera (e.g., Cry1, Cry9, and Cry15); Group 2 - Lepidoptera and Diptera (e.g., Cry2); Group 3 - Coleoptera (Cry3, Cry7, and Cry8); Group 4 - Diptera (Cry4, Cry10, Cry11, Cry16, Cry17, Cry19, and Cry20); Group 5 - Lepidoptera and Coleoptera (Cry1I); and Group 6 - Nematodes (Cry6). The Cry1I, Cry2, Cry3, Cry10, and Cry11 toxins (73–82 kDa) are unique in that they appear to be natural truncations of the larger Cry1 and Cry4 proteins (130–140 kDa).

[0006] Cry proteins are globular protein molecules that accumulate as protoxins in the form of crystals during the sporulation stage of Bt. After ingestion by pests, these crystals typically dissolve to release the protoxin, which can range in size from 130-140 kDa for many Cry proteins with lepidopteran activity, such as Cry1 and Cry9, to 60-80 kDa for the Cry3 protein with coleopteran activity and the Cry2 protein with lepidopteran / diptera activity. After these crystals are dissolved by susceptible insects, the released protoxins are processed by proteases in the insect gut, such as trypsin and chymotrypsin, to produce the protease-resistant core Cry protein toxin. This proteolytic processing involves the removal of amino acids from different regions of the various Cry protoxins. For example, Cry protoxins of 130-140 kDa are typically activated by proteolytic removal of a 25-30 amino acid N-terminal peptide and approximately half of the remaining protein at the C-terminus, producing a mature Cry toxin of approximately 60-70 kDa. Protoxins of 60-80 kDa (e.g., Cry1I, Cry2, and Cry3) are also processed, but not to the same extent as larger protoxins. Compared to larger protoxins, smaller protoxins typically have equal or more amino acids removed from the N-terminus, but fewer amino acids are removed from the C-terminus. For example, proteolytic activation of Cry2 family members typically involves removal of approximately 40-50 N-terminal amino acids. Many Cry proteins are quite toxic to specific target insects, but many have narrow activity spectra.

[0007] Cry proteins typically have five conserved sequence domains and three conserved structural domains (see, for example, de Maagd et al., (2001) Trends Genetics, 17: 193-199). The first conserved structural domain (referred to as domain I) is typically composed of seven α helices and is involved in membrane insertion and pore formation. Domain II is typically composed of three β sheets arranged in a Greek key configuration, and domain III is typically composed of two antiparallel β sheets in a "jelly-roll" configuration (de Maagd et al., 2001, supra). Domains II and III are involved in receptor recognition and binding and are therefore considered to be determinants of toxin specificity.

[0008] In addition, non-endotoxin genes and the proteins they encode have also been isolated from Bacillus thuringiensis. Unlike Cry proteins, which are produced during sporulation and maintained intracellularly as parasporal crystals, these new insecticidal proteins are secreted from Bacillus during the plant growth phase and have therefore been designated as vegetative insecticidal proteins (VIPs). (See, for example, U.S. Patent Nos. 5,877,012; 6,107,279; 6,137,033; 5,849,870 and 5,889,174, incorporated herein by reference).

[0009] These proteins belong to the Cry1I family, unique insecticidal proteins from Bacillus thuringiensis, wherein they have biochemical properties similar to both Cry and VIP. For example, Cry1Ia has the conserved domains of other Cry proteins but is not produced in parasporal crystals. Previous reports have shown the implicit nature of cry1Ia-type genes based on the absence of Cry1Ia-type proteins in parasporal crystals. Kamenidou et al. (1996. J. Bacteriol. [Journal of Bacteriology] 178: 2141-2144) first reported the secretion of Cry1Ia and the presence of the N-terminal domain of Cry1I, which may serve as a secretion signal peptide. Previous reports have shown that Cry1Ia is active against both Lepidoptera and Coleopteran insects.

[0010] Many commercially valuable plants, including common crops, are susceptible to attack by plant pests, including insects and nematodes, resulting in substantial reductions in crop yield and quality. For example, plant pests are a major factor in the loss of important agricultural crops worldwide. In China, approximately 15% to 20% of the annual cereal harvest is lost due to pests and diseases. In addition, approximately $8 billion is lost annually in the United States alone due to infestations by invertebrate pests, including insects. Insect pests are also a burden for vegetable and fruit farmers, for producers of ornamental flowers, and for home gardeners.

[0011] Insect pests are primarily controlled through the intensive use of chemical pesticides, which are effective by inhibiting insect growth, preventing insect feeding or reproduction, or causing mortality. Biological pest control agents, such as strains of Bacillus thuringiensis that express pesticidal toxins (e.g., Cry proteins), have also been applied to crop plants with promising results, providing an alternative or supplement to chemical pesticides. Genes encoding some of these Cry proteins have been isolated, and their expression in heterologous hosts (e.g., transgenic plants) has been shown to provide another means for controlling economically important insect pests.

[0012] While good insect control can be achieved, some chemicals can sometimes also affect non-target beneficial insects, and some biological agents have very narrow activity spectra. Furthermore, the continued use of certain chemical and biological control methods increases the chances that insect pests will develop resistance to such control measures. This situation has been partially alleviated through various resistance management practices, but there remains a need to develop new and effective pest control agents that provide economic benefits to farmers and are environmentally acceptable. Particularly needed are control agents that can target a broader spectrum of economically important insect pests and effectively control insect strains that are, or may become, resistant to existing insect control agents. Summary of the Invention

[0013] In view of these needs, an object of the present invention is to provide new pest control agents by providing novel genes and pesticidal proteins that can be used to control a variety of plant pests.

[0014] The present invention provides compositions and methods for conferring pesticidal activity on bacteria, plants, plant cells, tissues and seeds. In particular, chimeric genes comprising novel polynucleotides encoding Cry proteins are provided, these novel polynucleotides are derived from assembled polynucleotides and sequences substantially identical thereto, and the expression of these chimeric genes produces proteins with toxicity to economically important insect pests (particularly insect pests that infect plants). The present invention further relates to novel Cry proteins produced by expression of these polynucleotides, and to compositions and formulations containing these Cry proteins, which are toxic to insects by inhibiting the survival, growth and reproduction of insect pests or limiting the ability of insects to cause damage or loss to crop plants. The Cry proteins of the present invention include Cry proteins derived from assembled polynucleotides and mutant or variant Cry proteins having one or more amino acid substitutions, additions or deletions. Examples of mutant Cry proteins include, but are not limited to, those that have been mutated to have a broader spectrum of activity or higher specific activity than their native Cry protein counterparts, those that have been mutated to introduce epitopes to generate antibodies that differentially recognize the mutated protein from the native protein, or those that have been mutated to regulate expression in transgenic organisms. The novel Cry proteins of the present invention are highly toxic to insect pests.For example, the Cry protein of the present invention can be used to control one or more economically important insect pests, such as Asian corn borer (Asian corn borer (Ostrinia furnacalis)), black cutworm (Agrotis ipsilon), cotton bollworm (Helicoverpa armigera), yellow peach borer (Conogethes punctiferalis), Oriental armyworm (Mythimna sepatate), European corn borer (Ostrinia nubilalis), fall armyworm (Spodoptera frugiperda), corn earworm (Helicoverpa zea), sugarcane borer (Diatraea spp. saccharalis), velvet bean caterpillar (Anticarsia gemmatalis), soybean looper (Chrysodeixis includes), southwest corn borer (Diatraea grandiosella), western bean cutworm (Richia albicosta), tobacco budworm (Heliothis virescens), striped stem borer (Chilo suppressalis), pink stem borer (Sesamia calamistis), rice leaffolder (Cnaphalocrocis medinalis), and the like.

[0015] The present invention also provides synthetic polynucleotides encoding the Cry proteins of the present invention, which have been optimized for expression in transgenic organisms (eg, transgenic bacteria or transgenic plants) using one or more codons.

[0016] The present invention further relates to expression cassettes and recombinant vectors comprising polynucleotides encoding the Cry proteins of the present invention. The present invention also provides transformed bacteria, plants, plant cells, tissues, and seeds comprising chimeric genes, or expression cassettes or recombinant vectors, which are useful for expressing the Cry proteins of the present invention in transformed bacteria, plants, plant cells, tissues, and seeds.

[0017] The present invention also relates to isolated Bacillus thuringiensis (Bt) strains that produce the Cry proteins of the present invention.

[0018] The present invention also relates to methods of using these polynucleotides of the present invention, for example, in DNA constructs or chimeric genes or expression cassettes or recombinant vectors for transformation and expression in organisms (including plants and microorganisms, such as bacteria). The nucleotide or amino acid sequence can be an assembled, native or codon-optimized sequence designed for expression in an organism (such as a plant or bacteria), or a hybrid Cry toxin with enhanced pesticidal activity. The present invention further relates to methods of preparing these Cry proteins and methods of using these polynucleotide sequences and Cry proteins, for example, to control insects in microorganisms or to confer protection from insect damage in transgenic plants.

[0019] Another aspect of the present invention includes insecticidal compositions and formulations comprising the Cry proteins or Bacillus thuringiensis strains of the present invention; and methods of using these compositions or formulations to control insect populations, for example, by applying these compositions or formulations to areas infested by insects, or to areas or plants susceptible to insect infestation for preventative treatment to confer protection against insect pests. Optionally, in addition to the Cry proteins or Bt strains of the present invention, these compositions or formulations of the present invention may also comprise other pesticides (such as chemical pesticides) to strengthen or enhance the insect control ability of the compositions or formulations.

[0020] These compositions and methods of the present invention can be used to control insect pests that attack plants, especially crop plants. These compositions of the present invention are also useful for producing altered or improved Cry proteins with pesticidal activity, or for detecting the presence of Cry proteins or nucleic acids in commercial products or transgenic organisms.

[0021] These and other features, aspects, and advantages of the present invention will become better understood with reference to the following detailed description and claims.

[0022] Brief description of the sequences in the sequence listing

[0023] SEQ ID NO: 1 is a polynucleotide encoding the assembly of BT204 protein.

[0024] SEQ ID NO: 2 is a polynucleotide encoding the assembly of BT235 protein.

[0025] SEQ ID NO: 3 is a polynucleotide encoding the assembly of BT645 protein.

[0026] SEQ ID NO: 4 is a polynucleotide encoding the assembly of BT727 protein.

[0027] SEQ ID NO: 5 is a polynucleotide encoding the assembly of BT1047 protein.

[0028] SEQ ID NO: 6 is a polynucleotide encoding the assembly of BT1280 protein.

[0029] SEQ ID NO: 7 is a polynucleotide encoding the assembly of BT1555 protein.

[0030] SEQ ID NO: 8 is a polynucleotide encoding the assembly of BT1559 protein.

[0031] SEQ ID NO: 9 is a polynucleotide encoding the assembly of BT1563 protein.

[0032] SEQ ID NO: 10 is the assembled polynucleotide encoding the BT1571 protein.

[0033] SEQ ID NO: 11 is a polynucleotide encoding the assembly of BT1633 protein.

[0034] SEQ ID NO: 12 is the maize codon-optimized sequence encoding BT204.

[0035] SEQ ID NO: 13 is the maize codon-optimized sequence encoding BT235.

[0036] SEQ ID NO: 14 is the maize codon-optimized sequence encoding BT645.

[0037] SEQ ID NO: 15 is the maize codon-optimized sequence encoding BT727.

[0038] SEQ ID NO: 16 is the maize codon-optimized sequence encoding BT1047.

[0039] SEQ ID NO: 17 is the maize codon-optimized sequence encoding BT1280.

[0040] SEQ ID NO: 18 is the maize codon-optimized sequence encoding BT1555.

[0041] SEQ ID NO: 19 is the maize codon-optimized sequence encoding BT1559.

[0042] SEQ ID NO: 20 is the maize codon-optimized sequence encoding BT1563.

[0043] SEQ ID NO: 21 is the maize codon-optimized sequence encoding BT1571.

[0044] SEQ ID NO: 22 is the maize codon-optimized sequence encoding BT1633.

[0045] SEQ ID NO: 23 is the maize codon-optimized sequence encoding mBT204.

[0046] SEQ ID NO: 24 is the maize codon-optimized sequence encoding mBT235.

[0047] SEQ ID NO: 25 is the maize codon-optimized sequence encoding mBT645.

[0048] SEQ ID NO: 26 is the soybean codon-optimized sequence encoding mBT645-2.

[0049] SEQ ID NO: 27 is the soybean codon-optimized sequence encoding mBT645-3.

[0050] SEQ ID NO: 28 is the maize codon-optimized sequence encoding mBT727.

[0051] SEQ ID NO: 29 is the maize codon-optimized sequence encoding mBT1047.

[0052] SEQ ID NO: 30 is the maize codon-optimized sequence encoding mBT1280.

[0053] SEQ ID NO: 31 is the maize codon-optimized sequence encoding mBT1555.

[0054] SEQ ID NO: 32 is the maize codon-optimized sequence encoding mBT1559.

[0055] SEQ ID NO: 33 is the maize codon-optimized sequence encoding mBT1563.

[0056] SEQ ID NO: 34 is the maize codon-optimized sequence encoding mBT1571.

[0057] SEQ ID NO: 35 is the maize codon-optimized sequence encoding mBT1633.

[0058] SEQ ID NO: 36 is the amino acid sequence of BT204 protein.

[0059] SEQ ID NO: 37 is the amino acid sequence of BT235 protein.

[0060] SEQ ID NO: 38 is the amino acid sequence of BT645 protein.

[0061] SEQ ID NO: 39 is the amino acid sequence of BT727 protein.

[0062] SEQ ID NO: 40 is the amino acid sequence of BT1047 protein.

[0063] SEQ ID NO: 41 is the amino acid sequence of BT1280 protein.

[0064] SEQ ID NO: 42 is the amino acid sequence of BT1555 protein.

[0065] SEQ ID NO: 43 is the amino acid sequence of BT1559 protein.

[0066] SEQ ID NO: 44 is the amino acid sequence of BT1563 protein.

[0067] SEQ ID NO: 45 is the amino acid sequence of BT1571 protein.

[0068] SEQ ID NO: 46 is the amino acid sequence of BT1633 protein.

[0069] SEQ ID NO: 47 is the amino acid sequence of the mutant BT204 (mBT204) protein.

[0070] SEQ ID NO: 48 is the amino acid sequence of the mutant BT235 (mBT235) protein.

[0071] SEQ ID NO: 49 is the amino acid sequence of the mutant BT645 (mBT645) protein.

[0072] SEQ ID NO: 50 is the amino acid sequence of the mutant BT645-2 (mBT645-2) protein.

[0073] SEQ ID NO: 51 is the amino acid sequence of the mutant BT645-3 (mBT645-3) protein.

[0074] SEQ ID NO: 52 is the amino acid sequence of the mutant BT727 (mBT727) protein.

[0075] SEQ ID NO: 53 is the amino acid sequence of mutant BT1047 (mBT1047) protein.

[0076] SEQ ID NO: 54 is the amino acid sequence of mutant BT1280 (mBT1280) protein.

[0077] SEQ ID NO: 55 is the amino acid sequence of the mutant BT1555 (mBT1555) protein.

[0078] SEQ ID NO: 56 is the amino acid sequence of the mutant BT1559 (mBT1559) protein.

[0079] SEQ ID NO: 57 is the amino acid sequence of the mutant BT1563 (mBT1563) protein.

[0080] SEQ ID NO: 58 is the amino acid sequence of the mutant BT1571 (mBT1571) protein.

[0081] SEQ ID NO: 59 is the amino acid sequence of the mutant BT1633 (mBT1633) protein.

[0082] SEQ ID NO: 60-66 are the amino acid sequences of Cry1I proteins. DETAILED DESCRIPTION

[0083] This description is not intended to be an exhaustive list of all the different ways in which the invention may be implemented or all the features that may be added to the invention. For example, features described with respect to one embodiment may be incorporated into other embodiments, and features described with respect to a particular embodiment may be deleted from that embodiment. Thus, the present invention contemplates that in some embodiments of the invention, any feature or combination of features set forth herein may be excluded or omitted. Furthermore, in view of this disclosure, numerous variations and additions to the various embodiments suggested herein will be apparent to those skilled in the art without departing from the invention. Therefore, the following description is intended to illustrate some specific embodiments of the invention and is not intended to be an exhaustive description of all permutations, combinations, and variations thereof.

[0084] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention belongs. The terms used in the description of the invention herein are for the purpose of describing particular embodiments only and are not intended to be limiting of the invention.

[0085] definition

[0086] As used herein and in the appended claims, the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to "a plant" is a reference to one or more plants and includes equivalents thereof known to those skilled in the art, and so forth.

[0087] As used herein, the term "and / or" refers to and encompasses any and all possible combinations of one or more of the associated listed items, as well as the lack of combinations when interpreted in the alternative ("or").

[0088] The term "about" is used herein to mean approximately, roughly, about, or around. When the term "about" is used in conjunction with a numerical range, it defines the range by extending the boundaries above and below the stated values. In general, the term "about" is used herein to define a numerical value to a variation of 20%, preferably 10% above and below (higher or lower) above and below the stated value. With respect to temperature, the term "about" means ±1°C, preferably ±0.5°C. When the term "about" is used in the context of the present invention (e.g., in combination with a temperature or molecular weight value), the exact value (i.e., without "about") is preferred.

[0089] As used herein, the term "amplified" means using at least one nucleic acid molecule as a template to construct multiple copies of a nucleic acid molecule or multiple copies complementary to the nucleic acid molecule. Amplification systems include polymerase chain reaction (PCR) systems, ligase chain reaction (LCR) systems, nucleic acid sequence-based amplification (NASBA, Cangene, Mississauga, Ontario), Q-β replicase systems, transcription-based amplification systems (TAS) and strand displacement amplification (SDA). See, for example, Diagnostic Molecular Microbiology: Principles and Applications [diagnostic molecular microbiology: principles and applications], PERSING et al., eds., American Society for Microbiology [American Society for Microbiology], Washington (Washington, DC), (1993). The product of amplification is referred to as "amplicon".

[0090] According to the present invention, an "assembled sequence", "assembled polynucleotide", "assembled nucleotide sequence", etc. is a synthetic polynucleotide prepared by aligning overlapping sequences of polynucleotides or portions of sequenced polynucleotides (i.e., k-mers, all possible subsequences of length k of a read obtained by DNA sequencing), which are determined from genomic DNA using DNA sequencing technology. The assembled sequence typically contains base-calling errors, which may be incorrectly determined bases, insertions and / or deletions compared to the natural DNA sequence contained in the genome from which the genomic DNA was obtained. Thus, for example, an "assembled polynucleotide" may encode a protein, and according to the present invention, neither the polynucleotide nor the protein is a natural product, but exists only through human action.

[0091] As used herein, the term "chimeric construct" or "chimeric gene" or "chimeric polynucleotide" or "chimeric nucleic acid" (or similar terms) refers to a construct or molecule comprising two or more polynucleotides from different sources assembled into a single nucleic acid molecule. The term "chimeric construct," "chimeric gene," "chimeric polynucleotide," or "chimeric nucleic acid" refers to any construct or molecule containing, but not limited to, (1) a polynucleotide (e.g., DNA) comprising a regulatory polynucleotide and a coding polynucleotide that are not found together in nature (i.e., at least one polynucleotide in the construct is heterologous with respect to at least one of its other polynucleotides), or (2) a polynucleotide that encodes a portion of a protein that is not naturally contiguous, or (3) a portion of a promoter that is not naturally contiguous. Additionally, a chimeric construct, chimeric gene, chimeric polynucleotide, or chimeric nucleic acid may comprise a regulatory polynucleotide and a coding polynucleotide derived from different sources, or a regulatory polynucleotide and a coding polynucleotide derived from the same source but arranged in a manner different from that found in nature. In some embodiments of the present invention, a chimeric construct, chimeric gene, chimeric polynucleotide or chimeric nucleic acid comprises an expression cassette comprising a polynucleotide of the present invention under the control of a regulatory polynucleotide, particularly a regulatory polynucleotide functional in plants or bacteria.

[0092] A "coding sequence" is a nucleic acid sequence that is transcribed into RNA (such as mRNA, rRNA, tRNA, snRNA, sense RNA or antisense RNA). Preferably, the RNA is then translated in an organism to produce a protein.

[0093] As used herein, " codon optimized " sequence means following nucleotide sequence, and wherein these codons are selected to reflect the specific codon preference that host cell or organism can have.This typically is to complete in such a way, and this mode is in order to keep the amino acid sequence of the polypeptide encoded by the nucleotide sequence to be optimized.In certain embodiments, the dna sequence dna of recombinant DNA construct comprises the cell (for example, animal, plant or fungal cell) that has been expressed therein for this construct and has carried out codon optimized sequence.For example, the construct to be expressed in plant cell can make its whole or part of sequence (for example, the first gene suppression element or gene expression element) carry out codon optimized for expression in plant.See for example, U.S. Patent number 6,121,014, is incorporated herein by reference.

[0094] "Controlling" insects means inhibiting the ability of insect pests to survive, grow, feed, or reproduce through toxic effects, or limiting insect-related crop plant damage or loss, or protecting the yield potential of crops when grown in the presence of insect pests. "Controlling" insects may or may not mean killing the insects, although it preferably means killing the insects.

[0095] The terms “comprises” or “comprising” when used in this specification indicate the presence of stated features, integers, steps, operations, elements, or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, or groups thereof.

[0096] As used herein, the transition phrase "consisting essentially of (and grammatical variations) means that the scope of the claim is to be interpreted to encompass the specified materials or steps recited in the claim and those that do not materially alter one or more of the basic and novel characteristics of the claimed invention. Thus, the term "consisting essentially of" when used in the claims of the present invention is not intended to be interpreted as equivalent to "comprising."

[0097] In the context of the present invention, "corresponding to or corresponds to" means that when the amino acid sequences of variant or homolog Cry proteins are aligned with each other, the amino acids "corresponding to" certain enumerated positions in the variant or homolog proteins are those aligned with these positions in the reference protein, but not necessarily those located at these exact numerical positions (relative to the specific reference amino acid sequence of the present invention). For example, if SEQ ID NO: 36 is a reference sequence and is aligned with SEQ ID NO: 38, SEQ ID NO: Thr237 of 38 "corresponds to" SEQ ID NO: Thr241 of 36, or, for example, SEQ ID NO: Ala601 of 38 "corresponds to" SEQ ID NO: Val605 of 36.

[0098] As used herein, the term "Cry protein" means an insecticidal protein that can exist in crystalline form in Bacillus thuringiensis or related bacteria, or can be a soluble protein having Cry protein-like domains (e.g., domains I, II, and III) that is secreted outside the Bt cell during vegetative growth. The term "Cry protein" can refer to the original toxin form or any insecticidal fragment or toxin thereof.

[0099] "Delivering" a composition or toxic protein means that the composition or toxic protein contacts the insect, which promotes oral uptake of the composition or toxic protein, resulting in a toxic effect and control of the insect. The composition or toxic protein can be delivered in a number of recognized ways, including but not limited to transgenic plant expression, one or more formulated protein compositions, one or more sprayable protein compositions, a bait matrix, or any other art-recognized protein delivery system.

[0100] The term "domain" refers to a group of amino acids that are conserved at specific positions along the alignment of the sequences of evolutionarily related proteins. Although amino acids at other positions may differ between homologs, amino acids that are highly conserved at specific positions indicate amino acids that are likely to be essential in the structure, stability, or function of the protein. They are identified by their high degree of conservation in aligned sequences of a family of protein homologs and can be used as identifiers to determine whether any polypeptide in question belongs to a previously identified group of polypeptides.

[0101] "Effective insect controlling amount" means a concentration of a toxic protein that inhibits the ability of insects to survive, grow, feed, or reproduce through toxic effects, or limits insect-related damage or loss of crop plants, or protects the yield potential of crops when grown in the presence of insect pests. An "effective insect controlling amount" may or may not mean killing the insects, although it preferably means killing the insects.

[0102] As used herein, "expression cassette" means a nucleic acid sequence capable of directing the expression of at least one polynucleotide of interest (e.g., a polynucleotide encoding a Cry protein of the present invention) in an appropriate host cell, including a promoter operably linked to the polynucleotide of interest, which is operably linked to a termination signal. An "expression cassette" typically also comprises additional polynucleotides required for the correct translation of the polynucleotide of interest. The expression cassette may also be included in other polynucleotides that are not essential for the direct expression of the polynucleotide of interest but exist due to convenient restriction sites for removing the expression cassette from an expression vector. The expression cassette comprising one or more polynucleotides of interest may be chimeric, meaning that at least one of its components is heterologous relative to at least one of its other components. The expression cassette may also be naturally occurring but already be an expression cassette obtained in a recombinant form useful for heterologous expression. However, typically, the expression cassette is heterologous relative to the host, i.e., the polynucleotide of interest in the expression cassette is not naturally occurring in the host cell and must have been introduced into the host cell or an ancestor of the host cell by a transformation process or a breeding process. The expression of one or more polynucleotides of interest in the expression cassette is typically under the control of a promoter. In the case of multicellular organisms (such as plants), the promoter may also be specific or preferential for a particular tissue, or organ, or developmental stage. When transformed into a plant, the expression cassette or fragment thereof may also be referred to as an "inserted polynucleotide" or "inserted polynucleotide."

[0103] A "gene" is defined herein as a unit of inheritance comprising one or more polynucleotides that occupies a specific location on a chromosome or plasmid and contains the genetic instructions for a specific characteristic or trait in an organism.

[0104] "Gut proteases" are proteases naturally found in the digestive tract of insects. Such proteases are generally involved in the digestion of ingested proteins. Examples of gut proteases include trypsin, which typically cleaves peptides on the C-terminal side of lysine (K) or arginine (R) residues; and chymotrypsin, which typically cleaves peptides on the C-terminal side of phenylalanine (F), tryptophan (W), or tyrosine (Y).

[0105] When used in reference to a gene or polynucleotide or polypeptide, the term "heterologous" means that the gene or polynucleotide or polypeptide is not in its natural environment or contains a part that is present in its non-natural environment (i.e., has been artificially altered). For example, a heterologous gene may include a polynucleotide introduced from one species into another species. A heterologous gene may also include a polynucleotide that is native to an organism that has been altered in some way (e.g., by mutation; addition in multiple copies; linkage to a non-native promoter or enhancer polynucleotide, etc.). A heterologous gene may include a plant gene polynucleotide that includes a cDNA form of a plant gene; these cDNAs may be expressed in the sense direction (to produce mRNA) or the antisense direction (to produce an antisense RNA transcript that is complementary to the mRNA transcript). In one aspect of the present invention, a heterologous gene is distinguished from an endogenous plant gene in that the heterologous gene polynucleotide is typically linked to a polynucleotide containing regulatory elements, such as a promoter, and these polynucleotides are not found naturally associated with the gene for the protein encoded by the heterologous gene or with the plant gene polynucleotide in the chromosome, or are associated with a portion of the chromosome not found in nature (e.g., a gene expressed in a locus where the gene is not normally expressed). Additionally, a "heterologous" polynucleotide refers to a polynucleotide not naturally associated with the host cell into which the polynucleotide is introduced, including non-naturally occurring multiple copies of a naturally occurring polynucleotide.

[0106] "Homologous recombination" is the exchange of DNA fragments between two DNA molecules or chromatids of paired chromosomes in the region of the same polynucleotide ("crossing over"). A "recombination event" is understood herein to mean a meiotic crossover.

[0107] A nucleic acid sequence is "co-encoding" with a reference nucleic acid sequence when the sequence encodes a polypeptide having the same amino acid sequence as the polypeptide encoded by the reference nucleic acid sequence. For example, SEQ ID NO:12 is co-encoding with SEQ ID NO:1 because both encode the amino acid sequence represented by SEQ ID NO:36.

[0108] The term "isolated" nucleic acid molecule, polynucleotide, or protein is a nucleic acid molecule, polynucleotide, or protein that is no longer present in its natural environment. The isolated nucleic acid molecule, polynucleotide, or protein of the present invention can exist in a purified form, or can exist in a recombinant host, such as a transgenic bacterium or a transgenic plant. Thus, claims to "isolated" nucleic acid molecules as recited herein encompass nucleic acid molecules when the nucleic acid molecule is contained within the genome of a transgenic plant.

[0109] A "nucleic acid molecule" is a single-stranded or double-stranded DNA or RNA that can be isolated from any source or can be prepared synthetically. In the context of the present invention, the nucleic acid molecule is preferably a DNA segment.

[0110] "Operably linked" refers to the association of polynucleotides on a single nucleic acid fragment such that the function of one affects the function of the other. For example, a promoter is operably linked to a coding polynucleotide or functional RNA when it is capable of affecting the expression of the coding polynucleotide or functional RNA (i.e., the coding polynucleotide or functional RNA is under the transcriptional control of the promoter). A coding polynucleotide in either the sense or antisense orientation can be operably linked to a regulatory polynucleotide.

[0111] As used herein, "killing pests", "killing insects", etc. refer to the ability of the Cry proteins of the present invention to control pests or the amount of Cry proteins that can control pests as defined herein. Therefore, pesticidal Cry proteins can kill or inhibit the ability of pests (e.g., insect pests) to survive, grow, feed, or reproduce.

[0112] A "plant" is any plant at any stage of development, particularly a seed plant.

[0113] A "plant cell" is a structural and physiological unit of a plant, comprising a protoplast and a cell wall. A plant cell can be in the form of an isolated single cell or a cultured cell, or as part of a higher-order organizational unit such as, for example, a plant tissue, a plant organ, or a whole plant.

[0114] "Plant cell culture" means a culture of plant units such as, for example, protoplasts, cell culture cells, cells in plant tissue, pollen, pollen tubes, ovules, embryo sacs, zygotes, and embryos at various stages of development.

[0115] "Plant material" refers to leaves, stems, roots, flowers or flower parts, fruits, pollen, egg cells, zygotes, seeds, cuttings, cell or tissue cultures, or any other part or product of a plant.

[0116] A "plant organ" is a distinct and clearly structured and differentiated part of a plant, such as a root, stem, leaf, flower bud or embryo.

[0117] As used herein, "plant tissue" means a group of plant cells organized into a structural and functional unit. This includes any plant tissue in a plant or in culture. This term includes, but is not limited to, whole plants, plant organs, plant seeds, tissue cultures, and any group of plant cells organized into a structural or functional unit. The use of this term in conjunction with or by itself with any specific type of plant tissue, as listed above or otherwise encompassed by this definition, is not intended to exclude any other type of plant tissue.

[0118] "Polynucleotide" refers to a polymer composed of many nucleotide monomers covalently bonded in a chain. Such "polynucleotides" include DNA, RNA, modified oligonucleotides (e.g., oligonucleotides containing bases atypical for biological RNA or DNA, such as 2'-O-methylated oligonucleotides), etc. In some embodiments, nucleic acids or polynucleotides can be single-stranded, double-stranded, multi-stranded, or a combination thereof. Unless otherwise indicated, in addition to any explicitly indicated polynucleotides, specific nucleic acids or polynucleotides of the present invention optionally further comprise or encode complementary polynucleotides.

[0119] A "polynucleotide of interest" refers to any polynucleotide that, when transferred into an organism (e.g., a plant), confers a desired trait to that organism, such as insect resistance, disease resistance, herbicide tolerance, antibiotic resistance, improved nutritional value, improved performance in an industrial process, production of a commercially valuable enzyme or metabolite, or altered reproductive capacity.

[0120] The term "promoter" refers to a polynucleotide, usually upstream (5') of its coding polynucleotide, that controls the expression of the coding polynucleotide by providing the recognition of RNA polymerase and other factors required for proper transcription.

[0121] "Protoplasts" are isolated plant cells without or with only a partial cell wall.

[0122] As used herein, the term "recombination" refers to the following form of nucleic acid molecules (for example, DNA or RNA) or protein or organisms, which are not usually found in nature and are produced by human intervention for this reason. As used herein, "recombinant nucleic acid molecules" are nucleic acid molecules comprising a combination of polynucleotides, which polynucleotides do not naturally coexist and are the result of human intervention, for example, nucleic acid molecules composed of a combination of at least two polynucleotides heterologous to each other, or artificially synthesized (for example, polynucleotides synthesized using the nucleotide sequence of assembly) and comprising nucleic acid molecules different from polynucleotides typically present in nature, or nucleic acid molecules comprising artificial incorporation into the genomic DNA of a host cell and the transgenic nucleic acid molecules in the relevant flanking DNA of the host cell genome. Another example of recombinant nucleic acid molecules is the DNA molecule produced by inserting transgenic into the genomic DNA of a plant, which can ultimately result in the expression of recombinant RNA / or protein molecules in the organism. As used herein, "recombinant plant" is a plant that is not usually present in nature, is the result of human intervention, and contains transgenic and / or heterologous nucleic acid molecules incorporated into its genome. Due to this type of genome change, recombinant plants are significantly different from relevant wild-type plants.

[0123] "Regulatory elements" refer to sequences involved in controlling the expression of a nucleotide sequence. Regulatory elements include promoters operably linked to a nucleotide sequence of interest and termination signals. They also typically encompass sequences required for proper translation of the nucleotide sequence.

[0124] In the context of two nucleic acid or amino acid sequences, the term "identity" or "identical" or "substantially identical" refers to two or more sequences or subsequences that have at least 60%, preferably at least 80%, more preferably 90%, even more preferably 95%, and most preferably at least 99% nucleotide or amino acid residue identity when compared and aligned for maximum correspondence, as measured using one of the following sequence comparison algorithms or by visual inspection. Preferably, substantial identity exists over a region having a length of at least about 50 residues or bases, more preferably over a region of at least about 100 residues or bases, and most preferably, the sequences are substantially identical over at least about 150 residues or bases. In a particularly preferred embodiment, the sequences are substantially identical over the entire length of the coding region. In addition, substantially identical nucleic acid or amino acid sequences perform essentially the same function.

[0125] For sequence comparison, typically, one sequence serves as a reference sequence to which a test sequence is compared. When using a sequence comparison algorithm, the test sequence and the reference sequence are input into a computer (if necessary, subsequence coordinates are specified), and the parameters of the sequence algorithm program are specified. The sequence comparison algorithm then calculates the sequence identity percentages of the test sequence(s) relative to the reference sequence based on the specified program parameters.

[0126] Optimal alignment of sequences for comparison can be performed, for example, by the local homology algorithm of Smith and Waterman, Adv. Appl. Math. 2:482 (1981), by the homology alignment algorithm of Needleman and Wunsch, J. Mol. Biol. 48:443 (1970), by the search by similarity method of Pearson and Lipman, Proc. Nat'l. Acad. Sci. USA 85:2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Street, Madison, Wisconsin), or by visual inspection (see generally Ausubel et al., infra).

[0127] An example of an algorithm suitable for determining percent sequence identity and sequence similarity is the BLAST algorithm, which is described in Altschul et al., J. Mol. Biol. 215: 403-410 (1990). Software for performing BLAST analysis is publicly available through the National Center for Biotechnology Information (NCBI, US National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894). This algorithm involves first identifying high-scoring sequence pairs (HSPs) by identifying short words of length W in the query sequence that match or meet some positive threshold score T when compared to words of the same length in the database sequence. T is referred to as the neighborhood word score threshold (Altschul et al., 1990). These initial neighborhood word hits serve as seeds for initiating searches to find longer HSPs containing them. The word hits are then extended in both directions along each sequence for as far as the cumulative alignment score can be increased. For nucleotide sequences, the cumulative score is calculated using the parameters M (reward score for a pair of matching residues; always >0) and N (penalty score for mismatched residues; always <0). For amino acid sequences, a scoring matrix is ​​used to calculate the cumulative score. Extension of the word hits in each direction is stopped when the cumulative alignment score decreases by the amount X from its maximum achieved value; when the cumulative score approaches 0 or below due to the accumulation of one or more negative-scoring residue alignments; or when the end of either sequence is reached. The BLAST algorithm parameters W, T, and X determine the sensitivity and speed of the alignment. The BLASTN program (for nucleotide sequences) uses a word length (W) of 11, an expectation (E) of 10, a cutoff of 100, M=5, N=-4, and a comparison of both chains as defaults. For amino acid sequences, the BLASTP program uses as defaults a wordlength (W) of 3, an expectation (E) of 10, and the BLOSUM62 scoring matrix (see Henikoff and Henikoff, Proc. Natl. Acad Sci. USA 89:10915 (1989)).

[0128] In addition to calculating percent sequence identity, the BLAST algorithm also performs a statistical analysis of the similarity between two sequences (see, e.g., Karlin and Altschul, Proc. Nat'l. Acad. Sci. USA 90:5873-5787 (1993)). One measure of similarity provided by the BLAST algorithm is the smallest sum probability (P(N)), which provides an indication of the probability that a match between two nucleotide or amino acid sequences would occur by chance. For example, a test nucleic acid sequence is considered similar to a reference sequence if the smallest sum probability in a comparison of the test nucleic acid sequence to the reference nucleic acid sequence is less than about 0.1, more preferably less than about 0.01, and most preferably less than about 0.001.

[0129] Another indication that two nucleic acid sequences are substantially identical is that the two molecules hybridize to each other under stringent conditions. The phrase "specifically hybridizes" means that a molecule binds, double-strands, or hybridizes only to a specific nucleotide sequence under stringent conditions when that sequence is present in a complex mixture (e.g., total cellular) DNA or RNA. "Substantially binds" refers to complementary hybridization between a probe nucleic acid and a target nucleic acid, and encompasses minor mismatches that can be accommodated by reducing the stringency of the hybridization medium to achieve the desired detection of the target nucleic acid sequence.

[0130] In the context of nucleic acid hybridization experiments (such as DNA hybridization and RNA hybridization), "stringent hybridization conditions" and "stringent hybridization wash conditions" are sequence-dependent and are different under different environmental parameters. Longer sequences hybridize specifically at higher temperatures. An extensive guide to nucleic acid hybridization is found in Tijssen (1993) Laboratory Techniques in Biochemistry and Molecular Biology—Hybridization with Nucleic Acid Probes, Chapter 2, Part I "Overview of principles of hybridization and the strategy of nucleic acid probe assays", Elsevier, New York. Typically, highly stringent hybridization and wash conditions are selected to be higher than the thermal melting point (T for the specific sequence) at a defined ionic strength and pH. m Typically, under "stringent conditions," a probe will hybridize to its target sequence, but to no other sequences.

[0131] Tm It is the temperature (under defined ionic strength and pH) at which 50% of the target sequence hybridizes to a perfectly matched probe. Very stringent conditions are selected to be equal to the T for a specific probe. m . An example of stringent hybridization conditions for hybridization of complementary nucleic acids (which have more than 100 complementary residues on the filter in a Southern or Northern blot) is 50% formamide with 1 mg of heparin at 42°C, and the hybridization is carried out overnight. An example of a high stringency wash condition is 0.15 M NaCl at 72°C for about 15 minutes. An example of a stringent wash condition is a 0.2×SSC wash at 65°C for 15 minutes (see, Sambrook, below, for a description of SSC buffer). Typically, a high stringency wash is preceded by a low stringency wash to remove background probe signal. An example of a medium stringency wash for, for example, a duplex of more than 100 nucleotides is 1×SSC at 45°C for 15 minutes. An example of a low stringency wash for, for example, a duplex of more than 100 nucleotides is 4-6×SSC at 40°C for 15 minutes. For short probes (e.g., about 10 to 50 nucleotides), stringent conditions typically involve a salt concentration of less than about 1.0 M Na ions, typically about 0.01 to 1.0 M Na ion concentration (or other salts) at pH 7.0 to 8.3, and the temperature is typically at least about 30° C. Stringent conditions can also be achieved by adding destabilizing agents such as formamide. In general, a signal-to-noise ratio that is 2-fold (or higher) is observed in a particular hybridization assay compared to an unrelated probe, indicating that specific hybridization has been detected. Nucleic acids that do not hybridize to each other under stringent conditions are still substantially identical if the proteins they encode are substantially identical. This occurs, for example, when a copy of a nucleic acid is created using the maximum codon degeneracy permitted by the genetic code.

[0132] The following are examples of settings of hybridization / wash conditions that can be used to clone homologous nucleotide sequences that are substantially identical to the reference nucleotide sequences of the present invention: a reference nucleotide sequence preferably hybridizes to the reference nucleotide sequence under the following conditions: in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO4, 1 mM EDTA at 50°C, and washing in 2×SSC, 0.1% SDS at 50°C; more desirably in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO4, 1 mM EDTA at 50°C, and washing in 1×SSC, 0.1% SDS at 50°C; still more desirably in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO4, 1 mM EDTA at 50°C, and washing in 0.5×SSC, 0.1% SDS at 50°C; preferably in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO4, 1 mM EDTA at 50°C, and washing in 0.5×SSC, 0.1% SDS at 50°C. EDTA at 50°C and washed in 0.1×SSC, 0.1% SDS at 50°C; more preferably in 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO 4 , 1 mM EDTA at 50°C and in 0.1×SSC, 0.1% SDS at 65°C.

[0133] Another indication that two nucleic acid sequences or proteins are substantially identical is that the protein encoded by the first nucleic acid immunologically cross-links with or specifically binds to the protein encoded by the second nucleic acid. Thus, a protein is typically substantially identical to a second protein, e.g., where the two proteins differ only by conservative substitutions.

[0134] As used herein, "synthetic polynucleotide" refers to a polynucleotide comprising bases or structural features not present in naturally occurring polynucleotides. For example, a synthetic polynucleotide encoding a Cry protein of the present invention (which comprises a nucleotide sequence having a G+C content and a normal codon distribution more similar to that of a dicot or monocot gene) is described as synthetic. The synthetic polynucleotide of the present invention may also, for example, comprise an assembled nucleotide sequence of the present invention.

[0135] As used herein, a Cry protein that is "toxic" to insect pests means that the Cry protein acts as an orally active insect control agent to kill insect pests, or that the Cry protein is capable of destroying or preventing insect feeding, or causing growth inhibition of insect pests, both of which may or may not cause insect death. When the Cry protein of the present invention is delivered to an insect or an insect comes into oral contact with the Cry protein, the result is typically the death of the insect, or a slowing of the growth of the insect, or the cessation of feeding on a source of the toxic Cry protein that the insect can utilize.

[0136] "Transformation" is a process for introducing heterologous nucleic acid into a host cell or organism. In particular, "transformation" means that a DNA molecule is stably integrated into the genome of the organism of interest.

[0137] "Transformed / transgenic / recombinant" refers to a host organism (e.g., bacteria or plant) into which a heterologous nucleic acid molecule has been introduced. The nucleic acid molecule can be stably integrated into the host's genome, or the nucleic acid molecule can also exist as an extrachromosomal molecule. Such extrachromosomal molecules can replicate autonomously. Transformed cells, tissues, or plants should be understood to encompass not only the end product of the transformation process, but also their transgenic progeny. A "non-transformed," "non-transgenic," or "non-recombinant" host refers to a wild-type organism, such as a bacteria or plant, that does not contain the heterologous nucleic acid molecule.

[0138] Nucleotides are represented herein by the following standard abbreviations: adenine (A), cytosine (C), thymine (T), and guanine (G). Amino acids are also represented by the following standard abbreviations: alanine (Ala; A), arginine (Arg; R), asparagine (Asn; N), aspartic acid (Asp; D), cysteine ​​(Cys; C), glutamine (Gln; Q), glutamic acid (Glu; E), glycine (Gly; G), histidine (His; H), isoleucine (Ile; I), leucine (Leu; L), lysine (Lys; K), methionine (Met; M), phenylalanine (Phe; F), proline (Pro; P), serine (Ser; S), threonine (Thr; T), tryptophan (Trp; W), tyrosine (Tyr; Y), and valine (Val; V).

[0139] The present invention provides compositions and methods for controlling harmful plant pests. In particular, the present invention relates to Cry-like proteins encoded by polynucleotides assembled from genomic DNA isolated from bacteria (such as Bacillus thuringiensis), which are toxic to insect pests; and to assembled polynucleotides and related polynucleotides comprising nucleotide sequences encoding these Cry-like proteins; and to the preparation and use of these assembled polynucleotides and related polynucleotides and Cry proteins to control insect pests.

[0140] According to some embodiments, the present invention provides a nucleic acid molecule or an optionally isolated nucleic acid molecule, which comprises, consists essentially of, or consists of a nucleotide sequence encoding a Cry protein in its protoxin form or a biologically active fragment or toxin fragment thereof, wherein the nucleotide sequence (a) has at least 80% to at least 99% sequence identity with the assembled sequence of any one of SEQ ID NOs: 1-11 or its toxin encoding fragment; or (b) encodes a protein comprising the following amino acid sequence, which has at least 80% to at least 99% sequence identity with any one of SEQ ID NOs: 36-46 or its toxin fragment; or (c) is an assembled nucleotide sequence of (a) or (b); or (d) is a synthetic sequence of (a), (b) or (c), which synthetic sequence has been codon-optimized for expression in transgenic organisms. In other embodiments, the nucleotide sequence comprises SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, or any toxin encoding fragment of any one of SEQ ID NOs: 1-11. In other embodiments, the synthetic nucleotide sequence comprises SEQ ID NO:12, SEQ ID NO:13, SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, SEQ ID NO:24, SEQ ID NO:25, SEQ ID NO:26, SEQ ID NO:27, SEQ ID NO:28, SEQ ID NO:29, SEQ ID NO:30, SEQ ID NO:31, SEQ ID NO:32, SEQ ID NO:33, SEQ ID NO:34, SEQ ID NO:35, or any toxin encoding fragment of any one of SEQ ID NOs:12-35.

[0141] The present invention also encompasses polynucleotides that are fragments of a polynucleotide encoding a Cry protein protoxin. A "fragment" is intended to encode a portion of the nucleotide sequence of a Cry protein. A fragment of a nucleotide sequence may encode a biologically active portion of a Cry protein, a so-called "toxic fragment," or it may be a fragment that can be used as a hybridization probe or PCR primer using the methods disclosed below. The nucleic acid molecule of the fragment of the nucleotide sequence encoding the Cry protein includes at least about 15, 20, 50, 75, 100, 200, 300, 350, 400, 450, 500, 550, 600, 650, 700, 750, 800, 850, 900, 950, 1000, 1050, 1100, 1150, 1200, 1250, 1300, 1350, 1400, 1450 consecutive nucleotides, or up to the number of nucleotides with one codon less than the full-length Cry protein encoding nucleotide sequence disclosed herein (for example, 2157 nucleotides for SEQ ID NO: 1). "Contiguous" nucleotides are intended to be nucleotide residues directly adjacent to each other. Some fragments of the nucleotide sequence of the present invention will encode toxic fragments that retain the biological activity of the Cry protein and therefore retain insecticidal activity. By "retaining insecticidal activity" is meant that the fragment will have at least about 30%, preferably at least about 50%, more preferably at least about 70%, and even more preferably at least about 80% of the insecticidal activity of the Cry protein. Methods for measuring insecticidal activity are well known in the art. See, for example, Czapla and Lang (1990) J. Econ. Entomol. 83:2480-2485; Andrews et al. (1988) Biochem. J. 252:199-206; Marrone et al. (1985) J. of Economic Entomology 78:290-293; and U.S. Pat. No. 5,743,477, all of which are incorporated herein by reference in their entirety.

[0142] The toxin fragments of the Cry protein of the present invention will encode at least about 15, 25, 30, 50, 75, 100, 125, 150, 175, 200, 250, 300, 350, 400, and 450 consecutive amino acids, or up to a length of one amino acid less than the full-length Cry protein of the present invention (e.g., 718 amino acids for SEQ ID NO: 36).

[0143] In some embodiments, the nucleic acid molecule of the present invention comprises, consists essentially of, or consists of a nucleotide sequence encoding a Cry protein comprising an amino acid sequence having at least 80% to at least 99% sequence identity with any one of SEQ ID NOs: 36-46 or a toxin fragment thereof. In some other embodiments, the amino acid sequence comprises, consists essentially of, or consists of any one of SEQ ID NOs: 36-46 or a toxin fragment thereof. Thus, in some embodiments, a Cry protein that has been activated by proteolytic processing (e.g., by a protease prepared from the intestine of an insect) can be characterized and the N-terminal or C-terminal amino acid of the activated toxin fragment identified. In this aspect of the invention, those skilled in the art can determine that: for example, the toxin fragment of SEQ ID NO: 36 can comprise about 149-719 or about 153-719 amino acids of SEQ ID NO: 36, or the Cry protein containing a secretion signal at the N-terminus can remove the secretion signal to produce a toxin fragment of the protein, for example, the toxin fragment of SEQ ID NO: 38 can comprise about 33-715 amino acids, or the toxin fragment of the Cry protein variant produced by introducing or eliminating a protease processing site at an appropriate position of the coding sequence to allow or eliminate the proteolytic cleavage of the larger variant protein by insect, plant or microbial proteases is also within the scope of the present invention. The final result of such operations is understood to be the production of toxin fragment molecules having the same or better activity as the intact Cry prototoxin protein.

[0144] In some embodiments of the present invention, a chimeric gene is provided, comprising a heterologous promoter operably linked to a polynucleotide comprising, consisting essentially of, or consisting of a nucleotide sequence encoding a Cry protein that is toxic to a lepidopteran pest, wherein the nucleotide sequence (a) is identical to SEQ ID NO: 1-11 or a toxin encoding fragment thereof having at least 80% (e.g., 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 99.1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8%, 99.9%) to at least 99% (99%, 99.1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8%, 99.9%) sequence identity; or (b) encodes a protein comprising an amino acid sequence identical to SEQ ID Any of NOs: 36-46 or a toxin fragment thereof has at least 80% (e.g., 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 99.1%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8%, 99.9%, 99.10%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8%, 99.9%, 99.11%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8%, 99.9%, 99.9%, 99.12%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8%, 99.9%, 99.9%, 99.13%, 99.2%, 99.3%, 99.4%, 99.5%, 99.6%, 99.7%, 99.8%, 99.9 ... or (c) is a synthetic sequence of (a) or (b) that has been codon-optimized for expression in a transgenic organism.

[0145] In other embodiments, the heterologous promoter is a plant-expressible promoter. For example, but not limited to, the plant-expressible promoter is selected from the group consisting of ubiquitin, tuberose yellow virus, maize TrpA, OsMADS6, maize H3 histone, bacteriophage T3 gene 9 5'UTR, maize sucrose synthase 1, maize alcohol dehydrogenase 1, maize light-harvesting complex, maize heat shock protein, maize mtl, pea small subunit RuBP carboxylase, rice actin, rice cyclophilin, Ti plasmid mannopine synthase, Ti plasmid nopaline synthase, petunia chalcone isomerase, legume glycine-rich protein 1, potato patatin, lectin, CaMV 35S, and S-E9 small subunit RuBP carboxylase promoters.

[0146] In further embodiments, the protein encoded by the chimeric gene is toxic to one or more lepidopteran pests selected from the group consisting of: Asian corn borer (Asian corn borer), black cutworm (Agrotissima minor), cotton stem borer (Helicoverpa armigera), yellow peach borer (Cornia oleracea), oriental armyworm (Oriental armyworm), European corn borer (European corn borer), fall armyworm (Spodoptera frugiperda), corn ear moth (Zea mays), sugarcane borer (Stichopus malus), velvet bean caterpillar (Spodoptera frugiperda), soybean armyworm (Soybean looper), southwestern corn borer (Southwestern corn borer), western bean cutworm (Western bean cutworm), tobacco budworm (Heliothis virescens), striped stem borer (Chilo suppressalis), powdery stem borer (African stem borer), and rice leaf roller (Cnaphalocrocis medinalis).

[0147] In further embodiments, the polynucleotide comprises, consists essentially of, or consists of a nucleotide sequence having at least 85% to at least 99% sequence identity to SEQ ID NO: 1, or a toxin encoding fragment thereof, or a nucleotide sequence having at least 85% to at least 99% sequence identity to SEQ ID NO: 2, or a toxin encoding fragment thereof, or a nucleotide sequence having at least 85% to at least 99% sequence identity to SEQ ID NO: 3, or a toxin encoding fragment thereof, or a nucleotide sequence having at least 85% to at least 99% sequence identity to SEQ ID NO: 4, or a toxin encoding fragment thereof, or a nucleotide sequence having at least 85% to at least 99% sequence identity to SEQ ID NO: 5, or a toxin encoding fragment thereof, or a nucleotide sequence having at least 85% to at least 99% sequence identity to SEQ ID NO: 6, or a toxin encoding fragment thereof, or a nucleotide sequence having at least 85% to at least 99% sequence identity to SEQ ID NO: 7, or a toxin encoding fragment thereof, or a nucleotide sequence having at least 85% to at least 99% sequence identity to SEQ ID NO: 8, or a toxin encoding fragment thereof, or a nucleotide sequence having at least 85% to at least 99% sequence identity to SEQ ID NO: 9. In some embodiments, the polynucleotide comprises, consists essentially of, or consists of any one of SEQ ID NOs: 1-11, or a toxin-encoding fragment thereof.

[0148] In other embodiments, the polynucleotide comprises, consists essentially of, or consists of a nucleotide sequence encoding a protein comprising, consists essentially of, or consists of an amino acid sequence having at least 80% to at least 99% sequence identity to any one of SEQ ID NOs: 36-46 or a toxin fragment thereof.

[0149] In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:36 or a toxin fragment thereof.

[0150] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:37 or a toxin fragment thereof.

[0151] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:38 or a toxin fragment thereof.

[0152] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:39 or a toxin fragment thereof.

[0153] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:40 or a toxin fragment thereof.

[0154] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:41 or a toxin fragment thereof.

[0155] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:42 or a toxin fragment thereof.

[0156] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:43 or a toxin fragment thereof.

[0157] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:44 or a toxin fragment thereof.

[0158] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:45 or a toxin fragment thereof.

[0159] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:46 or a toxin fragment thereof.

[0160] In some embodiments, the chimeric gene of the present invention comprises a polynucleotide comprising, consisting essentially of, or consisting of: a synthetic sequence of a nucleotide sequence having the same sequence as SEQ ID NO:12-35 or a toxin encoding fragment thereof having at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% identity, wherein the synthetic sequence has been codon optimized for expression in a transgenic organism. In other embodiments, the chimeric gene of the present invention comprises a polynucleotide comprising, consisting essentially of, or consisting of: a synthetic sequence of a nucleotide sequence encoding a protein comprising an amino acid sequence corresponding to SEQ ID NO: 36-59 or a toxin fragment thereof having at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity, wherein the synthetic sequence has been codon-optimized for expression in a transgenic organism. In further embodiments, the transgenic organism is a transgenic bacterium or a transgenic plant.

[0161] In some embodiments, the present invention provides a synthetic polynucleotide comprising, consisting essentially of, or consisting of a nucleotide sequence encoding a protein toxic to a lepidopteran pest, wherein the nucleotide sequence is identical to SEQ ID Any of NO:12-35 or its toxin encoding fragment has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity.

[0162] In other embodiments, the present invention provides a synthetic polynucleotide comprising, consisting essentially of, or consisting of a nucleotide sequence encoding a protein toxic to a lepidopteran pest, wherein the nucleotide sequence encodes an amino acid sequence that is identical to SEQ ID Any of NOs:36-46 or a toxin fragment thereof has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity.

[0163] The Cry proteins of the present invention can be assembled using genomes from Bacillus thuringiensis (Bt) strains. Bt strains can be isolated by standard techniques and tested for toxicity to the lepidopteran pests of the present invention or used to isolate genomic DNA without testing the toxicity of Bt strains to insects. Typically, Bt strains can be isolated from any environmental sample, including soil, plants, insects, grain elevator dust, and other sample materials, by methods known in the art. See, for example, Travers et al. (1987) Appl. Environ. Microbiol. [Applied Environmental Microbiology] 53: 1263-1266; Saleh et al. (1969) Can J. Microbiol. [Canadian Journal of Microbiology] 15: 1101-1104; DeLucca et al. (1981) Can J. Microbiol. [Canadian Journal of Microbiology] 27: 865-870; and Norris et al. (1981) "The genera Bacillus and Sporolactobacillus [ Bacillus genus and Sporolactobacillus [Gene]", in Starr et al. (eds.), The Prokaryotes: A Handbook on Habitats, Isolation, and Identification of Bacteria, Volume II, Springer-Verlog, Berlin Heidelberg. After isolation, the toxicity of the Bt strain to insect pests can be tested and the Cry proteins encompassed by the present invention can be identified. Therefore, in some embodiments, the present invention provides an isolated Bacillus thuringiensis (Bt) strain that produces a Cry protein or a recombinant Cry protein, which comprises, consists essentially of, or consists of an amino acid sequence having at least 80% to at least 99% sequence identity with any one of SEQ ID NOs:35-56. In still other embodiments, the Cry protein or recombinant Cry protein comprises, consists essentially of, or consists of any one of SEQ ID NOs:36-59.

[0164] According to some embodiments, the present invention provides Cry proteins that are toxic to lepidopteran pests, and optionally isolated Cry proteins that are toxic to lepidopteran pests, wherein the Cry protein comprises, consists essentially of, or consists of: (a) an amino acid sequence having at least 80% sequence identity to at least 99% sequence identity with the amino acid sequence shown in any one of SEQ ID NOs: 36-46 or a toxin fragment thereof; or (b) an amino acid sequence encoded by a nucleotide sequence or an assembled nucleotide sequence having at least 80% sequence identity to at least 99% sequence identity with the nucleotide sequence shown in any one of SEQ ID NOs: 1-11 or a toxin-encoding fragment thereof.

[0165] In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:36 or a toxin fragment thereof.

[0166] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:37 or a toxin fragment thereof.

[0167] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:38 or a toxin fragment thereof.

[0168] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:39 or a toxin fragment thereof.

[0169] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:40 or a toxin fragment thereof.

[0170] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:41 or a toxin fragment thereof.

[0171] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:42 or a toxin fragment thereof.

[0172] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:43 or a toxin fragment thereof.

[0173] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:44 or a toxin fragment thereof.

[0174] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:45 or a toxin fragment thereof.

[0175] In other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:46 or a toxin fragment thereof.

[0176] In some embodiments, the amino acid sequence comprises, consists essentially of, or consists of any one of SEQ ID NOs: 36-59, or a toxin fragment thereof. In other embodiments, the amino acid sequence is encoded by a nucleotide sequence comprising, consisting essentially of, or consists of any one of SEQ ID NOs: 1-35, or a toxin-encoding fragment thereof.

[0177] In other embodiments, the Cry protein of the present invention is toxic to lepidopteran pests, which are selected from the group consisting of: Asian corn borer (Asian corn borer), black cutworm (small cutworm), cotton stem borer (cotton bollworm), yellow peach borer (peach borer), oriental armyworm (oriental armyworm), European corn borer (European corn borer), fall armyworm (spodoptera frugiperda), corn ear moth (corn ear moth), sugarcane borer (small sugarcane borer), velvet bean caterpillar (Spodoptera frugiperda), soybean moth (soybean looper), southwestern corn borer (southwestern corn borer), western bean cutworm (western bean groundworm), tobacco moth (civilus budworm), striped stem borer (striped stem borer), powdery stem borer (African borer), and rice leaf roller (rice leaf roller). In other embodiments, the Cry protein of the present invention is toxic to at least corn borer (Asian corn borer).

[0178] In some embodiments, the present invention covers mutant Cry proteins that are toxic to lepidopteran pests, wherein the mutant Cry protein comprises, consists essentially of, or consists of: (a) an amino acid sequence that has at least 80% to at least 99% sequence identity with the amino acid sequence shown in any one of SEQ ID NOs: 47-59 or a toxin fragment thereof; or (b) an amino acid sequence encoded by a nucleotide sequence that has at least 80% to at least 99% sequence identity with the nucleotide sequence shown in any one of SEQ ID NOs: 23-35 or a toxin-encoding fragment thereof.

[0179] In other embodiments, the mutant Cry protein comprises, consists essentially of, or consists of an amino acid sequence that has at least 80% to at least 99% sequence identity with any one of SEQ ID NOs: 47-59 or a toxin fragment thereof. In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:47 or a toxin fragment thereof.

[0180] In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:48 or a toxin fragment thereof.

[0181] In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:49 or a toxin fragment thereof.

[0182] In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:50 or a toxin fragment thereof.

[0183] In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:51 or a toxin fragment thereof.

[0184] In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:52 or a toxin fragment thereof.

[0185] In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:53 or a toxin fragment thereof.

[0186] In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:54 or a toxin fragment thereof.

[0187] In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:55 or a toxin fragment thereof.

[0188] In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:56 or a toxin fragment thereof.

[0189] In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:57 or a toxin fragment thereof.

[0190] In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:58 or a toxin fragment thereof.

[0191] In still other embodiments, the amino acid sequence has at least 80%, or at least 81%, or at least 82%, or at least 83%, or at least 84%, or at least 85%, or at least 86%, or at least 87%, or at least 88%, or at least 89%, or at least 90%, or at least 91%, or at least 92%, or at least 93%, or at least 94%, or at least 95%, or at least 96%, or at least 97%, or at least 98%, or at least 99%, or at least 99.1%, or at least 99.2%, or at least 99.3%, or at least 99.4%, or at least 99.5%, or at least 99.6%, or at least 99.7%, or at least 99.8%, or at least 99.9% sequence identity to SEQ ID NO:59 or a toxin fragment thereof.

[0192] In still other embodiments, the mutant Cry protein comprises, consists essentially of, or consists of: an amino acid sequence of any one of SEQ ID NOs: 47-59 or a toxin fragment thereof. In other embodiments, the mutant Cry protein is encoded by a nucleotide sequence comprising, consisting essentially of, or consists of: any one of SEQ ID NOs: 23-35 or a toxin encoding fragment thereof.

[0193] The present invention also encompasses antibodies produced in response to immune stimulation by assembled or mutant BT204, BT235, BT645, BT727, BT1027, BT1280, BT1555, BT1559, BT1563, BT1571 and BT1633, or related Cry proteins (including native Cry proteins). Such antibodies can be produced using standard immunological techniques for producing polyclonal antiserum, and if desired, antibody-producing cells of immortalized immune hosts are used for monoclonal antibody production sources. The techniques for producing antibodies to any substance of interest are well known, for example, as described in Harlow and Lane (1988. Antibodies a laboratory manual. p. 726. Cold Spring Harbor Laboratory) and Goding (Monoclonal Antibodies: Principles & practice. 1986. Academic Press, Inc., Orlando, FL). The present invention encompasses insecticidal proteins that cross-react with antibodies (particularly monoclonal antibodies) raised against one or more of the insecticidal Cry proteins of the present invention.

[0194] These antibodies produced in the present invention are also useful for determining the amount or presence of assembled or mutant BT204, BT235, BT645, BT727, BT1027, BT1280, BT1555, BT1559, BT1563, BT1571 and BT1633 Cry proteins, or related Cry proteins (including natural Cry proteins) in biological samples in immunoassays. Such determinations are also useful in quality control production of compositions containing one or more or related toxic proteins in the Cry proteins of the present invention. In addition, these antibodies can be used to evaluate the efficacy of recombinant production of one or more or related proteins in the Cry proteins of the present invention, together with the efficacy of screening expression libraries for the presence of one or more nucleotide sequences or related protein coding sequences encoding the Cry proteins of the present invention. Antibodies are also useful as affinity ligands for purifying or separating any one or more of the proteins of the present invention and related proteins. The Cry proteins of the present invention and proteins containing related antigenic epitopes can be obtained by overexpressing the full length or partial length of sequences encoding all or part of the Cry proteins of the present invention or related proteins in preferred host cells.

[0195] It should be recognized that the assembled DNA sequence encoding the Cry protein of the present invention can be altered by different methods, and these alterations can produce DNA sequences encoding proteins having amino acid sequences different from those encoded by the assembled Cry protein of the present invention. The resulting mutant Cry protein can be changed in different ways, including amino acid substitutions, deletions, truncations, and insertions of one or more amino acids of any one of SEQ ID NO: 36-46, including up to about 2, about 3, about 4, about 5, about 6, about 7, about 8, about 9, about 10, about 15, about 20, about 25, about 30, about 35, about 40, about 45, about 50, about 55, about 60, about 65, about 70, about 75, about 80, about 85, about 90, about 100, about 105, about 110, about 115, about 120, about 125, about 130, about 135, about 140, about 145, about 150, about 155, or more amino acid substitutions, deletions or insertions. Methods for such operations are generally known in the art. For example, amino acid sequence variants of natural Cry proteins can be prepared by mutations in the polynucleotides encoding the protein. This can also be accomplished by one of several forms of mutagenesis or in directed evolution. In some aspects, the changes encoded in the amino acid sequence will not substantially affect the function of the protein. Such variants will have the desired insecticidal activity. In some embodiments of the present invention, the nucleotide sequence shown in SEQ ID NO: 1-11 is changed to introduce amino acid substitutions in the encoded protein. In other embodiments, the resulting mutant protein is encoded by a synthetic mutant polynucleotide comprising the nucleotide sequence shown in any one of SEQ ID NO: 23-35. In other embodiments, the mutant Cry protein comprises, consists essentially of, or consists of the amino acid sequence shown in any one of SEQ ID NO: 47-59.

[0196] It should be understood that the ability of insecticidal proteins to impart insecticidal activity to the compositions of the present invention can be improved by using such techniques. For example, Cry proteins can be expressed in host cells that exhibit a high rate of base misincorporation during DNA replication, such as XL-1 Red (Stratagene, La Jolla, California). After propagation in such strains, DNA can be isolated (e.g., by preparing plasmid DNA, or by amplifying by PCR and cloning the resulting PCR fragments into vectors), the Cry protein mutants can be cultured in non-mutagenized strains, and the mutated genes with insecticidal activity can be identified, for example, by conducting experiments to test insecticidal activity. Typically, the protein is mixed and used in feeding experiments. See, for example, Marrone et al., (1985), J. of Economic Entomology 78: 290-293. Such experiments can include contacting a plant with one or more pests and determining the plant's ability to survive or cause the death of these pests. Examples of mutations that result in increased toxicity are found in Schnepf et al. (1998), Microbiol. Mol. Biol. Rev. 62: 775-806.

[0197] Alternatively, the amino acid sequences of the present invention may be altered at the amino or carboxyl termini without substantially affecting activity. This may include insertions, deletions, or alterations introduced by modern molecular methods such as PCR, including PCR amplification, which alters or extends the protein coding sequence by including the amino acid encoding sequence in the oligonucleotides used in the PCR amplification. Alternatively, the added protein sequence may include the entire protein coding sequence, such as those commonly used in the art to generate protein fusions. Such fusion proteins are often used to (1) increase expression of the protein of interest; (2) introduce binding domains, enzymatic activities, or epitopes to facilitate protein purification, protein detection, or other experimental uses known in the art; and (3) target protein secretion or translation to subcellular organelles, such as the periplasmic space of Gram-negative bacteria or the endoplasmic reticulum of eukaryotic cells, the latter often leading to glycosylation of the protein.

[0198] The Cry protein of the present invention can also be mutated to introduce an epitope to generate antibodies that recognize the mutated protein. Therefore, in some embodiments, the present invention provides a mutated Cry protein, wherein the amino acid substitution in the native Cry protein generates a mutant Cry protein having an antigenic region that allows the mutant Cry protein to be distinguished from the native Cry protein in protein detection analysis.

[0199] In some embodiments, the present invention provides a method for preparing an antibody that differentially recognizes a mutated Cry protein from an assembled or related natural Cry protein from which the mutated Cry protein is derived, the method comprising the following steps: replacing amino acids in the antigenic loop of the assembled or natural Cry protein; and generating an antibody that specifically recognizes the mutated antigenic loop of the mutated Cry protein but does not recognize the assembled or natural Cry protein. In one embodiment, the antigenic loop is identified in a non-conserved region outside domain I of the assembled or natural Cry protein. In another embodiment, the antigenic loop is not a loop involved in insect gut receptor recognition of the Cry protein or in protease activation of the Cry protein.

[0200] Variant nucleotide and amino acid sequence of the present invention also encompass sequences derived from programs (such as DNA shuffling) that are induced by mutagenesis and that cause restructuring. Using this type of program, one or more different toxic protein coding regions can be used to create new toxic proteins with desired characteristics. In this way, a recombinant polynucleotide library is produced from a population of related sequence polynucleotides that comprises following sequence regions that have basic sequence identity and can carry out homologous recombination in vitro or in vivo. For example, using this method, the sequence motifs encoding the target domain can be shuffled between the pesticidal gene of the present invention and other known pesticidal genes to obtain a new gene encoding the following protein that has improved target characteristics, such as increased insecticidal activity. The strategy for this type of DNA shuffling is known in the art. See, e.g., Stemmer (1994) Proc. Natl. Acad. Sci. USA 91: 10747-10751; Stemmer (1994) Nature 370: 389-391; Crameri et al. (1997) Nature Biotech. 15: 436-438; Moore et al. (1997) J. Mol. Biol. 272: 336-347; Zhang et al. (1997) Proc. Natl. Acad. Sci. USA 94: 4504-4509; Crameri et al. (1998) Nature 391: 288-291; and U.S. Pat. Nos. 5,605,793 and 5,837,458.

[0201] Domain exchange or shuffling is another mechanism for generating the altered Cry proteins of the present invention. Domains can be exchanged between Cry proteins to generate hybrid or chimeric toxic proteins with improved pesticidal activity or target spectrum. Methods for producing recombinant proteins and testing them for pesticidal activity are well known in the art (see, e.g., Naimov et al. (2001) Appl. Environ. Microbiol. 67:5328-5330; de Maagd et al., (1996) Appl. Environ. Microbiol. 62:1537-1543; Ge et al. (1991) J. Biol. Chem. 266:17954-17958; Schnepf et al., (1990) J. Biol. Chem. 265:20923-20930; Rang et al., (1999) Appl. Environ. Microbiol. 65:2918-2925).

[0202] In some embodiments, the present invention provides recombinant vectors comprising polynucleotides, assembled polynucleotides, nucleic acid molecules, expression cassettes, or chimeric genes of the present invention. In other embodiments, the vector is further defined as a plasmid, cosmid, phagemid, artificial chromosome, phage, or viral vector. Certain vectors for use in the transformation of plants and other organisms are known in the art.

[0203] Therefore, some embodiments of the present invention relate to expression cassettes designed to express polynucleotides and nucleic acid molecules of the present invention. As used herein, "expression cassette" means a nucleic acid molecule having at least one control sequence operably linked to a nucleotide sequence of interest (e.g., a nucleotide sequence of the present invention encoding a Cry protein of the present invention). In this way, for example, a plant promoter operably linked to a nucleotide sequence to be expressed can be provided in an expression cassette for expression in a plant, plant part, or plant cell.

[0204] The expression cassette comprising the polynucleotide of interest may be chimeric, meaning that at least one of its components is heterologous to at least one of its other components. An expression cassette may also be naturally occurring but has been obtained in a recombinant form suitable for heterologous expression. However, typically, the expression cassette is heterologous to the host, meaning that the specific nucleic acid sequence of the expression cassette is not naturally present in the host cell and must have been introduced into the host cell or an ancestor of the host cell by a transformation event.

[0205] In addition to being operably connected to the promoter of the nucleotide sequence of the present invention, the expression cassette of the present invention can also include other regulatory sequences. As used herein, "regulatory sequence" means a nucleotide sequence that is located upstream (5' non-coding sequence), inside or downstream (3' non-coding sequence) of the coding sequence and affects transcription, RNA processing or stability or translation of the relevant coding sequence. Regulatory sequences include but are not limited to enhancers, introns, translation leader sequences, termination signals, and polyadenylation signal sequences.

[0206] In certain embodiments, the expression cassette of the present invention may also include polynucleotides encoding other desired traits in addition to the Cry protein of the present invention. Such expression cassettes comprising stacked traits can be used to produce plants, plant parts or plant cells having the desired phenotype of stacked traits (i.e., molecular stacking). Such stacked combinations in plants can also be produced by other methods, including but not limited to hybrid breeding plants by any conventional methodology. If stacking is performed by genetically transforming these plants, the target nucleotide sequences can be combined at any time and in any order. For example, transgenic plants comprising one or more desired traits can be used as targets for introducing additional traits by subsequent transformation. Additional nucleotide sequences can be introduced simultaneously with the nucleotide sequences of the present invention, nucleic acid molecules, nucleic acid constructs or compositions provided by any combination of expression cassettes in a co-transformation scheme. For example, if two nucleotide sequences are to be introduced, they can be combined in separate cassettes (trans) or can be combined on the same cassette (cis). The expression of the polynucleotides can be driven by the same promoter or by different promoters. It is further recognized that polynucleotides can be stacked at the desired genomic location using a site-specific recombination system. See, for example, International Patent Application Publication Nos. WO 99 / 25821; WO 99 / 25854; WO 99 / 25840; WO 99 / 25855 and WO 99 / 25853.

[0207] The expression cassette may also include additional coding sequences for one or more polypeptides of interest or double-stranded RNA molecules (dsRNA) for agronomic traits, the primary beneficiaries of which are seed companies, growers, or grain processors. The polypeptide of interest may be any polypeptide encoded by a nucleotide sequence of interest. Non-limiting examples of polypeptides of interest suitable for production in plants include those that produce agronomically important traits, such as herbicide resistance (sometimes also referred to as "herbicide tolerance"), virus resistance, bacterial pathogen resistance, insect resistance, nematode resistance, or fungal resistance. See, for example, U.S. Patent Nos. 5,569,823; 5,304,730; 5,495,071; 6,329,504; and 6,337,431. The polypeptide may also be a polypeptide that increases plant vigor or yield (including traits that allow plants to grow under different temperatures, soil conditions, and light and precipitation levels), or a polypeptide that allows plants that exhibit the desired trait (e.g., selectable markers, seed coat color, etc.) to be identified. Various polypeptides of interest and methods of introducing these polypeptides into plants are described, for example, in U.S. Patent Nos. 4,761,373; 4,769,061; 4,810,648; 4,940,835; 4,975,374; 5,013,659; 5,162,602; 5,276,268; 5,304,730; 5,495,071; 5,554,798; 5,561,236; 5,569,823; 5,767,366; 5,879,903; 5,928,937; 6,084,155; 6,329,504 and 6,337,431; and in U.S. Patent Application Publication No. 2001 / 0016956. See also lifesci.sussex.ac.uk / home / Neil_Crickmore / Bt / on the World Wide Web.

[0208] The polynucleotides that confer resistance / tolerance to herbicides (such as imidazolinones or sulfonylureas) that inhibit growing points or meristems may also be applicable to some embodiments of the present invention. For example, exemplary polynucleotides in this classification number for mutant ALS and AHAS enzymes are described in, for example, U.S. Patent Nos. 5,767,366 and 5,928,937. U.S. Patent Nos. 4,761,373 and 5,013,659 relate to plants that are resistant to different imidazolinones or sulfonylurea herbicides. U.S. Patent No. 4,975,374 relates to plant cells and plants containing the following nucleic acid encoding mutant glutamine synthetase (GS), which is resistant to the inhibitory effects of known herbicides that inhibit GS (e.g., phosphine glufosinate and methionine sulfoximine). U.S. Patent No. 5,162,602 discloses plants that are resistant to the inhibitory effects of cyclohexanedione and aryloxyphenoxypropionic acid herbicides. This resistance is conferred by an altered acetyl-CoA carboxylase (ACCase) enzyme.

[0209] Polypeptides encoded by nucleotide sequences that confer resistance to glyphosate are also suitable for use in the present invention. See, for example, U.S. Patent No. 4,940,835 and U.S. Patent No. 4,769,061. U.S. Patent No. 5,554,798 discloses transgenic maize plants resistant to glyphosate, the resistance being conferred by an altered 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase gene.

[0210] Polynucleotides encoding resistance to phosphoryl compounds such as glufosinate or phosphinothricin, pyridinyloxypropionic acid or phenoxypropionic acid, and cyclohexanone are also suitable. See European Patent Application No. 0 242 246. See also U.S. Patent Nos. 5,879,903, 5,276,268, and 5,561,236.

[0211] Other suitable polynucleotides include those encoding resistance to herbicides that inhibit photosynthesis, such as triazines and benzocyanate (nitrile hydrolases), see U.S. Patent No. 4,810,648. Other suitable polynucleotides encoding for herbicide resistance include those encoding resistance to 2,2-dichloropropionic acid, sethoxydim, haloxyfop-ethyl, imidazolinone herbicides, sulfonylurea herbicides, triazolopyrimidine herbicides, s-triazine herbicides, and bromoxynil. The following polynucleotides are also suitable: these polynucleotides confer protoporphyrinogen oxidase resistance or provide enhanced plant disease resistance; Enhanced tolerance to adverse environmental conditions (abiotic stress), including but not limited to drought, excessive cold, excessive heat, or excessive soil salinity or extreme acidity or alkalinity; and changes in plant structure or development, including changes in development time. See, for example, U.S. Patent Publication No. 2001 / 0016956 and U.S. Patent No. 6,084,155.

[0212] Other suitable polynucleotides include those encoding pest-killing (e.g., insect-killing) polypeptides. These polypeptides can be produced in an amount sufficient to control, for example, insect pests (i.e., insect control amounts). It should be recognized that the production of pest-killing polypeptides necessary to controlling insects or other harmful organisms in plants can vary, depending on cultivar, the type of harmful organism, environmental factors, etc. The polynucleotides useful for other insect or harmful organism resistance include, for example, those encoding toxins identified in Bacillus (Bacillus) organisms. Polynucleotides comprising the nucleotide sequence of Bacillus thuringiensis (Bt) Cry proteins from several subspecies have been cloned, and it has been found that these recombinant clones are toxic to Lepidoptera, Diptera, and / or Coleopteran insect larvae. Examples of such Bt insecticidal proteins include Cry proteins such as Cry1Aa, Cry1Ab, Cry1Ac, Cry1B, Cry1C, Cry1D, Cry1Ea, Cry1Fa, Cry3A, Cry9A, Cry9B, Cry9C, etc., as well as vegetative insecticidal proteins such as Vip1, Vip2, Vip3, etc. A complete list of Bt-derived proteins can be found on the World Wide Web in the Bacillus thuringiensis Toxin Nomenclature Database maintained by the University of Sussex (see also Crickmore et al. (1998) Microbiol. Mol. Biol. Rev. 62:807-813).

[0213] Polypeptides suitable for production in plants further include those that improve or otherwise aid in the conversion of harvested plants or plant parts into commercially useful products, including, for example, increased or altered carbohydrate content or distribution, improved fermentation characteristics, increased oil content, increased protein content, improved digestibility, and increased nutrient content (e.g., increased phytosterol content, increased tocopherol content, increased stanol content, or increased vitamin content). Polypeptides of interest also include, for example, those that result in or contribute to a reduction in the level of undesirable components (e.g., phytic acid, or enzymes that degrade sugars) in the harvested crop. "Resulting in" or "contributing to" means that the polypeptide of interest can directly or indirectly contribute to the presence of the trait of interest (e.g., by increasing cellulose degradation through the use of heterologous cellulases).

[0214] In certain embodiments, the polypeptide contributes to the improved digestibility of food or feed. Xylanases are hemicellulolytic enzymes that improve the decomposition of plant cell walls, which results in animals making better use of these plant nutrients. This results in improved growth rates and feed conversion. Similarly, the viscosity of feeds containing xylanases can be reduced. Heterogeneous production of xylanases in plant cells can also promote the conversion of lignocellulose into fermentable sugars in industrial processing.

[0215] Many xylanases derived from fungal and bacterial microorganisms have been identified and characterized (see, e.g., U.S. Patent No. 5,437,992; Coughlin et al. (1993) "Proceedings of the Second TRICEL Symposium on Trichoderma reesei Cellulases and Other Hydrolases," Espoo; Souminen and Rein, eds., (1993) Foundation for Biotechnical and Industrial Fermentation Research 8: 125-135; U.S. Patent Application Publication No. 2005 / 0208178; and PCT Publication No. WO 03 / 16654). In particular, three specific xylanases (XYL-I, XYL-II, and XYL-III) have been identified in Trichoderma reesei (Tenkanen et al. (1992) Enzyme Microb. Technol. 14:566; Torronen et al. (1992) Bio / Technology 10:1461; and Xu et al. (1998) Appl. Microbiol. Biotechnol. 49:718).

[0216] In other embodiments, polypeptides useful in the present invention may be polysaccharide degrading enzymes. Plants of the present invention that produce such enzymes may be useful for producing fermentation feedstocks, for example, for bioprocessing. In some embodiments, enzymes useful in fermentation processes include alpha-amylases, proteases, pullulanases, isoamylases, cellulases, hemicellulases, xylanases, cyclodextrin glycosyltransferases, lipases, phytases, laccases, oxidases, esterases, cutinases, granular starch hydrolases, and other glucoamylases.

[0217] Polysaccharide degrading enzymes include: starch degrading enzymes such as α-amylase (EC 3.2.1.1), glucuronidase (EC 3.2.1.131); exo-1,4-α-D glucanases such as amyloglucosidase and glucoamylase (EC 3.2.1.3), β-amylase (EC 3.2.1.2), α-glucosidase (EC 3.2.1.20) and other exoamylases; starch debranching enzymes such as a) isoamylase (EC 3.2.1.68), pullulanase (EC 3.2.1.41), etc.; b) cellulases such as exo-1,4-3-cellobiohydrolase (EC 3.2.1.91), exo-1,3-β-D-glucanase (EC 3.2.1.39), β-glucosidase (EC 3.2.1.21); c) L-arabinase, such as endo-1,5-α-L-arabinase (EC 3.2.1.99), α-arabinosidase (EC 3.2.1.55), etc.; d) galactanase, such as endo-1,4-β-D-galactanase (EC 3.2.1.89), endo-1,3-β-D-galactanase (EC 3.2.1.90), α-galactosidase (EC 3.2.1.22), β-galactosidase (EC 3.2.1.23), etc.; e) mannanase, such as endo-1,4-β-D-mannanase (EC 3.2.1.78), β-mannosidase (EC 3.2.1.25), α-mannosidase (EC 3.2.1.24), etc.; f) xylanase, such as endo-1,4-β-xylanase (EC 3.2.1.8), β-D-xylosidase (EC 3.2.1.37), 1,3-β-D-xylanase, etc.; and g) other enzymes such as α-L-fucosidase (EC 3.2.1.51), α-L-rhamnosidase (EC 3.2.1.40), levanase (EC 3.2.1.65), inulinase (EC 3.2.1.7), etc. In one embodiment, the α-amylase is the synthetic α-amylase Amy797E described in U.S. Patent No. 8,093,453 (incorporated herein by reference in its entirety).

[0218] Other enzymes that can be used together with the present invention include proteases, such as fungal and bacterial proteases. Fungal proteases include but are not limited to those obtained from Aspergillus, Trichoderma, Mucor, and Rhizopus, such as A. niger, A. awamori, A. oryzae, and M. miehei. In certain embodiments, the polypeptide of the present invention can be a cellobiohydrolase (CBH) (EC 3.2.1.91). In one embodiment, the cellobiohydrolase can be CBH1 or CBH2.

[0219] Other enzymes for use with the present invention include, but are not limited to, hemicellulases, such as mannanases and arabinofuranosidases (EC 3.2.1.55); ligninases; lipases (e.g., EC 3.1.1.3), glucose oxidases, pectinases, xylanases, transglucosidases, α1,6 glucosidases (e.g., EC 3.2.1.20); esterases, such as feruloyl esterases (EC 3.1.1.73) and acetylxylan esterases (EC 3.1.1.72); and cutinases (e.g., EC 3.1.1.74).

[0220] Double-stranded RNA molecules used together with the present invention include but are not limited to those that inhibit target insect genes. As used herein, the term "gene inhibition" is intended to refer to any well-known method for reducing the level of protein produced as a result of gene transcription into mRNA and the subsequent translation of this mRNA when considered together. Gene inhibition is also intended to mean reducing the expression of protein from a gene or coding sequence, including post-transcriptional gene inhibition and transcriptional inhibition. Post-transcriptional gene inhibition is mediated by homology between all or a portion of the mRNA transcribed from the gene or coding sequence that is suppressed by the target and the corresponding double-stranded RNA for inhibition, and refers to the substantial and measurable reduction of the amount of available mRNA available for ribosome binding in the cell. The transcribed RNA can be in the sense direction and play a role, known as co-suppression, in the antisense direction and play a role, known as antisense inhibition, or produce dsRNA in both directions and play a role, known as RNA interference (RNAi). Transcriptional inhibition is mediated by the presence in the cell of a dsRNA that exhibits substantial sequence identity to a promoter DNA sequence or its complement as a gene inhibitor, known as promoter trans inhibition. Gene suppression can be effective for the natural plant genes associated with traits, for example, to provide a plant with a reduced level of protein encoded by the natural gene or with an enhanced or reduced level of affected metabolites. Gene suppression can also be effective for target genes in plant pests, which can be taken in or contacted with plant materials containing gene inhibitors designed specifically to suppress or inhibit the expression of one or more homologous or complementary sequences in the cells of the pest. Such genes targeted for suppression can encode essential proteins whose predicted functions are selected from the group consisting of: muscle formation, juvenile hormone formation, juvenile hormone regulation, ion regulation and transport, digestive enzyme synthesis, maintenance of cell membrane potential, amino acid biosynthesis, amino acid degradation, sperm formation, pheromone synthesis, pheromone sensing, antenna formation, wing formation, leg formation, development and differentiation, egg formation, larval maturation, digestive enzyme formation, hemolymph synthesis, hemolymph maintenance, neurotransmission, cell division, energy metabolism, respiration and apoptosis.

[0221] In some embodiments, the present invention provides transgenic non-human host cells comprising polynucleotides, nucleic acid molecules, chimeric genes, expression cassettes or recombinant vectors of the present invention. Transgenic non-human host cells may include, but are not limited to, plant cells, yeast cells, bacterial cells or insect cells. Therefore, in some embodiments, the present invention provides bacterial cells selected from the genus Bacillus, Brevibacillus, Clostridium, Xenorhabdus, Photorhabdus, Pasteuria, Escherichia, Pseudomonas, Erwinia, Serratia, Klebsiella, Salmonella, Pasteurella Teurella), Xanthomonas, Streptomyces, Rhizobium, Rhodopseudomonas, Methylophilius, Agrobacterium, Acetobacter, Lactobacillus, Arthrobacter, Azotobacter, Leuconostoc or Alcaligenes. Therefore, for example, as a biological insect control agent, the Cry protein of the present invention can be produced by expressing a chimeric gene encoding the Cry protein of the present invention in a bacterial cell. For example, in some embodiments, a Bacillus thuringiensis cell comprising the chimeric gene of the present invention is provided.

[0222] In another embodiment, the present invention provides transgenic plant cells that are dicotyledonous plant cells or monocotyledonous plant cells. In another embodiment, the dicotyledonous plant cells are selected from the group consisting of: soybean cells, sunflower cells, tomato cells, Brassica crop cells, cotton cells, sugar beet cells and tobacco cells. In another embodiment, the monocotyledonous plant cells are selected from the group consisting of: barley cells, maize cells, oat cells, rice cells, sorghum cells, sugarcane cells and wheat cells. In some embodiments, the present invention provides a plurality of dicotyledonous plant cells or monocotyledonous plant cells that express the Cry protein of the present invention encoded by the chimeric gene of the present invention. In other embodiments, the plurality of cells are juxtaposed to form apoplast and grown in natural light.

[0223] In other embodiments of the present invention, the insecticidal Cry protein of the present invention is expressed in higher organisms (e.g., plants). In this case, transgenic plants expressing an effective amount of the insecticidal protein protect themselves from plant pests such as insect pests. When insects begin to feed on such a transgenic plant, they ingest the expressed insecticidal Cry protein. This can prevent the insects from further biting plant tissue or can even injure or kill the insects. The polynucleotide of the present invention is inserted into an expression cassette, which is then stably integrated into the genome of the plant. In other embodiments, the polynucleotide is contained in a non-pathogenic self-replicating virus. Plants transformed according to the present invention can be monocots or dicots and include, but are not limited to, corn (maize), soybean, rice, wheat, barley, rye, oats, sorghum, millet, sunflower, safflower, sugar beets, cotton, sugarcane, rapeseed, alfalfa, tobacco, peanuts, vegetables (including sweet potatoes, beans, peas, endive, lettuce, cabbage, cauliflower, broccoli, turnips, carrots, eggplant, cucumber, radish, spinach, potato, tomato, asparagus, onion, garlic, melons, peppers, celery, pumpkin, zucchini, courgette), fruits (including apples, pears, quinces, plums, cherries, peaches, nectarines, apricots, strawberries, grapes, raspberries, blackberries, pineapples, avocados, papayas, mangoes, bananas) and specialty plants such as Arabidopsis thaliana, as well as woody plants such as coniferous and deciduous trees. Preferably, the plant of the present invention is a crop plant, such as maize, sorghum, wheat, sunflower, tomato, crucifers, pepper, potato, cotton, rice, soybean, sugar beet, sugar cane, tobacco, barley, rapeseed, etc.

[0224] Once a desired polynucleotide has been transformed into a particular plant species, it can be propagated within that species or transferred into other varieties of the same species, particularly including commercial varieties, using conventional breeding techniques.

[0225] The polynucleotides of the present invention are expressed in transgenic plants, thereby leading to the biosynthesis of the encoded Cry proteins in the form of protoxins or toxins in these transgenic plants. In this way, transgenic plants with enhanced yield protection under insect pressure are produced. For their expression in transgenic plants, the nucleotide sequences of the present invention may need to be modified and optimized. Although in many cases, genes from microorganisms can be expressed at high levels in plants without modification, low expression in transgenic plants may be due to microbial nucleotide sequences that have codons that are not preferred in plants. It is known in the art that living organisms have specific codon usage preferences, and the codons of the nucleotide sequences described in the present invention can be changed to conform to plant preferences while maintaining the amino acids encoded by them. In addition, high expression in plants (e.g., corn plants) is best achieved by coding sequences that have a GC content of at least about 35%, or at least about 45%, or at least about 50%, or at least about 60%. Microbial nucleotide sequences with low GC content may not express well in plants due to the presence of ATTTA motifs that may destabilize the message, and AATAAA motifs that may lead to inappropriate polyadenylation. Although some gene sequences can be fully expressed in both monocot and dicot species, the sequences can be modified to cater to the specific codon preferences and GC content preferences of monocot or dicot plants, as these preferences have been shown to be different (Murray et al., Nucl. Acids Res. [Nucleic Acids Research] 17: 477-498 (1989)). In addition, these nucleotide sequences are screened for the presence of abnormal splice sites that may lead to message truncation. Using methods described in, for example, U.S. Patent Nos. 5,625,136, 5,500,365 and 6,013,523, all changes that need to be made within these nucleotide sequences (such as those described above) are altered using well-known site-directed mutagenesis, PCR and synthetic gene construction techniques.

[0226] In certain embodiments, the invention provides synthetic coding sequences or polynucleotides prepared according to the program disclosed in U.S. Patent number 5,625,136 (incorporated herein by reference). In this program, the preferred codons of maize were used, i.e., the single codons that most frequently encode the amino acid in maize. The preferred codons of maize for specific amino acids can be derived from, for example, the known gene sequence that is derived from maize. For example, the maize codons for 28 genes derived from maize plants can be found in the following literature: Murray et al., Nucleic Acids Research [nucleic acid research] 17:477-498 (1989), which is incorporated herein by reference. The synthetic sequences prepared by maize optimized codons or soybean optimized codons of the exact examples of the present invention are represented by any one of SEQ ID NO:12-35. In this way, these nucleotide sequences can be optimized for expression in any plant. It should be appreciated that all or any part of the nucleotide sequence can be optimized or synthetic. That is, a polynucleotide may comprise a nucleotide sequence that is part native sequence and part codon-optimized sequence.

[0227] In order to start translation effectively, it may be necessary to modify the sequence adjacent to the starting methionine. For example, they can be modified by comprising a known sequence effective in plants. Joshi has proposed a suitable consensus sequence for plants (NAR 15:6643-6653 (1987)). These consensus sequences are suitable for use with nucleotide sequence of the present invention. These sequences are incorporated into the construct comprising the nucleotide sequence, reaching ATG and including ATG (keeping the second amino acid not modified simultaneously), or alternatively reaching the GTC after the ATG and including the GTC after the ATG (having the possibility of modifying the second amino acid of this transgenic).

[0228] The novel Cry protein coding sequences of the present invention (as their assembled sequences, natural sequences or as synthetic sequences as described above) can be operably fused to a variety of promoters for expression in plants (including constitutive, inducible, temporally regulated, developmentally regulated, chemically regulated, tissue-preferred and tissue-specific promoters) to prepare recombinant DNA molecules (i.e., chimeric genes). The choice of promoter will vary according to the temporal and spatial requirements of expression, and also varies according to the target species. Therefore, the expression of the nucleotide sequence of the present invention in leaves, in stalks or stems, in ears, in inflorescences (e.g., spikes, panicles, cobs, etc.), in roots or seedlings is preferred. However, in many cases, protection is sought for more than one type of insect pest, and therefore expression in multiple tissues is desirable. Although many promoters from dicots have been shown to be operable in monocots and vice versa, it is ideal to select dicot promoters for expression in dicots and monocot promoters for expression in monocots. However, there is no limitation on the origin of the promoters selected; it is sufficient that they can effectively drive expression of the nucleotide sequence in the desired cell.

[0229] Suitable constitutive promoters include, for example, the CaMV 35S promoter (SEQ ID NO: 1546; Odell et al., Nature 313: 810-812, 1985); the Arabidopsis thaliana At6669 promoter (SEQ ID NO: 1652; see PCT Publication No. WO 04081173A2); maize Ubi 1 (Christensen et al., Plant Mol. Biol. 18: 675-689, 1992); rice actin (McElroy et al., Plant Cell 2: 163-171, 1990); pEMU (Last et al., Theor. Appl. Genet. 81: 581-588, 1991); the CaMV 19S (Nilsson et al., Physiol. Plant 100:456-462, 1997); GOS2 (de Pater et al., Plant J Nov;2(6):837-44, 1992); ubiquitin (Christensen et al., Plant Mol. Biol. 18:675-689, 1992); rice cyclophilin (Bucholz et al., Plant Mol. Biol. 25(5):837-43, 1994); maize H3 histone (Lepetit et al., Mol. Gen. Genet. 231:276-285, 1992); actin 2 (An et al., Plant J. [Plant Journal] 10(1); 107-121, 1996), the constitutive root tip CT2 promoter (SEQ ID NO: 1535; see also PCT Application No. IL / 2005 / 000627), and Synthetic Super MAS (Ni et al., The Plant Journal [Plant Journal] 7: 661-76, 1995). Other constitutive promoters include those in U.S. Pat. Nos. 5,659,026, 5,608,149, 5,608,144, 5,604,121, 5,569,597, 5,466,785, 5,399,680, 5,268,463, and 5,608,142.

[0230] Useful tissue-specific or tissue-preferred promoters for expressing the novel cry protein coding sequences of the present invention in plants, particularly maize, are those that direct expression in roots, pith, leaves, or pollen. Suitable tissue-specific promoters include, but are not limited to, leaf-specific promoters [as described, for example, by Yamamoto et al., Plant J. 12:255-265, 1997; Kwon et al., Plant Physiol. 105:357-67, 1994; Yamamoto et al., Plant Cell Physiol. 35:773-778, 1994; Gotor et al., Plant J. 3:509-18, 1993; Orozco et al., Plant Mol. Biol. 23:1129-1138, 1993; and Matsuoka et al., Proc. Natl. Acad. Sci. USA 90:9586-9590, 1993], seed-preferred promoters [e.g., from seed-specific genes (Simon et al., Plant Physiology 105:357-67, 1994); Yamamoto et al., Plant Cell Physiol. 35:773-778, 1994; Gotor et al., Plant J. 3:509-18, 1993; Orozco et al., Plant Mol. Biol. 23:1129-1138, 1993; and Matsuoka et al., Proc. Natl. Acad. Sci. USA 90:9586-9590, 1993] Mol. Biol. 5:191, 1985; Scofield et al., J. Biol. Chem. 262:12202, 1987; Baszczynski et al., Plant Mol. Biol. 14:633, 1990), Brazil nut albumin (Pearson et al., Plant Mol. Biol. 18:235-245, 1992), legumin (Ellis et al., Plant Mol. Biol. 10:203-214, 1988), gluten (rice) (Takaiwa et al., Mol. Gen. Genet. 208:15-22, 1986; Takaiwa et al., FEBS FEBS Letters 221:43-47, 1987), zein (Matzke et al., Plant Mol Biol. 143:323-32, 1990), napA (Stalberg et al., Planta 199:515-519, 1996), wheat SPA (Albanie et al., Plant Cell 9:171-184, 1997), sunflower oleosin (Cummins et al., Plant Mol. Biol.[Plant Mol Biol 19:873-876, 1992)], endosperm-specific promoters [e.g., wheat LMW and HMW, glutenin-1 (Mol Gen Genet 216:81-90, 1989; NAR 17:461-2), wheat a, b, and g gliadins (EMB 03:1409-15, 1984), barley ltrl promoter, barley B1, C, D hordeins (Theor Appl Gen 98:1253-62, 1999; Plant J 4:343-55, 1993; Mol Gen Genet 250:750-60, 1996), barley DOF (Mena et al., The Plant J 4:343-55, 1993), barley DOF (Mena et al., The Plant J 4:343-55, 1996 ... Journal [Plant Journal] 116 (1): 53-62, 1998), Biz2 (EP 99106056.7), synthetic promoter (Vicente-Carbajosa et al., Plant J. [Plant Journal] 13: 629-640, 1998), rice prolamin NRP33, rice-globulin Glb-1 (Wu et al., Plant Cell Physiology [Plant Cell Physiology] 39 (8) 885-889, 1998), rice α-globulin REB / OHP-1 (Nakase et al., Plant Mol. Biol. [Plant Molecular Biology] 33: 513-S22, 1997), rice ADP-glucose PP (Trans Res 6: 157-68, 1997), maize ESR gene family (Plant J. Plant J. 12:235-46, 1997), sorghum gamma-kafirin (Plant Mol. Biol. 32:1029-35, 1996)], embryo-specific promoters [e.g., rice OSH1 (Sato et al., Proc. Nat. Acad. Sci. USA 93:8117-8122), KNOX (Postma-Haarsma et al., Plant Mol. Biol. 39:257-71, 1999), rice oleosin (Wu et al., J. Biochem. 123:386, 1998)], flower-specific promoters [e.g., AtPRP4, chalone synthase (chsA) (Van der Meer et al., Plant Mol.Biol.[Plant Molecular Biology]15,95-109,1990), LAT52 (Twell et al., Mol.Gen Genet.[Molecular and General Genetics] 217: 240-245; 1989), apetala-3, plant reproductive tissue [e.g., OsMADS promoter (U.S. Patent Application 2007 / 0006344)].

[0231] The nucleotide sequence of the present invention can also be expressed under the regulation of a chemically regulated promoter. This allows the Cry protein of the present invention to be synthesized only when crop plants are treated with inducing chemicals. Examples of such technologies for chemical induction of gene expression are detailed in published applications EP 0 332 104 and U.S. Patent number 5,614,395. In one embodiment, the chemically regulated promoter is the tobacco PR-1a promoter.

[0232] Another class of promoters useful in the present invention is wound-inducible promoters. Numerous promoters have been described that express at sites of wounding and also at sites of infection by plant pathogens. Ideally, such promoters would be only locally active at the site of insect invasion, so that the insecticidal proteins accumulate only in the cells where they are needed to synthesize them and kill the invading insect pests. Examples of such promoters include those described by Stanford et al., Mol. Gen. Genet. 215:200-208 (1989); Xu et al., Plant Molec. Biol. 22:573-588 (1993); Logemann et al., Plant Cell 1:151-158 (1989); Rohrmeier and Lehle, Plant Molec. Biol. 22:783-792 (1993); Firek et al., Plant Molec. Biol. 22:129-142 (1993); and Warner et al., Plant J. 3:191-201 (1993).

[0233] The limiting examples of the promoter that causes the tissue-specific expression pattern useful in the present invention include green tissue-specific, root-specific, stem-specific or flower-specific.Promoters suitable for expressing in green tissue include many promoters that regulate the gene related to photosynthesis, and many of these have been cloned from both monocots and dicots. A type of such promoter is the maize PEPC promoter (Hudspeth and Grula, Plant Molec.Biol. [plant molecular biology] 12:579-589 (1989)) derived from the phosphoenol carboxylase gene. Another type of promoter for root-specific expression is the promoter described by de Framond (FEBS 290:103-106 (1991) or U.S. Patent number 5,466,785). Another type of promoter useful in the present invention is the stem-specific promoter described in U.S. Patent number 5,625,136, which drives the expression of the maize trpA gene naturally.

[0234] In addition to selecting a suitable promoter, constructs for expressing insecticidal toxins in plants also require an appropriate transcription terminator operably linked downstream of the heterologous nucleotide sequence. Several such terminators are available and known in the art (e.g., tml from CaMV, E9 from rbcS). Any terminator known to function in plants can be used in the context of the present invention.

[0235] Numerous other sequences can be incorporated into the expression cassettes described herein. These sequences include sequences that have been shown to enhance expression, such as intron sequences (e.g., from Adhl and bronzel) and viral leader sequences (e.g., from TMV, MCMV, and AMV).

[0236] The nucleotide sequence of the present invention may be more preferred for the targeted expression of different cellular locations in plants. In some cases, localization in the cytosol may be desirable, while in other cases, localization in a certain subcellular organelle may be preferred. Any mechanism for targeting a gene product in, for example, a plant may be used to practice the present invention, and it is known that such mechanisms exist in plants and that the sequences controlling the functions of these mechanisms have been characterized in considerable detail. Sequences that result in targeting a gene product to other cellular compartments have been characterized. The amino-terminal sequence can be responsible for targeting the protein of interest to any cellular compartment, such as the vacuole, mitochondria, peroxisomes, proteosomes, endoplasmic reticulum, chloroplasts, starch granules, amyloplasts, apoplasts, or cell wall of plants (e.g., Unger et al. Plant Molec. Biol. 13:411-418 (1989); Rogers et al. (1985) Proc. Natl. Acad. Sci. USA 82:6512-651; U.S. Pat. No. 7,102,057; WO 2005 / 096704, all of which are hereby incorporated by reference). Optionally, the signal sequence can be an N-terminal signal sequence from a waxy protein, an N-terminal signal sequence from a gamma-zein protein, a starch binding domain, a C-terminal starch binding domain, a chloroplast targeting sequence that imports the mature protein into the chloroplast (Comai et al., (1988) J. Biol. Chem. 263: 15104-15109; van den Broeck et al., (1985) Nature 313: 358-363; U.S. Patent No. 5,639,949), or a secretion signal sequence from aleurone cells (Koehler and Ho, Plant Cell 2: 769-783 (1990)). In addition, an amino-terminal sequence coupled to a carboxy-terminal sequence is responsible for vacuolar targeting of the gene product (Shinshi et al. (1990) Plant Molec. Biol. 14: 357-368). In one embodiment, the selected signal sequence includes a known cleavage site, and the constructed fusion takes into account any amino acids that need to be cleaved after one or more cleavage sites. In some cases, this requirement can be met by adding a small number of amino acids between the cleavage site and the transgene ATG, or alternatively, by replacing some amino acids within the transgene sequence. These construction techniques are well known in the art and are equally applicable to any cellular compartment.

[0237] It will be appreciated that the above-described mechanisms for cellular targeting can be used not only in conjunction with their cognate promoters, but also in conjunction with heterologous promoters, thereby achieving specific cellular targeting goals under the transcriptional regulation of a promoter that has an expression profile that differs from the promoter from which the targeting signal is derived.

[0238] Plant transformation

[0239] The procedures for transforming plants are well known and conventional in the art and are generally described in the literature. Non-limiting examples of methods for plant transformation include transformation by bacteria-mediated nucleic acid delivery (e.g., via Agrobacterium), virus-mediated nucleic acid delivery, silicon carbide or nucleic acid whisker-mediated nucleic acid delivery, liposome-mediated nucleic acid delivery, microinjection, microparticle bombardment, calcium phosphate-mediated transformation, cyclodextrin-mediated transformation, electroporation, nanoparticle-mediated transformation, sonication, infiltration, PEG-mediated nucleic acid absorption, and any other electrical, chemical, physical (mechanical) or biological mechanism that allows nucleic acids to be introduced into plant cells, including any combination thereof. General guidance for the various plant transformation methods known in the art includes the following: Miki et al. ("Procedures for Introducing Foreign DNA into Plants" in Methods in Plant Molecular Biology and Biotechnology, Glick, BR and Thompson, JE, eds., CRC Press, Inc., Boca Raton, 1993, pp. 67-88) and Rakowoczy-Trojanowska (Cell. Mol. Biol. Lett. 7:849-858 (2002)).

[0240] For the conversion of agrobacterium mediation, binary vectors or the carrier that carries at least one T-DNA border sequence are suitable, and for direct gene transfer (for example, microprojectile bombardment etc.), any carrier is all suitable, and the linear DNA that only contains purpose construct can be preferred.In the case of direct gene transfer, can use conversion or the cotransformation (people such as Schocher, Biotechnology [biotechnology] 4:1093-1096 (1986)) with single DNA kind.For direct gene transfer and agrobacterium mediation transfer, conversion is usually (but not necessarily) carried out with following selective marker, and this selective marker can be positive selection (phosphomannose isomerase), provides resistance to antibiotic (kantlex, hygromycin or methotrexate) or weed killer herbicide (glyphosate or glyphosate-ammonium).But the selection of selective marker is not crucial for the present invention.

[0241] Agrobacterium-mediated transformation is a common method for transforming plants because of its high transformation efficiency and because of its wide practicality with many different species. Agrobacterium-mediated transformation typically involves transferring the binary vector carrying the foreign DNA of interest to an appropriate Agrobacterium strain, which may depend on the complement of the vir gene carried by the host Agrobacterium strain on a co-existing Ti plasmid or on the chromosome (Uknes et al. (1993) Plant Cell [plant cells] 5: 159-169). The recombinant binary vector is transferred to Agrobacterium and can be realized by a three-parent mating procedure using the Escherichia coli, auxiliary Escherichia coli strain (the auxiliary strain carries a plasmid that can move the recombinant binary vector to the target Agrobacterium strain) carrying the recombinant binary vector. Alternatively, the recombinant binary vector can be transferred to Agrobacterium by nucleic acid transformation ( and Willmitzer, (1988) Nucleic Acids Res. 16:9877).

[0242] Agrobacterium can be used to transform dicotyledons as well as monocotyledons. Methods for Agrobacterium-mediated rice transformation include well-known rice transformation methods, such as those described in any of the following documents: European Patent Application EP1198985 A1, Aldemita and Hodges (Planta [Plant] 199: 612-617, 1996); Chan et al. (Plant Mol Biol [Plant Molecular Biology] 22 (3): 491-506, 1993), Hiei et al. (Plant J [Plant Journal] 6 (2): 271-282, 1994), the disclosures of which are incorporated herein by reference to the same extent as if fully set forth. In the case of maize transformation, preferred methods are as described in Ishida et al. (Nat. Biotechnol. 14(6):745-50, 1996) or Frame et al. (Plant Physiol. 129(1):13-22, 2002), the disclosures of which are incorporated herein by reference to the same extent as if fully set forth. The methods are further described by way of example in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, eds. S. Kung and R. Wu, Academic Press (1993) 128-143 and Potrykus Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991) 205-225). The nucleic acid or construct to be expressed is preferably cloned into a vector suitable for transforming Agrobacterium tumefaciens, for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984) 8711). Agrobacterium transformed with this vector can then be used in a known manner to transform plants, such as plants used as models like Arabidopsis thaliana or crop plants such as tobacco plants, for example by immersing crushed or chopped leaves in an Agrobacterium solution and then culturing them in a suitable culture medium.The transformation of plants by Agrobacterium tumefaciens is described, for example, by Hagen and Willmitzer in Nucl. Acid Res. (1988) 16, 9877 or is known, inter alia, from FF White, Vectors for Gene Transfer in Higher Plants; Transgenic Plants, Vol. 1, Engineering and Utilization, ed. S. D. Kung and R. Wu, Academic Press, 1993, pp. 15-38.

[0243] Plant transformation by recombinant Agrobacterium typically involves co-cultivation of the Agrobacterium with explants from the plant and follows methods well known in the art. Transformed tissue is regenerated on selective media carrying an antibiotic or herbicide resistance marker located between the binary plasmid T-DNA borders.

[0244] As previously discussed, another method for transforming plants, plant parts, and plant cells involves advancing inert or biologically active particles on plant tissues and cells. See, for example, U.S. Patent Nos. 4,945,050; 5,036,006 and 5,100,792. Typically, this method involves advancing inert or biologically active particles at plant cells under conditions effective to penetrate the outer surface of the cell and provide for incorporation into its interior. When inert particles are used, the vector can be introduced into the cell by coating these particles with a vector containing the nucleic acid of interest. Alternatively, one or more cells can be surrounded by the vector so that the vector is brought into the cell by stimulation of the particle. Biologically active particles (e.g., dried yeast cells, dried bacteria, or bacteriophages, each containing one or more nucleic acids to be introduced) can also be advanced into plant tissue.

[0245] In other embodiments, the polynucleotides of the present invention can be directly transformed into the plastid genome. The main advantage of plastid transformation is that plastids are generally able to express bacterial genes without substantial modification, and plastids can express multiple open reading frames under the control of a single promoter. Plastid transformation techniques are widely described in the following literature: U.S. Patent Nos. 5,451,513, 5,545,817 and 5,545,818; PCT Application No. WO 95 / 16783; and McBride et al. (1994) Proc. Natl. Acad. Sci. USA [Proceedings of the National Academy of Sciences of the United States] 91, 7301-7305. Basic chloroplast transformation techniques involve, for example, using biolistic or protoplast transformation (e.g., calcium chloride or PEG-mediated transformation), introducing cloned plastid DNA regions flanked by a selective marker into the appropriate target tissue along with the gene of interest. These 1 to 1.5 kb flanking regions, designated targeting sequences, promote homologous recombination with the plastid genome and thus allow replacement or modification of specific regions of the plastome. Initially, point mutations in the chloroplast 16S rRNA and rps12 genes (conferring resistance to spectinomycin or streptomycin) were used as selectable markers for transformation (Svab, Z., Hajdukiewicz, P., and Maliga, P. (1990) Proc. Natl. Acad. Sci. USA 87, 8526-8530; Staub, JM, and Maliga, P. (1992) Plant Cell 4, 39-45). The presence of a cloning site between these markers allows the construction of plastid targeting vectors for the introduction of foreign genes (Staub, JM and Maliga, P., (1993) EMBO J. [European Journal of Molecular Biology] 12, 601-606). A substantial increase in transformation efficiency can be achieved by replacing recessive rRNA or r-protein antibiotic resistance genes with dominant selectable markers (the bacterial aadA gene encoding the spectinomycin detoxification enzyme aminoglycoside-3'-adenosyltransferase) (Svab, Z. and Maliga, P., (1993) Proc. Natl. Acad. Sci. USA [Proceedings of the National Academy of Sciences of the United States of America] 90, 913-917). Previously, this marker has been successfully used for high-frequency transformation of the plastid genome of the green alga Chlamydomonas reinhardtii (Goldschmidt-Clermont, M. (1991) Nucl. Acids Res. [Nucleic Acids Research] 19: 4083-4089). Other selective markers useful for plastid transformation are known in the art and are included within the scope of the present invention.Typically, approximately 15-20 cell division cycles are required after transformation to achieve a homoplasmic state. Plastid expression (wherein a gene is inserted into all of the thousands of copies of the circular plastid genome present in each plant cell by homologous recombination) takes advantage of the enormous copy number of genes over nuclear expression to allow expression levels that can easily exceed 10% of total soluble plant protein. In one embodiment, the polynucleotides of the present invention can be inserted into a plastid targeting vector and transformed into the plastid genome of a desired plant host. Thus, plants homologous to the plastid genome containing the nucleotide sequence of the present invention can be obtained, which are capable of highly expressing the polynucleotides.

[0246] The method for selecting the transgenic plant, vegetable cell or plant tissue culture for transformation is conventional in this area, and can be used in the method of the present invention provided herein.For example, the recombinant vector of the present invention can also include an expression cassette comprising a nucleotide sequence for a selective marker, and this selective marker can be used for selecting the plant, plant part or the plant cell for transformation. As used herein, " selective marker " means following nucleotide sequence, gives different phenotypes to the plant, plant part or the plant cell expressing this mark when this nucleotide sequence is expressed, and therefore allows the plant, plant part or the plant cell of this type of transformation to be distinguished from those without this mark. Such nucleotide sequence can encode selectivity or screening marker, and this depends on whether this mark gives the proterties that can be selected by chemical means, such as by using selection agents (for example, antibiotics, herbicides etc.), or depends on whether this mark is only the proterties that people can differentiate by observation or test, such as by screening (for example, R locus traits).Certainly, many examples of suitable selective markers are known in the art and can be used in expression cassette described herein.

[0247] Examples of selectable markers include, but are not limited to, nucleotide sequences encoding neo or nptll, which confer resistance to kanamycin, G418, and the like (Potrykus et al. (1985) Mol. Gen. Genet. 199: 183-188); nucleotide sequences encoding bar, which confer resistance to glufosinate; nucleotide sequences encoding altered 5-enolpyruvylshikimate-3-phosphate (EPSP) synthase, which confer resistance to glyphosate (Hinchee et al. (1988) Biotech. 6: 915-922); nucleotide sequences encoding nitrilase (e.g., from Klebsiella odorifera); ozaenae), which confers resistance to bromoxynil (Stalker et al. (1988) Science 242:419-423); a nucleotide sequence encoding an altered acetolactate synthase (ALS) that confers resistance to imidazolinones, sulfonylureas, or other ALS-inhibiting chemicals (European Patent Application No. 154204); a nucleotide sequence encoding a methotrexate-resistant dihydrofolate reductase (DHFR) (Thillet et al. (1988) J. Biol. Chem. Am. Am. [Journal of Biological Chemistry] 263: 12500-12508); a nucleotide sequence encoding a dalapon dehalogenase, which confers resistance to dalapon; a nucleotide sequence encoding a mannose-6-phosphate isomerase (also known as phosphomannose isomerase (PMI)), which confers the ability to metabolize mannose (U.S. Patent Nos. 5,767,378 and 5,994,629); a nucleotide sequence encoding an altered anthranilate synthase, which confers resistance to 5-methyltryptophan; or a nucleotide sequence encoding hph, which confers resistance to hygromycin. One skilled in the art will be able to select a suitable selectable marker for use in the expression cassette of the present invention.

[0248] Additional selectable markers include, but are not limited to, nucleotide sequences encoding beta-glucuronidase or uidA (GUS) encoding an enzyme for which a variety of chromogenic substrates are known; R-locus nucleotide sequences encoding products that regulate the production of anthocyanin pigments (red color) in plant tissues (Dellaporta et al., "Molecular cloning of the maize R-nj allele by transposon-tagging with Ac," 263-282 In: Chromosome Structure and Function: Impact of New Concepts, 18th Stadler Genetics Symposium (Gustafson and Appels, eds., Plenum Genetics); Press [Plenum Press] 1988); a nucleotide sequence encoding β-lactamase, an enzyme known for various chromogenic substrates (e.g., PADAC, a chromogenic cephalosporin) (Sutcliffe (1978) Proc. Natl. Acad. Sci. USA 75:3737-3741); a nucleotide sequence encoding xylE, which encodes catechol dioxygenase (Zukowsky et al. (1983) Proc. Natl. Acad. Sci. USA 80:1101-1105); a nucleotide sequence encoding tyrosinase, an enzyme capable of oxidizing tyrosine to DOPA and dopaquinone, which in turn condense to form melanin (K [General Microbiology] 129:2703-2714); a nucleotide sequence encoding β-galactosidase, an enzyme that is present in the presence of a chromogenic substrate; a nucleotide sequence encoding luciferase (lux), which can be used for bioluminescent detection (Ow et al. (1986) Science 234:856-859); a nucleotide sequence encoding aequorin, which can be used for calcium-sensitive bioluminescent detection (Prasher et al. (1985) Biochem. Biophys. Res. Comm. 126:1259-1268); or a nucleotide sequence encoding green fluorescent protein (Niedz et al. (1995) Plant Cell Reports 14:403-406). One skilled in the art will be able to select an appropriate selectable marker for use in the expression cassettes of the present invention.

[0249] In addition, as is well known in the art, complete transgenic plants can be regenerated from transformed plant cells, plant tissue cultures, or cultured protoplasts using any of a variety of known techniques. Plant regeneration from plant cells, plant tissue cultures, or cultured protoplasts is described in, for example, Evans et al. (Handbook of Plant Cell Cultures, Vol. 1, MacMilan Publishing Co., New York (1983)); and Vasil IR (ed.) (Cell Culture and Somatic Cell Genetics of Plants, Acad. Press, Orlando, Vol. I (1984) and Vol. II (1986).

[0250] In addition, the genetic characteristics engineered into the transgenic seeds and plants, plant parts or plant cells of the present invention described above can be transmitted by sexual reproduction or vegetative growth, and therefore can be maintained and passed down through the progeny plants. Typically, maintenance and passing down utilize known agricultural methods developed to suit a specific purpose (such as harvesting, sowing or farming).

[0251] In some embodiments, the polynucleotides are introduced into the plant, plant part or the plant cell by any number of methods well known in the art (as mentioned above). Therefore, there is no reliance on the ad hoc approach for introducing one or more polynucleotides into the plant, but rather any method that allows the one or more polynucleotides to be stably integrated into the genome of the plant. In the case of waiting to introduce more than one polynucleotide, these corresponding polynucleotides can be assembled as a part for a single nucleic acid molecule or as a separated nucleic acid molecule, and can be located on identical or different nucleic acid molecules. Therefore, these polynucleotides can be introduced into the target cell in a single transformation event, in a separated transformation event or, for example, as a part for a breeding scheme in a plant.

[0252] Other embodiments of the present invention include the results of the transgenic plant of the present invention or its part and the processed products produced from the results of the products. The results of the products can be the whole plant or any plant part as described herein. Therefore, in some embodiments, the limiting examples of the results of the products include seeds, fruits, flowers or its parts (for example, anthers, stigma etc.), leaves, stems etc. In other embodiments, the processed products include but are not limited to the fine powder, meal, oil, starch, cereals etc. produced from the seeds of the present invention or other plant parts of the results, wherein the seeds or other plant parts comprise nucleic acid molecules / polynucleotides / nucleotide sequences of the present invention.

[0253] In other embodiments, the present invention provides an extract from a transgenic seed or transgenic plant of the present invention, wherein the extract comprises a nucleic acid molecule, polynucleotide, nucleotide sequence, or toxic protein of the present invention. Extracts from plants or plant parts can be prepared according to procedures well known in the art (see, de la Torre et al., Food, Agric. Environ. 2(1):84-89 (2004); Guidet, Nucleic Acids Res. 22(9):1772-1773 (1994); Lipton et al., Food Agric. Immun. 12:153-164 (2000)).

[0254] Insecticidal composition

[0255] In some embodiments, the present invention provides an insecticidal composition comprising a Cry protein of the present invention in an agriculturally acceptable carrier. As used herein, "agriculturally acceptable carrier" may include natural or synthetic organic or inorganic materials that are combined with active Cry proteins to facilitate their application to plants or parts thereof. Examples of agriculturally acceptable carriers include, but are not limited to, powders, dusts, pills, granules, sprays, emulsions, colloids, and solutions. Agriculturally acceptable carriers further include, but are not limited to, inert components, dispersants, surfactants, adjuvants, tackifiers, adhesives, binders, or combinations thereof that can be used in agricultural formulations. Such compositions can be applied in any manner that brings insecticidal proteins or other pest control agents into contact with these pests. Therefore, these compositions can be applied to the surface of plants or plant parts, including seeds, leaves, flowers, stems, tubers, roots, etc. In other embodiments, plants that produce the Cry proteins of the present invention in plants are agricultural carriers of the expressed Cry proteins.

[0256] In another embodiment, the insecticidal composition comprises bacterial cells or transgenic bacterial cells of the present invention, wherein the bacterial cells or transgenic bacterial cells produce the Cry protein of the present invention. Such insecticidal compositions can be prepared by dehydrating, freeze-drying, homogenizing, extracting, filtering, centrifuging, sedimenting, or concentrating a culture of Bacillus thuringiensis (Bt). In another embodiment, the composition comprises from about 1% to about 99% by weight of the Cry protein of the present invention.

[0257] The Cry proteins of the present invention can be used in combination with other pest control agents to increase the pest target range or for preventing or managing insect resistance. Therefore, in some embodiments, the present invention provides a composition for controlling one or more plant pests, wherein the composition comprises a first Cry protein of the present invention and a second pest control agent different from the first Cry protein. In other embodiments, the composition is a preparation for topical application to plants. In still other embodiments, the composition is a transgenic plant. In further embodiments, the composition is a combination of preparations topically applied to transgenic plants. In some embodiments, when the transgenic plant comprises the second pest control agent, the preparation comprises the first Cry protein of the present invention. In other embodiments, when the transgenic plant comprises the first Cry protein of the present invention, the preparation comprises the second pest control agent.

[0258] In some embodiments, the second pest control agent can be an agent selected from the group consisting of: a chemical pesticide (such as an insecticide), a Bacillus thuringiensis (Bt) insecticidal protein, a Xenorhabdus insecticidal protein, a Photorhabdus insecticidal protein, a Brevibacillus laterosporus insecticidal protein, a Bacillus sphaericus insecticidal protein, a protease inhibitor (both serine and cysteine ​​types), a lectin, an alpha-amylase, a peroxidase, a cholesterol oxidase, and a double-stranded RNA (dsRNA) molecule.

[0259] In other embodiments, the second pest control agent is a chemical pesticide selected from the group consisting of pyrethroids, carbamates, neonicotinoids, neuronal sodium channel blockers, insecticidal macrolides, gamma-aminobutyric acid (GABA) antagonists, insecticidal ureas, and juvenile hormone mimetics. In other embodiments, the chemical pesticide is selected from the group consisting of abamectin, acephate, acetamiprid, amidoflumet (S-1955), avermectin, azadirachtin, azinphos-methyl, bifenthrin, binfenazate, buprofezin, carbofuran, chlorfenapyr, chlorpyrifos, chlorpyrifos-methyl, chromafenazide, clothianidin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, cypermethrin, diazinon, diflubenzuron, dimethoate, difenothiocarb, emamectin, endosulfan, esfenvalerate, ethiprole, fenothicarb, b), fenoxycarb, cypermethrin, fenpyroximate, cypermethrin, fipronil, flonicamid, flucythrin, t-fluvalinate, UR-50701, flufenoxuron, flufenoxam, chlorfenapyr, hexaflumuron, imidacloprid, indoxacarb, isofenphos, lufenuron, malathion, metaldehyde, methamidophos, methidathion, methomyl, methoprene, methoxychlor, monocrotophos, methoxyfenozide, thiazide, noflumuron, nobifenazol, xenuron (XDE-007), oxamyl, parathion, methyl parathion, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, pymetrozine, pyridalyl, pyriproxyfen, rotenone, spinosad, spiromesifin (BSN 2060), thiopromide, tebufenozide, tefluthrin, terbufos, chlorpyrifos, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, trichlorfon and triflumuron, aldicarb, oxamyl, fenamiphos, amitraz, chlorpyrifos, ethyl chlorpyrifos, cypermethrin, fenbutatin, cypermethrin, fenpropimorph, fenpyrad ... In still other embodiments, the chemical pesticide is selected from the group consisting of cypermethrin, cyhalothrin, cyfluthrin and beta-cyfluthrin, esfenvalerate, fenvalerate, tralomethrin, fenthiocarb, methomyl, oxamyl, thiodicarb, clothianidin, imidacloprid, thiacloprid, indoxacarb, spinosad, abamectin, avermectin, endosulfan, ethiprole, fipronil, flufenoxuron, triflumuron, difenocarb, pyriproxyfen, pyriproxyfen, and amitraz.

[0260] In other embodiments, the second pest control agent can be one or more of any number of Bacillus thuringiensis insecticidal proteins, including but not limited to Cry proteins, vegetative insecticidal proteins (VIPs), and insecticidal chimeras of any of the foregoing insecticidal proteins. In other embodiments, the second pest control agent is a Cry protein selected from the group consisting of Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ad, Cry1Ae, Cry1Af, Cry1Ag, Cry1Ah, Cry1Ai, Cry1Aj, Cry1Ba, Cry1Bb, Cry1Bc, Cry1Bd, Cry1Be, Cry1Bf, Cry1Bg, Cry1Bh, Cry1Bi, Cry1Ca, Cry1Cb, Cry1Da, Cry1Db, Cry1Dc, Cry1Dd, Cry1Ea, Cry1Eb, Cry1Fa, Cry1E y1Fb, Cry1Ga, Cry1Gb, Cry1Gc, Cry1Ha, Cry1Hb, Cry1Hc, Cry1Ia, Cry1Ib, Cry1Ic, Cry1Id, Cry1Ie, Cry1If, Cry1Ig, Cry1Ja, Cry1Jb, Cry1Jc, C ry1Jd, Cry1Ka, Cry1La, Cry1Ma, Cry1Na, Cry1Nb, Cry2Aa, Cry2Ab, Cry2Ac, Cry2Ad, Cry2Ae, Cry2Af, Cry2Ag, Cry2Ah, Cry2Ai, Cry2Aj, Cry2Ak,Cry2Al、Cry2Ba、Cry3Aa、Cry3Ba、Cry3Bb、Cry3Ca、Cry4Aa、Cry4Ba、Cry4Ca、Cry4Cb、Cry4Cc、Cry5Aa、Cry5Ab、Cry5Ac、Cry5Ad、Cry5Ba、Cry5Ca、Cry5Da、Cry5Ea、Cry6Aa、Cry6Ba、Cry7Aa、Cry7Ab、Cry7Ac、Cry7Ba、Cry7Bb、Cry7Ca、Cry7Cb、Cry7Da、Cry7Ea、Cry7Fa、Cry7Fb、Cry7Ga、Cry7Gb、Cry7Gc、Cry7Gd、Cry7Ha、Cry7Ia、Cry7Ja、Cry7Ka、Cry7Kb、Cry7La、Cry8Aa、Cry8Ab、Cry8Ac、Cry8Ad、Cry8Ba、Cry8Bb、Cry8Bc、Cry8Ca、Cry8Da、Cry8Db、Cry8Ea、Cry8Fa、Cry8Ga、Cry8Ha、Cry8Ia、Cry8Ib、Cry8Ja、Cry8Ka、Cry8Kb、Cry8La、Cry8Ma、Cry8Na、Cry8Pa、Cry8Qa、Cry8Ra、Cry8Sa、Cry8Ta、Cry9Aa、Cry9Ba、Cry9Bb、Cry9Ca、Cry9Da、Cry9Db、Cry9Dc、Cry9Ea、Cry9Eb、Cry9Ec、Cry9Ed、Cry9Ee、Cry9Fa、Cry9Ga、Cry10Aa、Cry11Aa、Cry11Ba、Cry11Bb、Cry12Aa,Cry13Aa、Cry14Aa、Cry14Ab、Cry15Aa、Cry16Aa、Cry17Aa、Cry18Aa、Cry18Ba、Cry18Ca、Cry19Aa、Cry19Ba、Cry19Ca、Cry20Aa、Cry20Ba、Cry21Aa、Cry21Ba、Cry21Ca、Cry21Da、Cry21Ea、Cry21Fa、Cry21Ga、Cry21Ha、Cry22Aa、Cry22Ab、Cry22Ba、Cry22Bb、Cry23Aa、Cry24Aa、Cry24Ba、Cry24Ca、Cry25Aa、Cry26Aa、Cry27Aa、Cry28Aa、Cry29Aa、Cry29Ba、Cry30Aa、Cry30Ba、Cry30Ca、Cry30Da、Cry30Db、Cry30Ea、Cry30Fa、Cry30Ga,Cry31Aa, Cry31Ab, Cry31Ac, Cry31Ad, Cry32Aa, Cry32Ab, Cry32Ba, Cry32Ca, Cry32Cb, Cry32Da, Cry32Ea, Cry32Eb, Cry3 2Fa, Cry32Ga, Cry32Ha, Cry32Hb, Cry32Ia, Cry32Ja, Cry32Ka, Cry32La, Cry32Ma, Cry32Mb, Cry32Na, Cry32Oa, Cry32Pa, Cry32Qa, Cry32Ra, Cry32Sa, Cry32Ta, Cry32Ua, Cry33Aa, Cry34Aa, Cry34Ab, Cry34Ac, Cry34Ba, Cry35Aa, Cry35Ab, Cry3 5Ac, Cry35Ba, Cry36Aa, Cry37Aa, Cry38Aa, Cry39Aa, Cry40Aa, Cry40Ba, Cry40Ca, Cry40Da, Cry41Aa, Cry41Ab, Cry41Ba, Cry42Aa, Cry43Aa, Cry43Ba, Cry43Ca, Cry43Cb, Cry43Cc, Cry44Aa, Cry45Aa, Cry46Aa, Cry46Ab, Cry47Aa, Cry48Aa, Cry4 8Ab, Cry49Aa, Cry49Ab, Cry50Aa, Cry50Ba, Cry51Aa, Cry52Aa, Cry52Ba, Cry53Aa, Cry53Ab, Cry54Aa, Cry54Ab, Cry54Ba, Cry55Aa, Cry56Aa, Cry57Aa, Cry57Ab, Cry58Aa, Cry59Aa, Cry59Ba, Cry60Aa, Cry60Ba, Cry61Aa, Cry62Aa, Cry63Aa, Cry64Aa, Cry65Aa, Cry66Aa, Cry67Aa, Cry68Aa, Cry69Aa, Cry69Ab, Cry70Aa, Cry70Ba, Cry70Bb, Cry71Aa, Cry72Aa, and Cry73Aa.

[0261] In another embodiment, the second pest control agent is a Vip3 vegetative insecticide protein selected from the group consisting of Vip3Aa1, Vip3Aa2, Vip3Aa3, Vip3Aa4, Vip3Aa5, Vip3Aa6, Vip3Aa7, Vip3Aa8, Vip3Aa9, Vip3Aa10, Vip3Aa11, Vip3Aa12, Vip3Aa a13, Vip3Aa14, Vip3Aa15, Vip3Aa16, Vip3Aa17, Vip3Aa18, Vip3Aa19, Vip3Aa20, Vip3Aa21 , Vip3Aa22, Vip3Aa2, Vip3Aa24, Vip3Aa25, Vip3Aa26, Vip3Aa27, Vip3Aa28, Vip3Aa29, Vip3 Aa30, Vip3Aa31, Vip3Aa32, Vip3Aa33, Vip3Aa34, Vip3Aa35, Vip3Aa36, Vip3Aa37, Vip3Aa3 8. Vip3Aa39, Vip3Aa40, Vip3Aa41, Vip3Aa42, Vip3Aa43, Vip3Aa44, Vip3Ab1, Vip3Ab2, Vip 3Ac1, Vip3Ad1, Vip3Ad2, Vip3Ae1, Vip3Af1, Vip3Af2, Vip3Af3, Vip3Ag1, Vip3Ag2, Vip3Ag3, HM117633, Vip3Ag4, Vip3Ag5, Vip3Ah1, Vip3Ba1, Vip3Ba2, Vip3Bb1, Vip3Bb2, and Vip3Bb3.

[0262] In still other embodiments, the first Cry protein of the present invention and the second pest control agent are co-expressed in transgenic plants. Co-expression of more than one pesticidal component in the same transgenic plant can be achieved by genetically engineering the plant to contain and express all the necessary genes. Alternatively, the plant (parent 1) can be genetically engineered for the expression of the Cry protein of the present invention. The second plant (parent 2) can be genetically engineered for the expression of the second pest control agent. By hybridizing parent 1 with parent 2, a progeny plant expressing all the genes introduced into parent 1 and parent 2 is obtained.

[0263] In other embodiments, the present invention provides a stacked transgenic plant resistant to plant pest infection, the plant comprising a DNA sequence encoding a dsRNA for suppressing essential genes in a target pest and a DNA sequence encoding a Cry protein of the present invention that exhibits biological activity against the target pest. It has been reported that dsRNAs are ineffective against certain lepidopteran pests (Rajagopol et al. 2002. J. Biol. Chem. [Journal of Biological Chemistry] 277: 468-494), which may be due to the high pH of the midgut destroying the stability of the dsRNA. Therefore, in embodiments where some target pests are lepidopteran pests, the Cry protein of the present invention acts to transiently reduce the midgut pH, which is used to stabilize the co-ingested dsRNA, thereby effectively silencing the target gene.

[0264] In addition to providing compositions, the present invention also provides methods for producing Cry proteins that are toxic to lepidopteran pests. Such a method includes culturing a transgenic non-human host cell under conditions in which the host cell produces a protein that is toxic to lepidopteran pests, and the host cell comprises a polynucleotide or chimeric gene or nucleic acid molecule or recombinant vector of the present invention. In certain embodiments, the transgenic non-human host cell is a plant cell. In some other embodiments, the plant cell is a maize cell. In other embodiments, the conditions under which the plant cell or maize cell grows include natural light. In other embodiments, the transgenic non-human host cell is a bacterial cell. In still other embodiments, the transgenic non-human host cell is a yeast cell.

[0265] In other embodiments of the method, the lepidopteran pest is selected from the group consisting of: Asian corn borer (Asian corn borer), black cutworm (Agrotissima), cotton bollworm (Helicoverpa armigera), yellow peach borer (Corn stem borer), oriental armyworm (Oriental armyworm), European corn borer (European corn borer), fall armyworm (Spodoptera frugiperda), corn ear moth (Corn ear moth), sugarcane borer (Spodoptera frugiperda), velvet bean caterpillar (Spodoptera frugiperda), soybean armyworm (Soybean looper), southwestern corn borer (Southwestern corn borer), western bean cutworm (Western bean cutworm), tobacco armyworm (Spodoptera tobago), striped stem borer (Chilo suppressalis), powdery stem borer (African stem borer), and rice leaf roller (Cnaphalocrocis medinalis), and any combination thereof.

[0266] In additional embodiments of this method, the chimeric gene comprises any one of SEQ ID NOs: 1-11. In still other embodiments, the protein produced comprises the amino acid sequence of any one of SEQ ID NOs: 36-46.

[0267] In some embodiments of this method, the chimeric gene comprises a nucleotide sequence that has been codon-optimized for expression in plants. In other embodiments, the chimeric gene comprises any one of SEQ ID NOs: 12-35. In further embodiments, the protein produced comprises the amino acid sequence of any one of SEQ ID NOs: 36-59.

[0268] In another embodiment, the present invention provides a method for producing a pest-resistant (e.g., insect-resistant) transgenic plant, the method comprising introducing into a plant a polynucleotide of the present invention, a chimeric gene, a recombinant vector, an expression cassette or a nucleic acid molecule comprising a nucleotide sequence encoding a Cry protein of the present invention, wherein the nucleotide sequence is expressed in the plant, thereby imparting resistance to lepidopteran pests to the plant, and producing an insect-resistant transgenic plant. In some embodiments, the pest-resistant transgenic plant is resistant to lepidopteran pests of the genus Ostrinia compared to a control plant lacking the polynucleotide of the present invention, the chimeric gene, the recombinant vector, the expression cassette or the nucleic acid molecule. In other embodiments, the insect of the genus Ostrinia is a corn borer (Asian corn borer). In some embodiments, introduction is achieved by transforming a plant. In other embodiments, introduction is achieved by hybridizing a first plant comprising a chimeric gene, a recombinant vector, an expression cassette or a nucleic acid molecule of the present invention with a second, different plant.

[0269] In some embodiments, the transgenic plants of the invention that are resistant to at least the Asian corn borer (Asian corn borer) are also resistant to at least one additional lepidopteran pest, wherein the additional lepidopteran pest includes, but is not limited to, black cutworm (Agrotissima), fall armyworm (Spodoptera frugiperda), corn earworm (Zea mays), sugarcane borer (Stichopus zea), velvet bean caterpillar (Spodoptera frugiperda), soybean armyworm (Soybean looper), southwestern corn borer (Ostrinia nubilalis), western bean cutworm (Western bean cutworm), tobacco armyworm (Heliothis virescens), cotton bollworm (Heliothis virescens), striped stem borer (Chilo suppressalis), powdery stem borer (African stem borer), or rice leaf folder (Cnaphalocrocis medinalis), and any combination thereof.

[0270] In another embodiment, a method for controlling lepidopteran pests such as corn borers (Asian corn borer) is provided, which comprises delivering an effective amount of the Cry protein of the present invention to these insects. In order to be effective, the Cry protein is first orally ingested by the insect. However, the Cry protein can be delivered to the insect in many recognized ways. The way of delivering the protein orally to the insect includes but is not limited to (1) providing the protein in a transgenic plant, wherein the insect feeds (ingests) one or more parts of the transgenic plant, thereby ingesting the polypeptide expressed in the transgenic plant; (2) providing the protein in one or more prepared protein compositions that can be applied to or incorporated into, for example, insect growth medium; (3) providing the protein in one or more protein compositions that can be applied to the surface of a plant part (e.g., sprayed onto the surface of a plant part), and then being ingested by the insect when the insect feeds on one or more sprayed plant parts; (4) bait base; (5) any other protein delivery system recognized in the art. Therefore, any method of oral delivery to insects can be used to deliver the toxic Cry protein of the present invention. In some specific embodiments, the Cry protein of the present invention is orally delivered to the insect, wherein the insect ingests one or more parts of the transgenic plant.

[0271] In other embodiments, the Cry protein of the present invention is orally delivered to insects, wherein the insects ingest one or more parts of a plant sprayed with a composition comprising the Cry protein of the present invention. Any method known to those skilled in the art for applying compounds, compositions, formulations, etc. to plant surfaces can be used to deliver the composition of the present invention to the plant surface. Some non-limiting examples of delivery to or contacting plants or parts thereof include spraying, dusting, sprinkling, dispersing, misting, atomizing, broadcasting, soaking, soil injection, soil incorporation, saturation (e.g., roots, soil treatment), impregnation, irrigation, coating, leaf or stem infiltration, side application or seed treatment, etc., and combinations thereof. These and other procedures for contacting plants or parts thereof with one or more compounds, one or more compositions, or one or more formulations are well known to those skilled in the art.

[0272] In some embodiments, the present invention encompasses a method for providing farmers with a means of controlling lepidopteran pests, the method comprising supplying or selling to the farmer plant material such as seeds, the plant material comprising a polynucleotide, chimeric gene, expression cassette or recombinant vector capable of expressing a Cry protein of the present invention in a plant grown from the seeds, as described above.

[0273] Embodiments of the present invention may be better understood by reference to the following examples. The foregoing and following embodiments of the present invention and the description of various embodiments are not intended to limit the claims, but are illustrative thereof. Therefore, it should be understood that the claims are not intended to be limited to the specific details of these examples. It should be understood by those skilled in the art that other embodiments of the present invention may be practiced without departing from the spirit and scope of the present disclosure, and the scope of the present disclosure is defined by the appended claims.

[0274] Examples

[0275] Example 1. Identification of Bt strains for genome sequencing

[0276] Bacillus thuringiensis (Bt) strains were isolated from environmental samples (e.g., soil, grain, or plants). The environmental samples were suspended in LB+2.5M sodium acetate liquid medium and subsequently heat-treated at 70°C for approximately 20 min. One microliter of the suspension was then plated on a T3+ penicillin agar plate and incubated at 28°C until colonies were formed. Colonies with Bacillus-like morphology were picked from these plates and re-streaked on the T3+ penicillin agar plate until they had formed spores, typically for approximately three days. The Bt strains were identified by staining the culture with Coomassie blue / acetic acid and visually inspecting the culture under a microscope. After spore formation, both the soluble and insoluble fractions were tested for activity against the Lepidoptera species of interest. Each fraction was tested in a surface contamination bioassay in which each fraction was covered on a multi-species artificial diet. Each isolate was screened against at least four Lepidoptera species, including the zea mays (corn earworm), black cutworm (black cutworm), European corn borer (European corn borer), and Spodoptera frugiperda (fall armyworm), with a sample size of 12 neonates. Each test lasted approximately 7 days at room temperature; plates were scored for mortality and larval growth inhibition. Efficacy was considered achieved when a 30% increase in mortality relative to the negative control was observed. Based on the initial insect testing, 12 Bt strains were selected for further analysis. After identification of the Bt strains, genomic DNA was isolated as described below.

[0277] Example 2. Genome assembly and analysis

[0278] The Bt cry gene of the present invention was assembled from the genome of the Bt strain isolated as described in Example 1 using a whole genome sequencing approach. Briefly, Bacillus DNA was sheared using a Covaris S2 ultrasonic device (Covaris, Inc., Woburn, MA) with the program DNA_400 bp set to duty cycle: 10%; intensity: 4; cycles / pulse: 200. Ultra TMEnd Repair / dA-tailing module (New England Biolabs, Inc., Ipswich, MA). The DNA was purified using NEB Quick Ligation as described by the supplier (New England Biolabs, Inc., Ipswich, MA). TM Biooscience indexed 1-57 aptamers (1-27 Brazil, 28-57 USA, UK and Switzerland) were ligated. Ligations were cleaned up using Agencourt AMPure XP beads as described by the supplier (Beckman Coulter, Inc., Indianapolis, IN).

[0279] The library was size fractionated as follows: 50 μL of sample was mixed with 45 μL of 75% bead mix (25% AMPure beads plus 75% NaCl / PEG solution, TekNova catalog number P4136). The mixture was stirred and placed on a magnetic stand. The resulting supernatant was transferred to a new well and 45 μL of 50% bead mix (50% AMPure beads plus 50% NaCl / PEG solution, TekNova catalog number P4136) was added. The mixture was stirred and placed on a magnetic stand. The resulting supernatant was removed and the beads were washed with 80% ethanol. 25 μL of elution buffer (EB) was added and the mixture was placed on a magnetic stand. The resulting final supernatant was removed and placed in a 1.5 mL tube. This method generated a library with a size range of 525 DNA base pairs (bp) (insert plus adaptor).

[0280] Amplify the size-defined DNA library using the KAPA Biosystem HiFi Hot Start (Kapa Biosystems, Inc., Wilmington, MA) using the following cycling conditions: [98°C, 45 s]; 12x [98°C, 15 s, 60°C, 30 s, 72°C, 30 s]; [72°C, 1 min]. Each reaction contained: 5 μl of DNA library, 1 μl of Bioscience universal primer (25 μM), 18 μl of sterile water, 1 μl of Bioscience indexed primer (25 μM), and 25 μl of 2X KAPA HiFi polymerase.

[0281] Libraries were run on an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA) using a high-sensitivity chip to determine library size range and average insert size. All libraries were processed for paired-end (PE) sequencing (100 cycles / read; 12-24 libraries / lane) on a HiSeq 2500 sequencing system using the standard manufacturer's sequencing protocol (Illumina, Inc., San Diego, CA).

[0282] A proprietary computational analysis tool developed for the identification and characterization of possible Cry-like genes in Bacillus was used to prioritize leads for further laboratory testing.

[0283] The assembly and analysis of the genome described above identified 11 Cry-like coding sequences and derived proteins, which are listed in Table 1. The skilled person will recognize that due to the genome sequencing and gene assembly process, the assembled nucleotide sequences and the amino acid sequences derived therefrom are unlikely to be naturally occurring, as it is known in the art that the assembly of sequences is not 100% accurate and may introduce bases that are different from the natural nucleotide sequence. Therefore, these nucleotide sequences are referred to herein as "assembled sequences" and the Cry proteins they encode are "derived from" assembled sequences.

[0284] Sequence homology searches were performed using the full-length Cry-like protein amino acid sequences derived from the assembled nucleotide sequences. Homology was determined using the NCBI protein-protein BLAST program. The known Cry proteins with the highest homology to each assembled Cry-like protein indicated the nearest Cry family to which the assembled Cry-like protein belonged. The identifying characteristics of the assembled coding sequences and proteins are shown in Table 1.

[0285] Although BT235 and BT727 have domains that place them in the Cry toxin superfamily, they do not share any significant identity (i.e., <45%) with any known Cry protein. Therefore, according to the current naming scheme (Crickmore et al.), both proteins are likely to be placed in their own Cry family. For example, according to the current nomenclature, BT235 is likely to be named Cry79Aa1, and BT727 would be named Cry79Ab1.

[0286] Table 1. Cry genes / proteins assembled from the Bacillus thuringiensis genome.

[0287]

[0288]

[0289] Example 3. Expression of Bt Protein in Recombinant Host Cells

[0290] Bacillus expression. The Cry proteins described in Example 2 were expressed in a crystal-free Bacillus thuringiensis (Bt) strain with no observable background insecticidal activity via a shuttle vector designated pCIB5634' designed for expression in both E. coli and Bt. The vector pCIB5634' includes the Cry1Ac promoter and an erythromycin resistance marker that drive expression of the cloned Bt Cry gene. The expression cassette containing the target Cry coding sequence was transformed into the host Bt strain via electroporation and transgenic Bt strains were selected on agar plates containing erythromycin. The selected transgenic Bt strains were grown in T3 medium at 28°C for 4-5 days to the sporulation stage. The cell pellet was harvested and repeatedly washed before being dissolved in a high pH carbonate buffer (50mM) containing 2mM DTT. Alternatively, the cell pellet was removed from the culture supernatant during the vegetative growth phase, and the spent culture medium was used to test the presence of Cry-like proteins secreted into the growth medium.

[0291] E. coli expression. Cry proteins were expressed in E. coli strains using pET28a or pET29a vectors (Merck KGaA, Darmstadt, Germany). The constructs were transformed by electroporation and transfected E. coli clones were selected on agar plates containing kanamycin. The selected transgenic E. coli strains were grown and induced to express Cry proteins using IPTG at 28°C. The cells were resuspended in a high pH carbonate buffer (50 mM) containing 2 mM DTT and then disrupted using a Microfluidics LV-1 homogenizer.

[0292] Expression analysis. The resulting cell lysates from transgenic Bt or E. coli strains were clarified via centrifugation and the purity of the samples was analyzed via SDS-PAGE and electropherogram using the BioRad Experion system (Biorad, Hercules, CA). Total protein concentration was determined via Bradford or Thermo 660 assays. The purified Cry proteins were then tested in the bioassays described below.

[0293] Example 4. Activity of Cry proteins in biological assays

[0294] The Cry proteins produced in Example 3 are tested against one or more of the following lepidopteran pest species using art-recognized artificial diet bioassays appropriate to the target pests: European cornborer (ECB; Ostrinia nubilalis), black cutworm (BCW; Agrotis ipsilon), fall armyworm (FAW; Spodoptera frugiperda), corn earworm (CEW; Helicoverpa zea), soybean looper (SBL; Pseudoplusia includens), velvet bean caterpillar (Chrysodeixis includes), tobacco budworm (TBW; Heliothis virescens), southern armyworm (SBL; Pseudoplusia includens), armyworm (SAW; southern armyworm (Spodoptera eridania)), cosmid armyworm (CAW; Spodoptera cosmioides)), Asian corn borer (ACB; Ostriniafurnacalis), cotton bollworm (CBW; Helicoverpa armigera), Oriental armyworm (OAW; Mythimna sepatate), and western corn rootworm (WCR, Diabrotica virgifera).

[0295] Equal amounts of the protein in the solution were applied to the surface of artificial insect diet (Bioserv (Bioserv, Inc., Frenchtown, New Jersey) in 24-well plates. After the diet surface dried, larvae of the insect species to be tested were added to each well. The plates were sealed and maintained under ambient laboratory conditions with respect to temperature, light, and relative humidity. The positive control group consisted of larvae exposed to a very active and broad-spectrum wild-type Bacillus strain. The negative control group consisted of larvae exposed to insect diet treated with buffer solution alone and larvae on untreated insect diet (i.e., diet alone). Mortality was assessed after approximately 120 hours and scored relative to the control.

[0296] The results are shown in Table 2, where "-" means no activity compared to the control, "+ / -" means 0-10% activity compared to the control (this category also includes 0% mortality with strong larval growth inhibition), "+" means 10%-25% activity compared to the control, "++" means 25%-75% activity compared to the control, and "+++" means 75%-100% activity compared to the control. The designation "nt" in Table 2 means that the indicated protein was not tested against that particular pest species.

[0297] Table 2. Bioassay results of assembled insecticidal proteins of the present invention.

[0298]

[0299] Table 3.

[0300]

[0301] Currently, no Cry1I proteins are known to be active against black cutworm (BCW, also known as black cutworm). Here, BT204, which shares 93% identity with Cry1Ia, Cry1Ib, and Cry1Ie, exhibits surprising activity against BCW. When the amino acid sequence of BT204 (SEQ ID NO:36) was aligned with three known Cry1I proteins (SEQ ID NO:60, SEQ ID NO:61, and SEQ ID NO:64), BT204 had unique amino acids at 17 positions throughout its sequence compared to the three known Cry1I proteins without BCW activity. Compared with the three Cry1I amino acid sequences, the amino acid substitutions at 17 positions of SEQ ID NO: 36 consist of the following: N or D113A, A164S, V223A, T249K, I or Q281H, D298N, N454T, S519P, L571V, Y651H, E659K, R670G, D675N, K677T, D678E, D693N and E716G, indicating that these positions explain the difference in BCW activity of BT204 compared with the inactive Cry1I protein.

[0302] Example 5. Gene Targeting for Plant Expression

[0303] Before expression in plants, polynucleotides encoding the Cry protein of the present invention, such as polynucleotides encoding any one of SEQ ID NOs: 36-59, are synthesized on an automated gene synthesis platform (e.g., Genscript, Inc., Piscataway, New Jersey). For this example, a first expression cassette comprising a plant-expressible promoter operably connected to a Cry protein coding sequence (the coding sequence being operably connected to a terminator) is prepared, and a second expression cassette comprising a plant-expressible promoter operably connected to a selective marker (the selective marker being operably connected to a terminator) is prepared. The expression of the selective marker allows transgenic plants to be identified on a selective culture medium. Two expression cassettes are cloned into a vector suitable for Agrobacterium-mediated rice or maize transformation.

[0304] Example 6. Expression and activity of Cry proteins in maize plants

[0305] Transformation of immature maize embryos was performed essentially as described in Negrotto et al., 2000, Plant Cell Reports 19:798-803. Briefly, Agrobacterium strain LBA4404 (pSB1) containing the expression vector described in Example 5 was grown at 28° C. on YEP (yeast extract (5 g / L), peptone (10 g / L), NaCl (5 g / L), 15 g / l agar, pH 6.8) solid medium for 2-4 days. Approximately 0.8×10 9 Agrobacterium cells were suspended in LS-inf medium supplemented with 100 μM As. The bacteria were pre-induced in this medium for approximately 30-60 minutes.

[0306] The immature embryos from inbred maize lines are excised from the ear in 8-12 days age in liquid LS-inf+100 μM As. These embryos are rinsed with fresh infection culture medium. Then add agrobacterium solution, and these embryos are vortexed for 30 seconds and allowed to settle for 5 minutes with bacterium. Then these embryo scutels are upwardly transferred to the LSA culture medium, and cultivated two to three days in the dark. Subsequently, about 20 and 25 embryos of every petri plate (petri plate) are transferred to the LSDc culture medium that is supplemented with cefotaxime (250mg / l) and silver nitrate (1.6mg / l), and cultivated 10 days in the dark at about 28 ℃.

[0307] The immature embryos that will produce embryonic callus are transferred to the LSD1M0.5S culture medium. On this culture medium, culture is continued the selection of about 6 weeks, in the time of about 3 weeks, carry out the subculture step. The callus that survives is transferred to the Reg1 culture medium that is supplemented with mannose. Then after (16 hours light / 8 hours dark scheme) cultivation in illumination, green tissue is transferred to the Reg2 culture medium that does not have growth regulator and hatches about 1 to 2 weeks. These plantlets are transferred to the Magenta GA-7 box (Magenta Corp, Chicago, Illinois) that contains the Reg3 culture medium and are grown in illumination. After about 2-3 week, the selected marker gene of plant and the existence of Bt cry gene by PCR test. The positive plant that measures from PCR is transferred to greenhouse and is used for further assessment.

[0308] In a leaf excision bioassay, transgenic plants were evaluated for copy number (determined by Taqman analysis), protein expression level (determined by ELISA), and efficacy against target insect species. Specifically, plant tissue (leaves or silks) was excised from single-copy events (V3-V4 stage) and infested with neonate larvae of the target pest and then incubated at room temperature for 5 days. Leaf discs from transgenic plants expressing BT204 (SEQ ID NO: 36), BT235 (SEQ ID NO: 37), BT645 (SEQ ID NO: 38), BT727 (SEQ ID NO: 39), BT1047 (SEQ ID NO: 40), BT1280 (SEQ ID NO: 41), BT1555 (SEQ ID NO: 42), BT1559 (SEQ ID NO: 43), BT1563 (SEQ ID NO: 44), BT1571 (SEQ ID NO: 45), or BT1633 (SEQ ID NO: 46), or mutant Cry proteins, mBT204 (SEQ ID NO: 47), mBT235 (SEQ ID NO: 48), mBT645 (SEQ ID NO: 49), mBT645-2 (SEQ ID NO: 50), mBT645-3 (SEQ ID NO: 51), or mBT645-4 (SEQ ID NO: 52). NO: 51), mBT727 (SEQ ID NO: 52), mBT1047 (SEQ ID NO: 53), mBT1280 (SEQ ID NO: 54), mBT1555 (SEQ ID NO: 55), mBT1559 (SEQ ID NO: 56), mBT1563 (SEQ ID NO: 57), mBT1571 (SEQ ID NO: 58) or mBT1633 (SEQ ID NO: 59). The results of the transgenic plant tissue bioassay will confirm that the Cry protein of the present invention is toxic to one or more of the target lepidopteran pests when expressed in the transgenic plant.

[0309] Example 7. Expression and activity of Cry proteins in soybean plants

[0310] Binary vectors for soybean transformation were constructed using a plant-expressible promoter operably linked to a soybean codon-optimized polynucleotide (SEQ ID NO: 26 or SEQ ID NO: 27) encoding a mutant BT645 (SEQ ID NO: 50 or SEQ ID NO: 51, respectively) operably linked to a terminator. For this example, the binary vector contained two expression cassettes, the first comprising the UBQ3 promoter operably linked to SEQ ID NO: 26 or SEQ ID NO: 27, which was operably linked to an AtUBQ3 terminator. The second expression cassette of each vector comprised the GmEF promoter operably linked to an NtALS coding sequence (serving as a selectable marker), which was operably linked to a GmEPSPS terminator. Binary vectors were constructed using a combination of methods well known to those skilled in the art, such as overlapping PCR, DNA synthesis, restriction fragment subcloning, and ligation.

[0311] Soybean plant material can be appropriately transformed and regenerated into fertile plants by various methods well known to those of ordinary skill in the art. For example, morphologically normal transgenic soybean plants with fertility can be obtained by: 1) producing somatic embryonic tissue from, for example, immature cotyledons, hypocotyls, or other suitable tissues; 2) transforming by particle bombardment or infection with Agrobacterium; and 3) regenerating plants. In one example, as described in U.S. Patent No. 5,024,944, cotyledonary tissue is excised from immature embryos of soybeans, the hypocotyls are optionally removed, and cultured in a hormone-containing culture medium to form somatic embryonic plant material. The material is transformed using, for example, direct DNA methods, DNA-coated microprojectile bombardment, or infection with Agrobacterium, cultured on a suitable selective culture medium, and optionally regenerated into fertile transgenic soybean plants in the continuous presence of a selection agent. The selection agent can be an antibiotic (e.g., kanamycin, hygromycin), or a herbicide (e.g., an HPPD inhibitor, phosphinothricin, or glyphosate), or alternatively, selection can be based on the expression of a visual marker gene (e.g., GUS). Target tissues for transformation include meristems, somatic embryonic tissues, and floral or flower-forming tissues. Other examples of soybean transformation include physical DNA delivery methods such as microprojectile bombardment (see, e.g., Finer and McMullen, In Vitro Cell Dev. Biol., 1991, 27P: 175-182; McCabe et al., Bio / technology, 1998, 6: 923-926), whiskering (Khalafalla et al., African J. of Biotechnology, 2006, 5: 1594-1599), aerosol beam injection (U.S. Pat. No. 7,001,754), or delivery methods mediated by Agrobacterium (Hinchee et al., Bio / Technology, 1988, 6: 915-922; U.S. Pat. No. 7,002,058; U.S. Patent Application Nos. 20040034889 and 20080229447; Paz et al., Plant Cell Transformation, 2006, 5: 1594-1599). Plant Cell Report, 2006, 25: 206-213).

[0312] Transgenic soybean plants were generated using the binary vector containing the mBT645-2 coding sequence or the mBT645-3 coding sequence of the present invention. The T0 plants were taken out of tissue culture and placed in a greenhouse. They were transplanted to a 2" square pot in a soil containing 1% granules at 5-10 g / gal. (Olympic Horticultural Products, Co., Mainland, Pennsylvania) mixed with water-saturated soil ( Plug and Seedling Mix (Sun GroHorticulture, Bellevue, WA, or Fafard Germinating Mix). The plants were covered with a humidity dome and placed in a Conviron room (Pembina, ND) with the following environmental conditions: 24°C daytime; 20°C nighttime; 16-23 hr light-1-8 hr dark photoperiod; 80% relative humidity.

[0313] After the plants have been established in the soil and new growth has emerged (about 1 to 2 weeks), the plants are sampled and stained using an appropriate probe for the Cry gene, or promoter (e.g., prUBQ3). The assay tests for the presence of the desired transgene. Positive plants are transplanted into 4" square pots filled with Fafard #3 soil. Sierra 17-6-12 slow release fertilizer is incorporated into the soil at the recommended rate. The plants are then relocated to a standard greenhouse to acclimate (approximately 1 week). Environmental conditions are: 27°C daytime and 21°C nighttime; 14 hour photoperiod (with supplemental light); ambient humidity. After acclimatization (approximately 1 week), the plants are sampled and tested in detail for the presence and copy number of the inserted transgene. The transgenic soybean plants are grown to maturity for T1 seed production. By The zygosity of the T1 plants was determined and homozygous plants were grown for seed production. The transgenic seeds and progeny plants were further evaluated for their tolerance to insect pest feeding damage and molecular characteristics.

[0314] For bioassays, transgenic soybean leaves expressing mBT645-2 (SEQ ID NO: 50) or mBT645-3 (SEQ ID NO: 51) proteins were tested against soybean looper, velvet bean caterpillar, and / or tobacco budworm. A negative isolate that did not express the BT645 protein served as a negative control. The results of the leaf bioassays showed that the mBT645 protein expressed in soybean leaves was toxic to the three insect pest species. Sequence Listing <110> Syngenta Paticipations AG SEGUIN, Katherine FLEMING, Christopher SESLER, Richard <120> Compositions and methods for controlling plant pests <130> 81318-WO-REG-ORG-P-1 <160> 66 <170> PatentIn version 3.5 <210> 1 <211> 2160 <212> DNA <213> Artificial sequence <220> <223> Assembled polynucleotides encoding BT204 <400> 1 atgaaactaa agaatccaga taagcatcaa agtttttcta gcaatgcgaa agtagataaa 60 atcgctacgg attcactaaa aaatgaaaca gatatagaat tgaaaaatat gaataatgaa 120 gattatttga gaatgtctga gcatgagagt attgatccgt ttgttagtgc atcaacaatt 180 caaacgggta ttggaattgc tggtaaaatc cttggtactc taggtgttcc ctttgctggg 240 caaatagcta gcctctatag ttttatccta ggcgagcttt ggccaaaggg gaaaagtcag 300 tgggaaatct ttatggaaca tgtagaagag cttattgcac aaaaaatatc aacttacgca 360 agaaacaaag cactcacaga tttaaaaggt ttaggagatg ctttggctgt ttaccatgag 420 tcacttgaaa gttggattaa aaatcgcaat aacacaaggg ctagaagtgt tgttaagagc 480 caatatatct ctctagaact tatgttgtt cagaagctgc cttcctttgc ggtatctgggg 540 gagaagttc ctctattacc atatacgcc caagctgcaa atctacactt gttgctatta 600 agagatgcat ctatttttgg aaagagtgg ggattatcat cttcagaat ttcacattt 660 tataaccgtc aagccgaaag aacgagtgac tattccgacc attgtgtgaa atggtatagt 720 acaggtctaa ataacttgag gggtaaaat gccgaaagct gggttcgcta taatcaattt 780 cgtaagata tgatattaat ggtactagat ttagtggcac tattcccaag ttatgataca 840 catatgtatc cattaaaac tacagcccaa cttactagag aagtatatac aaacgcaatt 900 gggacagtac atccgcatcc aagttttgca agtacgactt ggtataataa taatgcacct 960 tcgttttctg ccatagaggc tgccgttatc cgaagcccgc acctactcga tttctagaa 1020 caagttacaa tttacagctt attaagtcgg tggagtaca ctcagtatat gatatgtgg 1080 ggaggcata gacttgaatt ccgaacaata ggaggagcat taaataccctc aacacaagga 1140 tctactaata cttctattaa tcctgtaaca ttaccgttca cgtcacgaga cgtctatagg 1200 actgaatcat tggcagggct gatctattt ttactcaac ctgttaatgg agtacctagg 1260 gttgattttc attggaaatt cgtcacacat ccgatcgcat ctgataattt ctattatcca 1320 gggtatgctg gattgggac gcaattacaa gattcagaaa ctgaattacc acctgaaca 1380 acaggacagc caattatga atcatatagt catagatt ctcatatagg actcattca 1440 gcatcacatg tgaagcatt ggtatattct tggacgcatc gtagtgcaga tcgtacaaat 1500 acaattgagc aaatagcat acacaata ccattagtaa aagcattca tctccttca 1560 ggtgccgctg ttgttagagg accaggattt acaggtgggg atatccttcg agaacaat 1620 actggtacat ttggggatat acgagtaaat attaatccac cattgcaca aaggtatcgc 1680 gtaggattc gttatgcttc tactacagat gtacaatcc atacgtcaat taacggtaaa 1740 gctattaatc aagtaattt ttcagcaac atgatagag gagaggactt agactataa 1800 acctttagaa ctgtaggatt tactactcca tttagcttt cggatgtaca aagtacattc 1860 acaataggtg cttggaactt ctcttcaggt aacgaagttt atatagatag aattgaattt 1920 gttccggtag aagtaacata tgaggcagag catgattttg aaaaagcgca agaggaggtt 1980 actgcactgt ttacatctac gaatccaggt gggttaaaaa caaatgtaac ggagtatcat 2040 attgaccagg tatcaaattt agtagagtct ttatcaaatg aattctatct cgatgaaaag 2100 agagaattat tcgagatagt taaatacgcg aagcaactcc atattgggcg taacatgtag 2160 <210> 2 <211> 1878 <212> DNA <213> Artificial sequence <220> <223> Assembled polynucleotide encoding BT235 <400> 2 atgagaaatg cttcaaaaga ggtgaagata ttgagaacaa gacagtatga aaaagattct 60 gcgatggtat atgctatgga agatcaacct ctttcatttg gaggagtggt agagctttct 120 gggaaaatag gtttaggggt tgttaaaacg gtgatttctt ctattactcg acgtggtaga 180 gacgatgaaa ttgctggaag aatactatca gatgtttatg gcgtactttg gtcaaatcgt 240 aaagggtatt ggaatgaaat gatagaggct gtagagactt taattcgaca cgatattaat 300 gagaatgtaa aaaataacac cttagctgta ttaaccgata ttcgtaatgc tttactccta 360 tatcagcaag ctactgaagc ttggcaaaac aatcgaactg atccccaact tcaagaacga 420 atcagaaatc agtttattgc tacaaataca tttatagaat ttgctatgcc ttcgtttata 480 gtcccacatt atgaagtaat attactacct atattcgctc aagttgctaa ctttcattta 540 ttattattac gagatatcgc aatattcgga cttgaatgga ggatgagtaa agccgaaata 600 gatgattatt atttgcaaa cactggatta actggactta cctcaaaata caccagccat 660 tgtgtcaaat ggtattgtga aggtttatgt atagctacaa atgtagactt aggtcaatat 720 ccagaattt atcaacttga taaatggaat gcaatgaatg actttcgacg agaaatgacc 780 tttatggtt tagatattat tgcgttatgg ccaacgtatg atccgattag atatccacta 840 gggattaaaa cagagcttac aagagaagtc ttcaccccct tattaggaat aaacccgaat 900 agttcttggt tgatacacac tatggaagaa atagaggcta agctaacttt tttatctcct 960 ttcttgagtt ggatcagttt tgaacaatta gttaaacaag gtgatggtat atcaactttt 1020 acagattggg gaagttttac gctaagtaac acaatgctac cattaagcta cattctttggt 1080 ggggcgggat ctggaactgg tgagtctaca aacattcca taaaatcaga aaattatgat 1140 gtttataagg tgcttgttgg taccgatt agtcaccta gtaatgttcc aattcgaaag 1200 cttgaatact attgtacaa tggaactata gaaaatgtga ttactgctgg aacaggtaca 1260 actaatgccc ttttgaact tcctaataac ggatgtatag attatagtca ccgtgtatct 1320 agactttctt gttcgaacgt agaagtttat gatgggagg gggggcctaa gtatgcccta 1380 aaaatattg cttatggatg gacacatata agtgttgatt ctaaaaatac tttaagcgct 1440 aacgtaataa ctcaatttcc cgctaggaaa ggttactcat ctagtgagtc aaatccaagt 1500 atagcaggc cttattcac aggaggtgat ttgatagccc tacctaccta tggagctca 1560 ttgcaatgc gtgtgacccc tccagtatca tcctgcaca caattattg tgtacgactt 1620 cgttacgcaa gtagtggaaa tacgaata tatgtcgaaa gagtgcttcc ttctggtgat 1680 acttacggtg aactcatga tgtcccggct acatattatg gaggttcact atcatatagt 1740 tcctttgcat atgttgtaaa tttgacggcc atgttcgagg gggtcaatgt agaaataaaa 1800 atcaaaaata taggttcttc acaaatcatt cttgataaaa ttgaattcct tccaattaaa 1860 gaatcattga aagaatag 1878 <210> 3 <211> 2148 <212> DNA <213> Artificial sequence <220> <223> Assembled polynucleotide encoding BT645 <400> 3 atgaaactaa agaatcaaga taagcatcaa agttattcta gcaatgagaa ggtagataaa 60 atctctacaa ataaaacaga tatagaatta aaaaatatgg ataatgaaga ttatttgaga 120 gtgtctgagc acgagagcat taatccattt gttagtgcat caacaattca aacgggtatt 180 ggaattgctg gaaaaatcct tggtactcta ggtgttcctt ttgctggaca aatagcaagc 240 ctttatagtt ttatcttggg cgagctttgg cctaaaggga aaagccaatg ggaaatcttt 300 atggaacatg tagaagagat tattaatcaa aaaatatcaa cttatgcaag aaataaagca 360 cttacagact tgaaaggatt aggagatgct ttagctgtct accatgaatc gcttgaaagt 420 tgggttgaaa accgtaataa cacacgagcg aggagtgtag tcaagggcca atacatcgca 480 ttagaactga tgtttgttca gaaacttcct tctttgcag tatctggtga ggaagtacca 540 ttattaccga tatatgtaca agcggcaaat ttgcatttgt tgctattgag agatgcatct 600 atttttggaa aagaatgggg attgtcacct tcggaaattt caacttttta taaccgtcaa 660 gtcgatcgaa caagagatta ttccgaccat tgtgtaaaat ggtataatac aggcctaaat 720 aatttgagag gtacaaatgc cgaaagctgg gttcgttata atcaatttcg taaagatatg 780 acattaatgg tattagattt aattgcgcta ttcccaagct atgatacaat tgttatcct 840 attaaaacca cttcacaact tacaagagaa gtatatacag acgcaattgg gacagtacat 900 ccgcatgcaa gttttgcaag tacgacttg tataataata atgcaccttc gttctctgcc 960 atagaggctg ctgttatccg aagcccacac ctacttgatt ttctagaaaa agttacaatt 1020 tatagttat taagtcggtg gagtaatact cagtatatga atatgtgggg aggacataga 1080 cttgaatccc gcccaatagg aggggcatta aatatctcaa cacaaggatc taccaatact 1140 tctattaatc cagtacatt acagttcacg tctcgtgacg tctataggac agaatcatgg 1200 gcaggggctga attatttt aactcaacct gttaatggag tacctagagt tgatttccat 1260 tggaaatacc ccacacttcc atagcatct gataatttt attatctagg gtatgctgga 1320 gttgggacac attacaaga ttcagaaaat gatttaccac ctgaacac aggacagcca 1380 aattatgaat catatagtca tagattatct catataggac tcatttcagc atcccacgtg 1440 aaagcattag tatattcttg gacgcatagt agtgcaatc gtacaattac aattgaggca 1500 aacagcatta cacaatacc attagtaaa gcattcaatc ttccttcggg tgctactgtt 1560 gttagaggggc caggatttac aggaggat atccttcgaa gaacgaatac gggtacattt 1620 ggagatatac gagtaactat taatccgcca ttgcacaaa ggtatcgcgt aaggattcgt 1680 tatgcttcta spagattt acaatccat acatcatta atggaaggc tattaatca 1740 gggaattttt cagcaactat gataggaa actagaac ctttagaact 1800 gcgggattta cgactccatt tagctttca gatacacaa gtacattcac ataggtgct 1860 tggagcttct cttcaggtaa cgaagtttat atagatagaa ttgaatttgt tccggtagaa 1920 gtagcgcatg aggaaaatta tgattttgaa aaagtgcaag aggaggttac agcactgttt 1980 acacctacta atcctagagg attaaaaaca aatgtaacgg attatgatat tgaccaggta 2040 ttaaatctag tagagtctct atcagatgaa ttctacgtcg atgaaaagag agaattactc 2100 gaaattgtta aatatgcgaa gcaacttaat attgaccgta acatgtag 2148 <210> 4 <211> 1851 <212> DNA <213> Artificial Sequence <220> <223> Assembled polynucleotide encoding BT727 <400> 4 atgttgagaa caagacagta taaaaaaggt ccagagatgg tatacacggg gagggaacag 60 acccttccat ttgaagaagt ggtaaaaatt tctggtaaaa taggtctagg ggttgtaaaa 120 actgtgatta cttctatcat tcgatgtggt agagacaatg aaatagctgg aagaatacta 180 tcagatgttt acagcgtact ttggtcaact cctaaagggt attgggctga aatgatagag 240 gctgtagaga ctttaatcca acacgagatt agtgagaata tcagaaataa cgcctttgcg 300 gtattaaccg atgttcgtaa tgctttactc ctatatcagc aagctgctga agagtggcaa 360 agcaatcgaa ctgatcctca actacaagaa cgagtcagaa atcaatttat tgctacgaat 420 acacttatag aatttgctat gccttcgttt acagtcccac attatgaagt aatattacta 480 cctatattcg ctcaagctgc taaccttcat ttattattat tacgggatgt cgaaatattc 540 ggactcgaat ggggaatgag taagccgaa atagatgatt attattttgc aaactctgga 600 ttaactggac ttacacaaaa atacaccaac catagtgtca aatggtatcg tgaaggttta 660 tgtatagcta caaatataga cttaggtcaa tttccagaat tttatcaact tgataaatgg 720 aatgcaatga atgactttcg acgagaaatg acctttatgg ttttagatat tattgcgtta 780 tggccaacgt atgatccgat tagatatcca ctagggatta aaacagagct tacaagagaa 840 gtcttcaccc ccttattagg aataaaccct atagttctt ggttgataca cactatggaa 900 gaatagagg ctaagctaac ttttttatcc cctttcttaa gttggatcag ttttgaacaa 960 ttagttaaac aaggtgatgg tatagcaact tttacagatt ggggaaattt tacgctaagt 1020 aacacaatgc tgccattaag ttatattctt ggtggggcgg gctctgaac tggtgact 1080 acaaatattc caatgcaatc agaaattat gatgttatta aggtacatgt tggtaccgat 1140 tatagtcacc ctagtaatgt tccaattcga aagcttgaat actattgtac aaatggaacg 1200 atggaaaagg tgattactgt tggaacaggt agaactaatg cccttttga acttcctaat 1260 aacggctgtg tagattag tcaccgtata tctaggctgt cttgttcgaa cgtagaagtt 1320 tatgaatggg agggaggacc tatgaatgcc ctaaaaaata tgcttatgg atggacacat 1380 ataagtgtag actctaaaaa tacgttaagc gctaacgcaa taacccaat tcctgctagg 1440 aagggttacg catctagtgg gtcaatcta agtatagcag gtccttattt cacaggaggc 1500 gatttgatag tcctacctcc taatggagct cattgcaaa tacgagtgac ccctccagta 1560 tcatccaaat caaaaaata ttgtgtgaga ttcgttatg caagtagtgg gatacgaat 1620 atatatttcg aaagagtgct ttctctggt gatacttaca gtgaactca tgatgtcccg 1680 gccacatatc ctggaggtgc actatcttat agttccttg catatgttgt aaatttgacg 1740 gctatattcg agggattcaa tgtagaaata aaaatcaaaa atataggttc ttcgcaaatc 1800 attcttgata aaatcgaatt ccttccaatc aaagaatcat tgaaagaata g 1851 <210> 5 <211> 2277 <212> DNA <213> Artificial sequence <220> <223> Assembled polynucleotides encoding BT1047 <400> 5 atgaatctat gcttttatct aaatataaaa aatgctttat cttacactat attctggaaa 60 tgtttatttg aacaagattt tatcagaaaa ttgaaactaa ttataaatgg agtgattaat 120 atgaaaccaa aaaatcaaaa taagtgtcag agctttata gcaatgggac atttgatatg 180 gactctaaag cttcattaaa aaatgacaag aatatggaat tacaaagtat tactcatgaa 240 gattgtttga ggatgtctga gcatgaaagt atagagccgc ttgttagcgc gtcagtaatt 300 caaaatggga ttggaattgc tggtaaaatc cttggtacct taggtgttcc ttttgctgga 360 caaatagcta gtctctatag ttttatctta ggcgagcttt ggcctaaggg gaaaagtcaa 420 tgggagatct ttatggaaca tgtagaagaa cttattgacc aaaaaatatc aatttacgca 480 agaaataaag cactcacaga gttaaaagga ttaggagatg ctttggctgt ctaccatgaa 540 tcgcttgaaa gttggattga aaatcgtaat aatacaagag caagaagtgt tgtcaaaagc 600 caatacatta ctttggaact gatgttcgtt caggggctac cttcctttgc agtgtctggg 660 gaagaagttc tactattacc aatatatgcc caagctgcaa atctacactt gttgctatta 720 agagatgcgt ctatttttgg agaagagtgg ggattatcag cttcagaaat ttcaacattt 780 tataatcgac aagtcgagag agtgaatgat tatactgact attgtgtaaa attctataat 840 acaggtctaa attcgtcgag gggtacagat gcgaagagct gggctagtta taatcaattt 900 cgtaaagata tgacattaat ggtactagat ttagtcgcac tatttccaag ctatgataca 960 catgtatatc caattaaaac caattcccaa cttacaagag acgtatatatc agatgcaatt 1020 gggacagtac atccaaatcc aagttttgca agtacgactt ggtataataa taatgcacct 1080 gcgttcttg ctatagaggc cgctgttatc cgaagcccac atctacttga ttttttagaa 1140 gaagttacaa tttacagtgc attaagccga tggagtaaca ctcagtatat gaatatatgg 1200 tcaggtcata gtcttaaatt ccgaacaata ggaggaggat tgaataccctc aacccaagga 1260 tctaccaata gtactattag tcctgtaaca ttcagttc cagcccgaga cgtttataga 1320 acagaatcat tggccggtt gatatattt ctaactcaac ctgtaaatgg ggtaccttcg 1380 gttagcttcc attggatact tcctggaatt gaggtgggga attctattac ctataaccct 1440 gggtatgttg gagttgggac gcaattacaa gattcagaaa ctgaattacc accgaaacg 1500 acagaacggc caatttaga atcttacagt catagat ctcacatagg actattaca 1560 gcatcccatg tagagcatt agtatattct tggacgcatc gtagtgcaga acgtacaaat 1620 acaattgagc aaatagaat tacacaatc ccattagtaa aagcattgaa tctctattca 1680 ggtaccactg ttgtcaagg accaggggttt acaggtgggg atattctcg tagactaat 1740 acgggtatat ttggagat acgagtaaat atactgcac cattatcaca agatataga 1800 gtaagggttc gttatgcttc tactacagat ttagaatttt acacgagtgt taatggaacc 1860 actattaata tgggtaattt ctcgaaaact atggatagcg ggaataattt agaatttagt 1920 agttttaaga ctacaggatt tagtacgcct tttagttttt caaatgcgca aagtacattc 1980 acattaggta ctatggattt ttcaaatcag gaagtttata tagatagaat tgaatttttt 2040 ccggtagagg taacatatga ggaagagtgt gattttgaaa aagcgcaaga ggcggttact 2100 gcactgttta cacctaagaa tccaaaaggg ttaagaatga atgtaacgga ttatcatatt 2160 gaccaggtat caaatttagt agagggtcta tcggatgaat catatctcga tgaaaagaga 2220 gaattatttg agaaagtcga atacgcgaag caactcaata ttgagcgtaa catttag 2277 <210> 6 <211> 2205 <212> DNA <213> Artificial Sequence <220> <223> Assembled polynucleotide encoding BT1280 <400> 6 atgaaactaa agaatcaaga taagcatcaa agtttttcta gcaatgcgaa agtagataaa 60 atctctacgg attcactaaa aaatgaaaca gatatagaat tacaaaacat taatcatgaa 120 gattgtttga aaatgtctga gtatgaaaat gtagagccgt ttgttagtgc atcaacaatt 180 caaacaggta ttggtattgc gggtaaaata cttggtaccc taggcgttcc ttttgcagga 240 caagtagcta gtctttatag ttttatctta ggtgagctat ggcctaaggg gaaaaatcaa tgggaaatct ttatggaaca tgtagaagag attattaatc aaaaaatatc aacttatgca agaaataag cacttacaga cttgaaagga ttaggagatg ccttagctgt ctaccatgat tcgcttgaaa gttgggttgg aaatcgtaat aacacaaggg ctaggagtgt tgtcaagagc caatatatcg cattagaatt gatgttcgtt cagaaactac cttcttttgc agtgtctgga gaggaggtac cattattacc gatatatgcc caagctgcaa atttacattt gttgctatta aagagatgcat ctattttgg aaaagagtgg ggattatcat cttcagaaat ttcaacattt fathercgtc aagtcgacg agcaggagat fathercgtc attgtgtga atggtatagc acaggtctaa ataacttgag gggtacaaat gccgaaagtt gggtacgata taatcaattc cgtagagaca tgactttaat ggtactagat ttagtggcac tatttccaag ctatgataca 900. 900. 900. 900. 900. 900. 900. 900. 900. 900. 900. 900. 900. 900 gggacagtac atccgcatcc aagttttaca agtacgactt ggtataataa taatgcacct tcgttctctg ccatagaggc tgctgttgtt cgaaacccgc atctactcga tttctagaa 1020 caagttacaa tttacagctt attaagtcga tggagtaca ctcagtatat gatatgtgg 1080 ggaggacata aactagaatt ccgaacaata ggaggaacgt tataatctc aacachaagga 1140 tctactaata cttctattaa tcctgtaaca ttaccgttca ctagccgaga cgtctatagg 1200 actgaatcat tggcagggct gatctattt ttactcaac ctgttaatgg agtacctagg 1260 gttgattttc attggaaatt cgtcacacat ccgatcgcat ctgataattt ctattatcca 1320 gggtatgctg gattgggac gcaattacag gattcagaaa atgattacc acctgaagca 1380 acaggacagc caattatga atcttatagt catagattat ctcatatagg actcattca 1440 gcatcacatg tgaagcatt ggtatattct tggacgcatc gtagtgcaga tcgtacaaat 1500 acaatgagc aaatagcat acacaata ccattagtaa aagcgttca tctgtcttca 1560 ggtgccgctg tagtgagagg accaggattt acaggtgggg atatccttcg aagaaagaat 1620 actggtacat ttggggatat acgagtaaat attaatccac cattgcaca aagatatcgc 1680 gtgaggattc gctatgcttc taccacagat ttacaattcc atacgtcaat taacggtaaa 1740 gctattaatc aaggtaattt ttcagcaact atgaatagag gagaggactt agactataaa 1800 acctttagaa ctgtaggctt taccacccca tttagctttt ctaacggtaa agctattaat 1860 caaggtaatt tttcagcaac tatgaataga ggagaggact tagactataa aacctttaga 1920 actgtaggct ttaccactcc atttagcttt ttagatgtac aaagtacatt cacaataggt 1980 gcttggaact tctcttcagg taacgaagtt tatatagata gaattgaatt tgttccggta 2040 gaagtaacat atgaggcaga atatgatttt gaaaaagcgc aagagaaggt tactgcactg 2100 tttacatcta cgaatccaag aggattaaaa acagatgtaa aggattatca tattgaccag 2160 gtatcaaatt tagtagagtc tctatcagat gttctcttca ggtaa 2205 <210> 7 <211> 2040 <212> DNA <213> Artificial Sequence <220> <223> Assembled polynucleotide encoding BT1555 <400> 7 atggatctat caccagatgc tcgcattgag gatagcttgt gtgtagccga ggggaacaat 60 attgatccat ttgttagcgc atcaacagtc caaacaggta ttagtatagc tggtagaata 120 ttaggcgtat taggggtgcc gtttgccgga caactagcta gtttttatag ttttcttgtt 180 ggggaattat ggcctagcgg cagagatcca tgggaaattt tttggaaca tgtcgaacaa 240 attgtaagac aacaaataac ggacagtgtt agggataccg ctattgctcg tttagaaggt 300 ctaggaagag ggtatagatc ttaccagcag gctcttgaaa cttggttaga taaccgaaat 360 gatgcaagat caagaagcat tattcgtgag agatatattg ctttagaact tgacattact 420 actgctatac cgcttttcag catacgaaat caagaggttc cattattaat ggtatatgct 480 caagctgcaa attacacct attattatta agagatgcat ctatttttgg aaaagaatgg 540 ggattatcag cttcagaaat ttcaacattt tataaccgtc aagtcgaacg aacaagagat 600 tattccgacc attgtgtaaa atggtataat acaggcctaa ataacttgag gggtacaaat 660 gccaaaagtt gggttcgtta taatcaattt cgtaaagata tgacattaat ggtattagat 720 ttagttgcgc tattcccaag ctatgataca cttgtatatc ctattaaaac cacttcacaa 780 cttacaagag aagtatatac agacgcaatt gggaccgtgc atccgaatca agcttttgca 840 agtacgactt gtataataa taatgcacct tcgttctcta cgatagaggc tgctgttgtt 900 cgaaacccgc atctactcga tttctgaa caagttacaa tttacagctt attaagtcga 960 tggagtaca ctcagtatat gatatgtgg ggaggacata actagaatt ccgaacaata 1020 ggaggaacgt taaataccctc aacacaagga tctaata cttctattaa tcctgtaaca 1080 ttaccgttca cgagtcgaga cgtctatagg actgaatcat tggcaggct aaatctattt 1140 ttactcaac ctgttaatgg agtacctagg gttgattttc attggaaatt cgtcacacat 1200 ccgatcgcat ctgataattt ctattatcca gggtatgctg gattgggac gcaattacag 1260 gattcagaaa atgaattacc acctgaaaca acaggacagc caattatga atcatatagt 1320 catagattat cccatatagg actcatttca gcatcccatg tgaaagcgtt ggtatattct 1380 tggacgcatc gtagtgcaga tcgtacaat acaatgagc caatagcaat tacacaata 1440 ccattagtaa aagcattcaa tctccttca gtgccgctg tgttagagg accaggattt 1500 acaggtgggg atatccttca aagaacgaat acgggtacat ttggggatat acgagtaaat 1560 attaatccac catttgcaca acggtatcgc gtaaggattc gttatgcttc tactacaaat 1620 gtagaattcc atacgtcaat taacggtaaa gctattaatc aaggtaattt ttcagcaact 1680 atgaatagag gagaggactt agactataaa acctttagaa ctgtaggatt tactactcca 1740 tttagccttt cggatgtaca aagtacattc acaataggtg cttggaactt ctcttcaggt 1800 aacgaagttt atatagatag aattgaattt gttccggtag aagtaacata tgaggcagag 1860 tatgatttaa aaaaagcaca agatgagatt actgcaatgt ttacatctac gaatccaggt 1920 gggttaaaaa caaatgtaac ggagtatcat attgaccagg tatcaaattt agtagagtct 1980 ctatcggatg aattctacct cgatgaaaag agagaattat tcgagatagt taaatactag 2040 <210> 8 <211> 2040 <212> DNA <213> Artificial Sequence <220> <223> Assembled polynucleotide encoding BT1559 <400> 8 atgaatctat caaccgatgc tcgtattgag gatagcttgt gtatagccga ggggaacaat 60 atcgatccat ttgttagcgc atcaacagtc caaacgggta ttaacatagc tggtagaata ctaggtgtat tagcgtacc gtttgctgga caaatagcta gtttttag ttttcttgtt ggtgaattat ggccccgcgg cagagatcct tgggaattt tcctagaaca tgtcgaacaa cttataagac aacaagtaac agaaaatact agggatacgg ctcttgctcg attack ttaggaatt cctttagagc ctatcaacag tcacttgag attggctaga aaaccgtgat 420. gatgcaagaa cgagaagtgt tctttatacc caatatatag ccttagaact tgattttctt aatgcgatgc cgcttttcgc aattagaaac caagaagttc cats ggtatatgct caagctgcaa atttacacct attattattg agagatgcct ctctttttgg tagtgaattt gggcttacat cccaagaaat tcaacgttat tatgagcgcc aagtggaaaa aacgagagaa tattctgatt attgcgcaag atggtataat acgggtttaa aatttgag agggacaaat gctgaaagtt ggttgcgata taatcaattc cgtagagact taacgctagg agtattagat ctagtggcac tattcccaag ctagtgacacg cgtgtttatc caatgaatac cagtgctcaa ttaacagag aaatttatac agatccaatt gggagaacaa atgcaccttc aggatttgca 840 agtacgaatt ggtttaataa taatgcacca tcgttttctg ccatagaggc tgccgttatc 900 cgaagcccgc acctactcga tttctgaa caagttacaa tttacagctt attaagtcga 960 tggagtaca ctcagtatat gatatgtgg ggaggacata actagaatt ccgaacaata 1020 ggaggaacgt taaataccctc aacacaagga tctaata cttctattaa tcctgtaaca 1080 ttaccgttca cgagccgaga catctatagg actgaatcat tggcaggct gatctattt 1140 ttactcaac ctgttaatgg agtacctagg gttgattttc attggaaatt cgtcacacat 1200 ccgatcgcat ctgataattt ctattatcca gggtatgctg gattgggac gcaattacag 1260 gattcagaaa atgaattacc acctgaaaca acaggacagc caattatga atcttatagt 1320 catagattat ctcatatagg actcattca gcatcacatg tgaaagcatt ggtatattct 1380 tggacgcatc gtagtgcaga tcgtacgaat acaatcatt cagatat aacacaata 1440 ccactggtaa aagcacatac ccttcagtca ggtactactg ttgtaaagg gccaggtttt 1500 acaggtggag atatcctccg acgaactagt ggaggaccat ttgcttttag taatgttaat 1560 ttagactgga acttgtcaca aagatatcgt gctagaatac gctatgcttc tactactaat 1620 ctaagaatgt acgtaacgat tgcaggggaa cgaatttttg ctggtcaatt taataaaaca 1680 atgaatactg gtgatccatt aacattccaa tcttttagtt acgcaactat tgatacagca 1740 tttacattcc caacgaaagc gagcagcttg actgtaggtg ctgatacttt tagctcaggt 1800 aatgaagttt atgtagatag atttgaattg atcccagtta ctgcaacact tgaggcagta 1860 actgatttag aaagagcgca gaaggcggtt catgaactgt ttacatctac gaatccggga 1920 ggattaaaaa cggatgtaaa ggattatcat attgaccagg tatcaaattt agtagagtct 1980 ctatcagatg aattctatct tgatgaaaag agagaattat tcgagatagt taaatactag 2040 <210> 9 <211> 2040 <212> DNA <213> Artificial Sequence <220> <223> Assembled polynucleotide encoding BT1563 <400> 9 atgaatctat caaccgatgc tcgtattgag gatagcttgt gtatagccga ggggaacaat 60 atcgatccat ttgttagcgc atcaacagtc caaacgggta ttaacatagc tggtagaata ctaggtgtat tagcgtacc gtttgctgga caaatagcta gtttttag ttttcttgtt ggtgaattat ggccccgcgg cagagatcct tgggaattt tcctagaaca tgtcgaacaa cttataagac aacaagtaac agaaaatact agggatacgg ctcttgctcg attack ttaggaatt cctttagagc ctatcaacag tcacttgag attggctaga aaaccgtgat 420. gatgcaagaa cgagaagtgt tctttatacc caatatatag ccttagaact tgattttctt aatgcgatgc cgcttttcgc aattagaaac caagaagttc cats ggtatatgct caagctgcaa atttacacct attattattg agagatgcct ctctttttgg tagtgaattt gggcttacat cccaagaaat tcaacgttat tatgagcgcc aagtggaaaa aacgagagaa tattctgatt attgcgcaag atggtataat acgggtttaa aatttgag agggacaaat gctgaaagtt ggttgcgata taatcaattc cgtagagaca tgactttaat ggtactagat ttagtggcac tatttccaag ctatgatacg cgtgtttatc caatgaatac cagtgctcaa ttaacagag aaatttatac agatccaatt gggagaacaa atgcaccttc aggatttgca 840 agtacgaatt ggttaataa taatgcacct tcgttctctg ccatagaggc tgctgttgtt 900 cgaaacccgc atctactcga tttctgaa caagttacaa tttacagctt attaagtcga 960 tggagtaca ctcagtatat gatatgtgg ggaggacata actagaatt ccgaacaata 1020 ggaggaacgt taaataccctc aacacaagga tctaata cttctattaa tcctgtaaca 1080 ttaccgttca cttcacgaga cgtctatagg actgaatcat tggcaggct gatctattt 1140 ttactcaac ctgttaatgg agtacctagg gttgattttc attggaaatt cgtcacacat 1200 ccgatcgcat ctgataattt ctattatcca gggtatgctg gattgggac gcaattacag 1260 gattcagaaa atgaattacc acctgaagca acaggacagc caattatga atcttatagt 1320 catagattat ctcatatagg actcattca gcatcacatg tgaaagcatt ggtatattct 1380 tggacgcatc gtagtgcaga tcgtacaat acaatgagc caatagcaat tacacaata 1440 ccattagtaa aagctttcaa tctgtctca gtgccgctg tagtgagagg accaggattt 1500 acaggtgggg atatccttcg aagaacgaat actggtacat ttggggatat acgagtaaat 1560 attaatccac catttgcaca aagatatcgc gtgaggattc gctatgcttc taccacagat 1620 ttacaattcc atacgtcaat taacggtaaa gctattaatc aaggtaattt ttcagcaact 1680 atgaatagag gagaggactt agactataaa acctttagaa ctgtaggctt taccacccca 1740 tttagctttt cagatgtaca aagtacattc acaataggtg cttggaactt ctcttcaggt 1800 aacgaagttt atatagatag aattgaattt gttccggtag aagtaacata tgaggcagaa 1860 tatgattttg aaaaagcgca agagaaggtt actgcactgt ttacatctac gaatccaaga 1920 ggattaaaaa cagatgtaaa ggattatcat attgaccagg tatcaaattt agtagagtct 1980 ctatcagatg aattctatct tgatgaaaag agagaattat tcgagatagt taaatactag 2040 <210> 10 <211> 2118 <212> DNA <213> Artificial Sequence <220> <223> Assembled polynucleotide encoding BT1571 <400> 10 atgacttcaa ataggaaaaa tgagaatgaa attataaatg ccttatcgat tccagctgta 60 tcgaatcatt ccgcacaaat ggatctatcg ctagatgctc gtattgagga ttctttgtgt 120 atagccgagg ggaataatat caatccactt gttagcgcat caacagtcca aacgggtata 180 aacatagctg gtagaatatt gggcgtatta ggtgtgccgt ttgctggaca actagctagt 240 ttttatagtt ttcttgttgg ggaattatgg cctagtggca gagatccatg ggaaattttc 300 ctggaacatg tagaacaact tataagacaa caagtaacag aaataactag gaatacggct 360 attgctcgat tagaaggtct aggaagaggc tatagatctt accagcaggc tcttgaaact 420 tggttagata accgaaatga tgcaagatca agaagcatta ttcttgagcg ctatgttgct 480 ttagaacttg acattactac tgctataccg cttttcagaa tacgaaatga agaagttcca 540 ttattaatgg tatatgctca agctgcaaat ttacacctat tattattgag agacgcatcc 600 ctttttggta gtgaatgggg gatggcatct tccgatgtta accaatatta ccaagaacaa 660 atcagatata cagaggaata ttctaaccat tgcgtacaat ggtataatac agggctaaat 720 aacttaagag ggacaaatgc tgaaagttgg ttgcggtata atcaattccg tagagaccta 780 acgttagggg tattagatt agtagcccta ttcccaagct atgatactcg cacttatcca 840 atcaatacga gtgctcagtt aacaagagaa attackacag atccaattgg gagacaaat 900 gcaccttcag gatttgcaag tacgaatttgg tttaatata atgcaccatc gttctctgcc 960 atagagtctg ctgttgttcg aaacccgcat ctactcgatt ttttagaca agttacaatt 1020 tacagcttat tagtaggtg gagtaacact tagtatatga atatgtgggg aggacataga 1080 ctggaatttcc gaacaatagg tggagtgtta ataccca cacaagggtc tactaatact 1140 tctattaatc ctgtaacatt accgttcacg tcgcgagacg tctataggac tgaatcattg 1200 gcaggggctga atcttattt aactcaacct gttaatggag tacctaggtt tgatttcat 1260 tggaaattcg ccacacttcc gattgcatct gatattttt attatctagg gtatgctgga 1320 gttggtacgc attacaaga ttcagaaat gatttaccac ctgaacaac aggacagcca 1380 aattatgaat catatagtca tagattatcc catataggac tcatttcagc atcccacgtg 1440 aaagcattgg tatattcttg gandacatcgt agtgcagatc gtacaaatac aattgagcca 1500 aatagcatta cacaaatacc attagtaaaa gcgttcaatc tgtcttcagg tgccgctgta 1560 gtgagaggac caggatttac aggtggggat atccttcgaa gaacgaatac tggtacattt 1620 ggggatatac gagtaaatat taatccacca tttgcacaaa gatatcgcgt gaggattcgc 1680 tatgcttcta ctacagattt acaattccat acgtcaatta acggtaaagc tattaatcaa 1740 ggtaattttt cagcaactat gaatagagga gaggacttag actataaaac ctttagaact 1800 gtaggcttta ccactccatt tagcttttca gatgtacaaa gtacattcac aataggtgct 1860 tggaacttct cttcaggtaa cgaagtttat atagatcgaa ttgaatttgt tccggtagaa 1920 gtaacatatg aggcagaata tgattttgaa aaagcgcaag agaaggttac tgcactgttt 1980 acatctacga atccaagagg attaaaaaca gatgtaaagg attatcatat tgaccaggta 2040 tcaaatttag tagagtctct atcagatgaa ttctatcttg atgaaaagag agaattattc 2100 gagatagtta aatactag 2118 <210> 11 <211> 2121 <212> DNA <213> Artificial Sequence <220> <223> Assembled polynucleotide encoding BT1633 <400> 11 atgaaactaa agaatcaaaa tatgcatcaa agcttgtcta gcaatgcgac agttgataaa 60 agctttacag attcactaga acataacaca aatatggaat tacaaaactc taatcatgaa 120 gattgtttga aaatgtctga gtatgagagt attgagccgt ttgttagtgc atcaacaatt 180 caaacgggta ttggaattgc tggtaagatt cttggtactc taggtgttcc ttttgctgga 240 caaatagcta gcctctatag ttttatctta ggcgagcttt ggcctaaagg gaaaagtcaa 300 tgggaaatct ttatggaaca tgtagaagag cttattaatc aaaaaatatc aacttatgca 360 agaaataaag cacttgcaga tttaaaagga ttaggagatg ctttagctgt ctaccatgaa 420 tctcttgaaa gttggattga aaatcgtaat aacacaagag ctaggagtgt tgtcaagaac 480 caatatatcg cattagaact gatgtttgtt caaaaacttc cttcctttgc agtttctgga 540 gaagaggtgc cgctattacc aatctatgca caagctgcaa atttacactt gctgttatta 600 agagatgcgt ctatttttgg aaaagaatgg ggattgtcag aatcagagat ttcaacattt 660 tataaccgtc aagtcgaacg aacaagagat tattccgacc attgtgtaaa atggtataat 720 acaggtctaa atcgcttgag gggtacaaat gccaaagtt gggttcgtta taatcaattt 780 cgtaagata tgacattaat ggtattagat ttagttgcgc tattcccaag ctatgataca 840 cttgtatatc ctattaaaac cacttcacaa cttacaagag aagtatatac agacgcaatt 900 gggaccgtgc atccgaatca agctttgca agtacgactt ggtataataa taatgcacct 960 tcgttctctg ccatagaggc tgctgttatc cgaagtccac acctacttga tttctagaa 1020 aaagttacaa tttacagctt attaagtcgg tggagtaata ctcagtatat gatatgtgg 1080 ggaggacata aactagaatt ccgaacaata ggaggaacgt taaataccctc aacachaagga 1140 tctactaata cttctattaa tcctgtaaca ttaccgttca cgagtcgaga cgtctatagg 1200 actgaatcat tggcaggct aaatctattt tattactcac ctgttaatgg agtacctagg 1260 gttgattttc attggaaatt cgtcacacat ccgatcgcat ctgataattt ctattatcca 1320 gggtatgctg gattgggac gcaattacag gattcagaaa atgattacc acctgaaca 1380 acaggacagc caattatga atcttatagt catagactat ctcatatagg actcattca 1440 gcatcccacg tgaagcatt ggtatattct tggacacatc gtagtgcaga tcgtacaaat 1500 acaattgagc aaatagcat acacaata ccattagtaa aagcattca tctccttca 1560 ggtgccgctg ttgttagagg accaggtttt acaggtggtg atatccttcg agaacgaat 1620 actggcacat ttgcagatat gagagtaaat attactgggc cattatccca aagatatcgt 1680 gtaagaatttc gctatgcttc tactactgat ttacaattt tcacgaatt taatggaact 1740 accattaata tgggtaattt cccaaaaacc gtgaataatt cgagttctga aggctataga 1800 actgtatcat ttagtactcc atttagctt tcaatgcac aaagtatatt tattaggt 1860 atacaagctt tttctggatt cacgttgatt gattgaatt tgtcccggca 1920 gaggtaacat ttgaggcaga gtatgattta gaaagggcgc aaaggcggt aaatgcacta 1980 tttacatcta caatccaa agatatgaa acatgtga cagaatctca gattgaccaa 2040 gtgttcaatc tagtagagtg cttatcggac gaggtctgtc tcgatgagaa gagagaatta 2100 ttcaagaaag taaaatacta g 2121 <210> 12 <211> 2157 <212> DNA <213> Artificial sequence <220> <223> Zea mays codon-optimized BT204 coding sequence <400> 12 atgaagctca agaaccccga taagcatcag agcttcagca gcaatgccaa agtcgataaa 60 attgccaccg atagccttaa gaatgagacg gatatcgaac tcaaaaatat gaataacgaa 120 gattaccttc ggatgtcgga gcatgagagc atagatccgt ttgtctctgc atctacaatt 180 cagacgggaa ttggtatcgc tggaaaaatc ttgggcaccc ttggagtgcc cttcgctggg 240 cagatcgctt cgctttactc gttcatattg ggagaactgt ggccaaaggg taagtcccaa 300 tgggaaatct ttatggaaca tgtcgaagag ttgattgccc aaaagatctc aacatatgct 360 cgcaataaag cactcacgga tctcaagggt cttggtgacg ctttggcagt ttaccatgaa 420 tctcttgagt cttggattaa aaatcgcaac aatactaggg ctcggtcggt cgtcaagtcc 480 caatacatca gcttggagct gatgtttgtc cagaaactcc cgtcgtttgc tgtctcggga 540 gaagaggttc ctctgttgcc catatatgca caggctgcta acctgcacct ccttcttttg 600 cgcgacgcat ccatctttgg gaaagaatgg gggctgtctt cttctgagat cagcacgttt 660 tataaccggc aagccgaaag gacatccgac tactcggatc actgtgtcaa atggtattcc 720 acgggtctga ataacctcag gggcaaaaat gcggaaagct gggtgaggta taatcaattc 780 agaaaagata tgattcttat ggtcttggat cttgtggcgc tgtttccttc ctatgacaca 840 catgtatc cgatcaagac taccgcacaa ctgactaggg aggtgtatac taacgcgata 900 ggcacggtcc acccgcaccc ctccttcgcg tccacaactt ggtataacaa taatgcccct 960 tcgttctcag ccatagaagc cgccgttatt cgctcgccac acttgctgga ctttctggaa 1020 caagtcacaa tttatagcct gctgtcacgc tggtcgaaca cgcaatatat gaacatgtgg 1080 ggagggcacc ggctggagtt caggaccatt ggtggagctc tgaacactag cacgcaaggt 1140 tcaaccaaca ctagcatcaa tcctgtcaca ctccccgttta catcccgga cgtgtaccgc 1200 acagagtcct tggctgggct caacctcttc cttacgcaac ctgtcaatgg cgttccaaga 1260 gtggattttc actggaagtt cgttacccac ccaatcgcct ccgataattt ttactatcct 1320 ggctatgctg gaatcggcac tcaactccag gattctgaaa ctgagctccc acctgaaacc 1380 accgggcaac ctaactatga gtcttactca catcggttga gccatattgg acttatatcg 1440 gcatctcacg ttaaagcact ggtctatagc tggacccata gatcggctga tcggacaaat 1500 acaatcgaac ccaactcgat aactcaaata ccacttgtga aagcgtttaa cttgcctagc 1560 ggtgcagctg ttgtgagagg accgggtttc actgggggag acatccttag acggacaaac 1620 accgggactt tcggagatat acgggtcaac attaatcccc ccttcgccca gagatacagg 1680 gttcggatca gatacgcctc gacaacagat gtccagttcc atacaagcat caacggaaaa 1740 gcaatcaatc aggggaattt ttccgccacc atgaaccgcg gtgaggatct ggattacaaa 1800 acattcagaa ctgtcgggtt tacaactcct ttttccttct cggacgttca gtcgacgttc 1860 acgataggtg cttggaattt ctcttcaggg aatgaggtgt atatagatcg catagaattc 1920 gtgcctgtcg aggtgaccta tgaggcggag catgactttg aaaaagccca agaggaggtt 1980 accgccctgt tcacatctac aaacccgggt gggctgaaga ccaacgtcac cgagtatcac 2040 atagatcagg tctcgaattt ggtcgagtct ctgtccaatg aattctattt ggacgagaaa 2100 cgcgaactgt ttgaaattgt gaagtacgcc aagcagcttc atatcggtag aaatatg 2157 <210> 13 <211> 1875 <212> DNA <213> Artificial Sequence <220> <223> Maize-codon-optimized BT235 coding sequence <400> 13 atgagaaacg cttcaaaaga agtgaaaatt ctgcgcactc ggcaatatga gaaagacagc 60 gcgatggtgt acgcgatgga ggatcaacct ctctcattcg gtggtgtggt ggagctgtct 120 ggcaaaatcg ggctgggtgt ggtgaaaacg gttatatctt caataacccg gagagggagg 180 gatgacgaga tagccgggag aatcttgtca gacgtgtacg gtgtgctttg gtcaaacaga 240 aaaggctatt ggaacgaaat gattgaagct gtcgaaacac tgataagaca tgacatcaat 300 gaaaacgtca agaataatac gttggctgtg ctgacagaca ttcggaatgc tctccttctt 360 taccagcagg cgaccgaagc ctggcaaaac aatagaactg acccgcagct tcaggaaagg 420 atcaggaacc aattcattgc cacgaacacc ttcattgaat ttgctatgcc ttccttcatc 480 gttccgcact acgaggtgat tttgctcccg atattcgctc aagtcgcaaa ctttcatctt 540 cttcttttga gagacattgc catatttgga cttgaatggc ggatgtcgaa ggcagagatc 600 gacgactact acttcgcaaa taccgggctt acagggctca cgtctaagta cacgtcgcat 660 tgcgtcaagt ggtactgcga aggactgtgc atagctacca atgtcgacct cggtcagtac 720 ccagagtttt accaactcga caaatggaac gctatgaatg atttcagaag agaaatgacc 780 tttatggttt tggatattat cgctctgtgg cctacatatg accccataag ataccctctg 840 ggaatcaaaa ccgaattgac tcgggaggtc tttacacctc tccttgggat taatccgaac 900 agctcatggt tgatccatac catggaagag atagaagcta aactcacatt ccttagcccg 960 tttcttagct ggatttcgtt tgagcaactc gtcaagcaag gggatggcat ctccacattt 1020 acagactggg gatcatttac cttgtccaat accatgctcc cgctttcata catcctgggc 1080 ggagctggtt caggcacggg cgagtccacg aacatcccca ttaagtctga aaactatgac 1140 gtttacaagg ttctggttgg cactgattat tcacaccctt caaatgtgcc cataagaaag 1200 cttgaatatt attgcaccaa tggaacaatc gaaaacgtca tcacggcagg cactggtacg 1260 acgaacgctc tgtttgagct gcctaacaac ggttgtattg actactccca ccgggtctcg 1320 agactgtcgt gttccaatgt cgaagtctac gaatgggagg gtggaccgaa gtatgccttg 1380 aaaaatattg catatggatg gacccatatt tcagtcgact caaaaaacac tctgtccgcc 1440 aatgtcatta cgcagatacc cgcacgcaag ggttactctt cttcggaatc aaacccgtcc 1500 atagctggac cgtacttcac aggtggcgat cttatcgcat tgccgccaaa cggcgctcaa 1560 ctccaaatgc gggtcactcc tccagtttca tcatgtacaa caaactactg tgtcaggttg 1620 agatatgctt catctgggaa tactaacatt tacgtcgaga gggtcctgcc gagcggggat 1680 acgtacggag agacccacga cgttcccgcc acttattatg gaggctcact gtcatacagc 1740 tccttcgcct acgtggtgaa cttgacggcc atgttcgagg gggtcaacgt tgagataaag 1800 atcaaaaata ttggatcatc acaaatcatc ttggacaaga tcgaattcct ccctatcaaa 1860 gagtctctca aagaa 1875 <210> 14 <211> 2145 <212> DNA <213> Artificial Sequence <220> <223> Maize-Codon-Optimized Coding Sequence of BT645 <400> 14 atgaagctca agaatcaaga caagcaccag tcgtacagct cgaacgagaa agttgacaaa 60 atcagcacga acaaaacgga catagaactt aaaaacatgg ataatgagga ctatcttagg 120 gtctcagaac atgaatccat aaacccattt gttagcgctt caaccattca aaccggtatt 180 gggatcgcgg ggaagatact ggggacgttg ggcgtgccgt tcgccggtca gatagcttct 240 ctttactctt tcatacttgg tgagctttgg cccaagggca agtcacagtg ggaaattttt 300 atggagcatg tcgaggaaat cattaatcaa aagatctcaa cctatgcccg gaacaaggca 360 ctgaccgatc tcaagggctt gggcgacgca ctcgcagtct atcatgagtc cttggagagc 420 tgggttgaga acagaaacaa cacacgggct cggtccgtgg tcaaaggtca atatatcgcc 480 cttgagctga tgttcgtgca aaaacttcca tcgtttgcag tgtctggcga agaagtccct 540 cttttgccca tatacgtgca agcagccaat cttcacttgt tgcttctcag agatgcctct 600 atttttggga aggaatgggg gttgtcccca tccgagatca gcacgtttta taacagacaa 660 gtcgacagaa ctcgggacta ctcggatcac tgcgtgaagt ggtacaacac tgggctcaac 720 aatttgcggg gtacaaatgc ggagtcttgg gttcggtata accagtttcg gaaagatatg 780 acactcatgg tgttggatct tattgccctc ttcccgtcgt acgatactat tgtgtatccg 840 atcaaaacga cttctcaact caccagagaa gtctatacag acgctattgg tactgttcac 900 cctcatgcga gctttgcgtc aacgacgtgg tacaataata acgcaccgtc cttttctgcc 960 attgaagctg cggttattcg ctcacctcac ctgttggact ttctcgagaa ggtgaccata 1020 tactcccttc tgagcagatg gtctaacacg cagtatatga atatgtgggg gggacaccgc 1080 ctggaatcta ggcccattgg cggggcactt aatatatcta ctcaagggtc aacgaacaca 1140 tctataaacc ccgttaccct tcaatttacc tcgcgcgatg tttatcgcac tgaatcatgg 1200 gctggtctta atctctttct cacgcaacca gtcaacggag tccctagggt tgatttccac 1260 tggaagtacc ctactcttcc aatagcttct gataactttt actacctggg gtacgccggg 1320 gttgggaccc agctccaaga ctccgaaaat gaattgccac cagagacgac cggtcagccc 1380 aactacgaaa gctattctca ccggctttca catattggtt tgatttctgc gtcgcacgtt 1440 aaggcgttgg tttattcatg gacccactca tcggcaaacc gcaccaacac tatagaagcc 1500 aactcgatta cccagatccc gcttgtgaaa gccttcaacc ttccatcggg tgcaacggtg 1560 gttagggggc ctggatttac gggcggtgat atacttcgcc gcaccaacac aggtactttt 1620 ggtgacatcc gcgttacaat aaacccgccg tttgctcagc gctacagggt ccggatcagg 1680 tatgcatcaa ccactgactt gcaattccac acctccatca atgggcgcgc catcaaccag 1740 ggcaatttct ctgccacgat gaatagggaa gataacctca attacagaac gttccggacg 1800 gcaggattca caaccccttt ctcattctcg gacacgcaaa gcacatttac tatcggcgcg 1860 tggtcgttta gctccggcaa tgaagtctat atcgatcgca tagagttcgt tccggtcgag 1920 gttgcacatg aggaaaatta cgactttgag aaggtgcagg aggaggttac ggcattgttc 1980 acccccacca atcctagggg attgaagaca aacgtcacag attacgacat cgaccaagtc 2040 cttaatctgg tcgagtcgtt gtccgacgag ttttacgtcg acgagaagcg ggagctcctt 2100 gaaattgtga aatacgcaaa gcagttgaac atagatagga acatg 2145 <210> 15 <211> 1848 <212> DNA <213> Artificial Sequence <220> <223> Maize-Codon-Optimized Coding Sequence of BT727 <400> 15 atgctcagaa cgaggcaata taaaaagggc ccggagatgg tctatacggg cagggaacag 60 acccttccgt tcgaggaagt ggtcaaaata tccgggaaaa tagggctcgg tgtggttaaa 120 actgtgataa cctcaatcat tagatgtggc cgggataacg agattgcggg ccgcatcctc 180 tcagacgtgt actcggtcct gtggagcacg cctaaagggt actgggcaga aatgatagaa 240 gccgtggaaa ctctgatcca gcatgagatc tccgagaaca tcaggaacaa cgctttcgcc 300 gtcctgactg acgtgagaaa cgcacttctt ctttaccaac aggcggcgga ggaatggcaa 360 tccaacagaa ccgaccctca actgcaggag agagtgagaa atcagtttat tgcaacgaac 420 acacttatcg aattcgcaat gccctcgttt accgtccctc attacgaggt gattcttctc 480 cctatctttg cgcaagcggc gaacctccat ttgctcctcc ttagagatgt ggagatattt 540 gggctcgagt ggggcatgag caaggcggaa attgacgact actattttgc aaattccggc 600 ctcaccggcc tgacacaaaa atacacaaat cactccgtta aatggtacag agaggggctc 660 tgcatcgcaa ctaatataga cctcggacag tttccagagt tttaccagct ggacaaatgg 720 aacgccatga atgattttag gagggaaatg actttcatgg ttttggacat cattgcgctg 780 tggcccacgt atgatcctat aaggtatcca ctcggaataa aaacagagtt gacaagagag 840 gtctttacgc ctcttctcgg aattaatccg aactcttcgt ggctgataca tacaatggaa 900 gaaatcgaag cgaaattgac ttttctgtcg ccgttctttgt cgtggattc cttcgagcaa 960 ctggtcaagc aaggggatgg cattgcaaca ttcaccgatt ggggtaactt cacactgtca 1020 aataccatgc tgcctctttc atatattctt ggaggggcag gttcggggac aggagactca 1080 actaatatac cgatgcagtc agaaaactac gatgtgtaca aggttcatgt ggggactgat 1140 tactcccatc cgtccaatgt gccgatccgc aaactcgaat actactgtac caacgggaca 1200 atggaaaaag tgattactgt ggggacagga aggactaacg ctctttttga gcttccgaat 1260 aatggttgtg ttgattactc tcatcgcatc tcaagattgt catgtagcaa cgttgaagtc 1320 tatgaatggg agggcggccc gaggtatgcg cttaaaaaca ttgcctacgg ctggacgcac 1380 atcagcgtgg atagcaagaa tactttgagc gccaacgcca ttacgcaaat tcccgcacgg 1440 aagggctatg catcttccgg tagcaatctc tccatagcgg ggccctactt tactggaggt 1500 gacctcatcg ttctcccacc caatggcgcc caacttcaaa tacgggttac gccaccggtg 1560 tcaagcaagt ctaagaagta ctgtgttagg ttccggtatg ccagctccgg aaacacgaac 1620 atttatttcg aacgggtcct gtcttcaggt gatacgtatt cagaaaccca cgatgtcccg 1680 gcgacctatc cgggtggcgc actttcttat tcgagctttg cctatgttgt gaatttgacg 1740 gcgatttttg aggggttcaa cgttgagatc aaaatcaaaa acataggttc gtcccaaatc 1800 atactcgaca agatagagtt ccttccgata aaagaatcgc tgaaagaa 1848 <210> 16 <211> 2277 <212> DNA <213> Artificial sequence <220> <223> Maize-codon-optimized BT1047 coding sequence <400> 16 atgaacctgt gcttctactt gaacatcaag aacgcactct catataccat attttggaag 60 tgcttgttcg aacaggactt tatacgcaag ttgaaactta ttattaatgg agtcataaat 120 atgaagccga aaaaccaaaa caaatgtcag agcctttact ccaatggtac cttcgatatg 180 gacagcaaag cttctcttaa gaatgacaag aacatggaat tgcagtcaat aactcacgag 240 gactgcttgc gcatgtccga gcatgaatca atagaaccac tggtgtcagc ttctgtgata 300 caaaacggga taggaatagc agggaaaata ttgggtacac ttggagtgcc attcgcgggg 360 cagattgcat ctctctattc ctttattctc ggcgagctct ggcccaaagg aaagtcacag 420 tgggagatat tcatggagca tgttgaggag ctcatcgatc aaaaaatttc tatatacgcc 480 cggaacaaag cgcttactga gctcaagggc ctcggcgatg ccttggccgt ttatcatgag 540 tccctcgaat cttggataga gaacaggaac aacaccagag cgagatccgt cgtcaaaagc 600 caatacataa ccttggagct catgtttgtc caaggtctcc cttccttcgc tgtgagcggt 660 gaggaagtct tgttgctccc gatttacgca caagcggcca acctccatct cctccttctg 720 cgcgacgcgt ctattttcgg tgaggagtgg ggtctgtccg catccgaaat atccaccttt 780 tataacagac aggttgagcg ggtgaacgac tataccgatt actgcgttaa attttacaac 840 actggcctga atagctcacg cgggaccgac gccaagtcct gggccagcta taaccaattc 900 agaaaagata tgactctcat ggttctcgac ctcgtggcac tttttccctc ctacgataca 960 catgtgtatc cgatcaaaac caattcccaa ctcacgagag atgtctatac tgatgccata 1020 gggacggttc atccgaaccc atctttcgcg agcacgacct ggtacaataa taatgcacct 1080 gcgttttcag ctatcgaggc cgcagtgatc aggtcccctc accttcttga cttcttggag 1140 gaggtcacga tatattcagc cttgtctcgg tggtccaata cgcaatacat gaacatatgg 1200 tcagggcact ccctcaagtt taggacgata ggaggtggtt tgaatacttc tacccaaggg 1260 tcgacgaact ctacaatatc ccccgtcacc ttccaattcc ctgcgcggga cgtgtaccgg 1320 accgagtctt tggcaggtct taacattttt ctgactcaac ccgtgaacgg cgttccatct 1380 gtttcgtttc actggatcct gcccggtata gaggtgggta actccataac atataatccg 1440 gggtacgttg gtgtggggac acaattgcaa gattctgaaa cagaactccc accggagact 1500 actgaacggc ccaattatga atcttacagc catcgcctga gccacatagg actgatcacc 1560 gcgagccatg tcagggctct ggtttattca tggactcata ggtctgcgga gaggacaaac 1620 actattgagc ccaaccgcat tactcaaata ccactcgtga aagccctcaa cttgtactcg 1680 ggtacaacag ttgttaaagg acctggattt acgggtggcg acattctgag aaggacgaat 1740 acgggtatct ttggggacat tcgggtgaac atcacggcac ctctttcaca acggtatcgc 1800 gtccgggtta gatacgctag cacaacggac ctcgaatttt atacttccgt taacgggact 1860 acgatcaata tgggtaattt ttccaagaca atggactctg gaaacaattt ggagttttca 1920 tcgtttaaga ccacaggctt ttccacccca ttttctttct ccaacgccca atccaccttc 1980 actctgggga ctatggattt ctcaaaccaa gaggtctata tagatcggat cgaatttttc 2040 ccggttgaag tgacatacga ggaggaatgc gactttgaga aggcccaaga ggctgtcaca 2100 gcactgttca cgccgaaaaa tccaaagggg ctgagaatga atgtgacaga ctaccatatt 2160 gatcaggttt cgaatcttgt ggagggtctg tctgatgagt cgtatctgga tgaaaaacgc 2220 gagttgttcg aaaaggtgga gtatgcaaag caacttaata tagagcggaa catctag 2277 <210> 17 <211> 2205 <212> DNA <213> Artificial sequence <220> <223> Maize-codon-optimized BT1280 coding sequence <400> 17 atgaaattga aaaaccaaga taaacatcaa tcgttctcaa gcaacgccaa agttgataaa 60 atctcgactg attcgcttaa aaacgaaact gacattgaac tccagaacat caaccatgag 120 gattgtctga agatgtccga gtacgagaat gtcgagccat ttgtctctgc atcgacaata 180 cagactggaa ttggtattgc tgggaaaata ttgggtaccc ttggcgtgcc tttcgccgga 240 caggtggcat ccttgtatag ctttatattg ggcgagctgt ggccgaaggg aaaaaatcag 300 tgggaaattt tcatggaaca cgttgaagag ataataaatc agaagatatc aacatacgca 360 aggaacaaag cccttacgga tctgaaggga ctcggcgacg cactcgcggt ttatcacgac 420 tctcttgaat catgggtcgg aaaccggaac aataccaggg cccgctctgt ggtcaaaagc 480 கெட்டுக்கு cattggagct catgtttgtt cagaagctcc caagctttgc ggtttccggc 540 gaggaggtcc ctctcctgcc tatttacgca caggcggcaa acttgcacct gttgttgctt 600 agggatgcct ctatcttcgg taaagaatgg ggcctcagct cttcggaaat atctactttt 660 tacaatcgcc aggttgaaag ggcgggtgac tactctgacc attgtgtcaa gtggtattcg 720 actggcctta ataatcttag ggggaccaat gcggaatcct gggtgcgcta taaccaattc 780 aggcgcgaca tgacgcttat ggttcttgac cttgttgctt tgttcccaag ctatgacacc 840 caaatgtacc ccataaaac gactgcgcaa ttgacccgcg aggtctacac tgatgccatc 900 gggacggttc atccgcatcc gagcttcact tcgactacat ggtataacaa caatgcaccc 960 agctttagcg ccattgaagc ggccgtggtt cggaaccccc accttctgga cttccttgaa 1020 caagtgacga tatatagcct gctttctcgc tggtccaata ctcaatatat gaatatgtgg 1080 gggggacaca agctggaatt ccgcaccata gggggtacac tgaacatctc cactcagggc 1140 tctacaaata catccattaa cccggtcaca ttgccattca cgtcacggga tgtgtataga 1200 accgaatctt tggccggcct gaatctcttt cttactcagc cggttaacgg ggtgccacgc 1260 gtggactttc actggaaatt tgtcacgcat ccaatcgcat ctgacaattt ctattatcct 1320 gggtatgctg gcattgggac ccagctccag gactcagaaa acgaactgcc tccagaggcc 1380 actgggcagc ctaactacga atcatactcc caccggctct ctcatattgg gttgataagc 1440 gcttctcacg tgaaggctct cgtttattcg tggacacatc ggtccgcaga cagaacaaat 1500 acaattgagc caaactcaat cacccagatc cccctggtca aagcgttcaa cctgtcttca 1560 ggcgctgccg tggtgagggg ccctgggttc actggtggag atatcctccg cagaaagaat 1620 acgggcactt tcggggatat ccgggtgaat ataaatccgc cgtttgcgca gagatacaga 1680 gtccgcataa ggtatgcctc cacaacagac ttgcaattcc atacgtccat caatggaaag 1740 gcaattaatc aagggaattt ctcggccaca atgaaccggg gcgaggatct cgactataag 1800 acttttagaa cagttggctt tacgacacct ttctcattct cgaacggaaa agccataaat 1860 caaggcaatt ttagcgcgac catgaatcgc ggtgaagatc ttgattacaa aacttttagg 1920 accgtgggct tcacaacgcc attttccttc ctggacgtcc aatctacgtt tacaataggt 1980 gcctggaact tctcctctgg taatgaggtt tacatcgatc ggatagaatt cgtccctgtt 2040 gaggtcacat atgaggctga gtacgacttc gagaaagccc aagagaaggt cactgccctc 2100 tttactagca ccaatcctcg cggattgaaa acggacgtta aagactatca catagatcag 2160 gtctcaaatc tggtcgagtc cctttctgat gtgctcttcc ggtaa 2205 <210> 18 <211> 2040 <212> DNA <213> Artificial sequence <220> <223> Optimized BT1155 coding sequence for maize codons <400> 18 atggacctct cacctgatgc caggattgaa gattccctct gcgtggccga aggtaacaat 60 atcgatcctt ttgtctccgc ttccacagtc caaacgggca tatcaatagc ggggcgcatc 120 ctgggtgtgc tcggcgttcc ctttgctggt caactggcct ccttctactc ctttctggtc 180 ggcgaactct ggccgtctgg ccgcgaccca tgggagatct tcatggagca tgtcgaacaa 240 attgttcggc agcaattac cgattctgtc cgggataccg caatagcgcg cctggaggga 300 cttggccggg ggtatcggtc gtaccaacaa gctcttgaga cgtggctgga caaccggaat 360 gacgccaggt cgcggtccat catcagggag aggtatatcg cactggaact ggacattaca 420 acggccattc cccttttttc aattagaaat caagaggtcc ctcttcttat ggtttatgct 480 caggctgcaa acttgcacct tctcctcctc agggacgctt caatcttcgg taggagtgg 540 ggtcttagcg cgagcgaaat cagcaccttt tataaccggc aagtcgaacg cacgcgggat 600 tacagcgacc attgtgttaa atggtataat accggtctta ataaccttcg cggtacaaat 660 gcaaagtcct gggttcggta caatcagttc agaaaggata tgactctcat ggttcttgac 720 ctcgtcgctc ttttcccttc gtatgataca ctcgtttacc ctataaaaac cacctcacag 780 cttactcggg aggtttatac agatgccata ggcacggttc atcccaatca agcgtttgca 840 tcaacgacct ggtataacaa caatgctcct tcctttcga ctagaagc agcggttgtt 900 aggaatcccc atcttttgga ttttctggag caggttacga tatacagcct cctgtcccgg 960 tggtcgaaca cgcaatatat gaacatgtgg ggtgggcata agttggaatt tcgcactatc 1020 ggcggcactc tcaatacgtc cacccagggg agcactaaca cctccatcaa tccagtgaca 1080 ctccccttta cgtctcggga cgtctacaga actgagtcac tggctgggct caatcttttc 1140 cttacgcagc ccgttaacgg cgtccctcgg gttgacttcc attggaaatt cgtgacacac 1200 ccaatagcaa gcgataactt ctactatccc ggatatgctg gaattggcac gcagcttcaa 1260 gattcagaga acgaactccc tcctgaaaca accggacaac ccaattatga gtcgtattct 1320 cacagattga gccatagg tctgatctct gcgtcgcatg tcaaggctct cgtctacagc 1380 tggacccaca gatctgcaga caggaccaac actattgaac ctaactcaat aacccaaatc 1440 cctcttgtta aggcgttcaa ccttccgtcc ggtgccgcgg tcgtcagggg gcctggtttc 1500 acaggtggcg atatattgca gagaacaaat acaggcacat tcggtgatat tcgcgtcaac 1560 attaatccgc cttttgctca gaggtatcgc gtgagaattc gctacgcgtc tacaaccaat 1620 gttgagtttc acacgtctat caacggcaaa gctatcaatc agggtaactt tagcgccacg 1680 atgaacaggg gggaagatct tgactacaag acctttagga ctgtgggctt tactactccg 1740 ttctccttgt cagatgtgca gtccacattc acaatcggtg catggaattt cagctcaggg 1800 aatgaagttt atatagacag aatagagttc gtgcctgttg aagttactta cgaggctgag 1860 tatgatctca agaaggcaca agacgaaata actgctatgt tcacgtcaac gaaccctgga 1920 ggcctgaaaa cgaatgttac ggaatatcac atcgatcaag tgtcaaacct cgttgagtcg 1980 ctgtcagacg agttttattt ggatgaaaag cgcgagctct ttgagattgt taaatactag 2040 <210> 19 <211> 2040 <212> DNA <213> Artificial Sequence <220> <223> Maize-codon-optimized BT1559 Coding Sequence <400> 19 atgaacctct ccacggatgc gaggatcgaa gactccctct gtatagcaga aggcaataac 60 attgatcctt tcgtttcagc ttctacggtg cagacaggga taaacatcgc aggccgcata 120 ttgggagtcc ttggagttcc tttcgcaggc caaatagctt cgttttattc ctttctggtc 180 ggcgaacttt ggccccgcgg acgggatccc tgggaaatat ttctggaaca cgtcgagcag 240 ttgatccggc agcaagtgac ggagaatacg cgcgataccg ctttggcaag gctccagggt 300 ttggggaatt ccttcagggc ctatcaacag agccttgagg actggttgga gaatcgcgac 360 gatgcgcgga cgcgcagcgt cctgtatacc caatatattg cactggagct tgatttcctt 420 aatgcgatgc ctctgtttgc gataagaaac caagaagttc ccttgctcat ggtgtatgca 480 caggccgcca acctccacct gcttttgctc agggatgcgt cgctttcgg ttcggagttt 540 ggacttacgt cacaggagat ccaaagatat tatgaaagac aggtggaaaa gacgcgcgaa 600 tactcggact actgtgccag gtggtacaac acaggactta ataacttgcg ggggacaaac 660 gccgagtcat ggttgcggta taaccaattt aggagggacc ttacgttggg tgtgttggac 720 ttggtggcac ttttccttc gtatgacacc agggtttatc cgatgaatac ctcagctcag 780 ctcaccaggg agatctatac ggaccccatc gggcggacta atgcgccgtc tggcttcgca 840 tcaacaaatt ggtttaacaa taacgcacca tcgttttctg ctatcgaagc agctgtgatc 900 cggtcaccac acttgcttga cttcttggaa caggttacga tttattctct gctctcaaga 960 tggtcgaaca cccagtacat gaatatgtgg ggcggccata agctcgaatt cagaacaatc 1020 ggcggtactc tcaacacaag cacacagggg tcaactaata cgtccattaa cccagttacg 1080 ctcccattca cgagccgcga catctaccgg accgagtctt tggcagggct caatctgttc 1140 ctgacccaac cggtcaatgg ggtcccgcgg gtcgattttc actggaaatt cgtgacacat 1200 cccatcgctt ctgacaactt ttattatccc gggtacgcgg gtattgggac tcagttgcaa 1260 gactcggaga atgagctccc accggagacc acggggcagc caaattacga aagctattcc 1320 catcgcctta gccacatagg tctcatcagc gcctcacacg tgaaagcatt ggtttactcg 1380 tggacacatc ggagcgccga caggacaaac acaatccatt cagactctat cacacagatc 1440 cctctggtga aagcacatac cttgcaatcg ggcactaccg ttgtgaaagg tccgggattc 1500 actgggggtg atattttgag gcgcacatcc ggtggaccct tcgccttttc aaatgttaat 1560 ttggattgga acctgtccca gagatatcgc gcaaggatca gatatgcgtc tacgactaat 1620 cttcggatgt atgtgacgat agcaggtgag aggatattcg ccgggcaatt taacaaaacg atgaacacag gggacccctt gacattccaa agcttcagct atgccacgat agatacagca ttcaccttcc cgacgaaagc ttcgtctttg acggtggggag ccgacacgtt ttctagcggg aatgaggtct atgtggatag atttgagctg atccctgtca cagccactct ggaagccgtg accgacctcg aacgcgccca gaaagctgtt catgagcttt ttacctccac taaccctggt ggcctgaaaa cggatgtcaa agattaccat atcgatcagg ttagcaatct tgttgagtcc ctctcagatg agttctatct cgatgaaaaa agagaactgt ttgagatcgt gaaatactag <210> 20 <211> 2040 <212> DNA <213> The snowstorm <220> <223> Install the BT1563 mounting kit <400> 20 atgaacctct caaccgatgc caggataga gacagcctgt gtatcgctga gggaatac attgatccgt ttgtgtccgc gtcgacggtc caaacgggga taaatatagc cgggagaata ctcggagttc tggggagtccc tttcgcaggc cagattgcaa gcttttag ctttcttgtg 180 ggggagcttt ggccgagagg ccgcgatcca tgggaaatct ttttggagca tgtggaacaa 240 ctcataagac agcaagtgac ggaaaacacc cgggacacag cacttgccag gctccaagga 300 cttgggaatt cttttcgggc gtaccagcag tccctggagg actggctcga gaaccgcgac 360 gacgccagga ctagaagcgt gctctacaca cagtacatcg ctttggaact cgactttctc 420 aatgcgatgc ctctgttcgc cataaggaac caagaagttc ctcttctcat ggtgtatgcg 480 caggccgcaa acttgcatct gctcctgttg agggatgctt ccctcttcgg gagcgaattc 540 ggcctcacct cccaagagat tcagaggtac tatgagcggc aggtggaaaa gaccagggag 600 tactcagatt actgcgccag gtggtataac accggcctca acaacctgag aggaactaac 660 gcagagagct ggctcagata caaccaattt agacgcgaca tgaccctcat ggtgctggat 720 ctcgttgcgc ttttcccctc atacgacacc cgggtctatc ccatgaacac gtccgcacag 780 ttgacaagag aaatttatac agacccaata gggagaacaa atgccccatc tggtttcgca 840 tccactaact ggtttaacaa taatgctcct tccttcagcg caatagaagc tgcggtggtc 900 cggaacccgc accttttgga ttttctcgag caagttacca tatacagcct tctgtcccgc 960 tggtccaata ctcaatatat gaatatgtgg ggtggccaca agctggaatt tagaaccatc 1020 ggtggaaccc tcaacacgtc tacgcaaggt tcgactaaca catctattaa tcccgtcaca 1080 ctccctttca catcacggga cgtctatcgc actgaatcgt tggcagggtt gaacctcttt 1140 cttacacagc cggtcaatgg tgtccctcgg gttgacttcc actggaaatt tgtgacgcat 1200 cctatagcta gcgacaattt ttattaccca ggttacgccg gcatcgggac tcaactccaa 1260 gattcagaaa acgaacttcc ccccgaggca actggtcaac ctaattatga gtcgtactca 1320 cacaggcttt defectattgg actgatctcc gcctcacacg tcaaagcgct ggtctattct 1380 tggacccaca ggtcagccga caggacgaat accatagaac ccaattcaat cacccagatc 1440 ccccttgtca aggcatttaa tctcagcagc ggggcagcag ttgtcagggg ccccggcttt 1500 accggtggtg atatactcag acggacaaat accggcacct ttggtgatat aagagtgaat 1560 attaaccctc cgttcgcgca aaggtataga gtccggataa gatatgcctc gacaacggac 1620 ctgcagtttc acaccagcat aaacggcaaa gcgatcaacc agggcaattt ttctgcgact 1680 atgaatcggg gcgaggatct ggactataaa acatttcgga cagtcggttt tactacccct 1740 ttttcattct cggatgtcca gtcaacattt acgattgggg catggaactt ctcttcgggg 1800 aacgaggtgt acatcgaccg cattgaattc gtcccggtcg aagttacata tgaagctgaa 1860 tacgatttcg aaaaggcgca agaaaaggtg accgcccttt ttacttccac gaatcccagg 1920 ggcttgaaga cggatgtgaa ggattatcat atagatcagg tgtccaattt ggtcgaatca 1980 ctttctgacg agttctacct cgatgagaaa cgcgaattgt tcgaaattgt caagtactag 2040 <210> 21 <211> 2118 <212> DNA <213> Artificial Sequence <220> <223> Maize-Codon-Optimized BT1571 Coding Sequence <400> 21 atgacctcta accggaaaaa cgagaatgag ataattaacg cgctctcgat tccggcagtt 60 agcaaccatt cagcccagat ggacctttca cttgatgcca ggatcgagga cagcctctgc 120 attgccgaag gtaataacat aaaccctctc gtctcagctt ccaccgtcca aacaggcatt 180 aacatcgcag gacggatcct cggggtgctc ggggtccctt ttgctggcca attggcctcc 240 ttctactctt tcctcgtggg cgagctgtgg ccctctggca gagatccatg ggaaatcttc 300 cttgaacatg tcgaacagtt gatacggcaa caagtcactg aaaacactcg gaatacggcg 360 atcgcgaggc ttgaaggact cggccggggc tatagatcat atcaacaagc tttggaaacg 420 tggctcgaca accggaatga tgcccggagc agatcaatta tactcgagcg ctacgttgca 480 cttgaactgg atatcacaac agcaattcca ctgtttagga tcaggaatga ggaggtgccc 540 ttgctgatgg tctacgccca ggccgcgaac ctccacttgc ttcttcttcg cgatgcctca 600 ctgttcggtt ccgagtgggg tatggcttca agcgacgtta accaatacta ccaagagcaa 660 attagataca ccgaagaata ttctaatcac tgcgtgcaat ggtataatac tgggctcaac 720 aatctgcgcg gtaccaacgc tgaatcatgg cttcggtata accagttccg gcgcgacctc 780 accctgggag tgctcgacct cgtcgctctg tttcccagct atgacacgcg cacataccct 840 atcaacacat ctgcacaact cacacggag atctacacgg atccgattgg gcgcacgaac 900 gctccgtcgg gttcgcatc tacaaattgg tttaataca acgcgccttc cttcagcgct 960 attgagtccg cggttgttcg caacctcat ttgctggact tcctggagca ggtgacgatc 1020 tactcactgc ttagccggtg gtccaatacg cagtacatga atatgtgggg agggcatcgc 1080 ctcgagttca ggacaatagg gggggtgctg aacacctcca cccaaggaag cactacacc 1140 tccattaatc cagtgacact gccctttaca agcagagacg ttataggac tgagtcactc 1200 gccggggttga acttgttccct gacagccc gttaacgggg ttccagagt ggattttcat 1260 tggaaatttg ccacactccc tatcgcgagc gandactttt attactggg gtacgctgga 1320 gttgggactc agctgcaaga ttctgaaat gaactgccac ctgaacgac gggacacca 1380 aattatgaat cgtactcaca ccggcttagc cacataggct tgatatctgc ctcgcacgtt 1440 aaagcgcttg tctactcctg gacccatcgg tctgctgata ggacgacac tatagaacca 1500 aattccataa cccagatccc tcttgttaag gcgtttaatc ttcaagcgg cgccgcggtg 1560 gttagggtc cgggatttac aggcggtgat atactcagga gaacgaatc ggggacattc 1620 ggcgacatta gagtgaatat aaacccacct tttgctcagc ggtaccgggt ccggatccgg 1680 tacgcatcca caacggatct ccaattccat acatcaatca acggaaaagc aataaatcag 1740 ggaaactttt cagcaaccat gaatcgcggt gaggatctgg actataagac attccgcacg 1800 gtgggattca cgacaccgtt ctcgttttct gatgtccaat cgacattcac cattggagcc 1860 tggaatttct cttctggcaa tgaggtttat atagaccgca ttgaatttgt cccagtcgaa 1920 gttacgtatg aagccgaata cgacttcgaa aaggcgcagg agaaagtcac ggcgttgttt 1980 actagcacca acccccgcgg cctcaagaca gatgttaaag actaccacat agatcaagtt 2040 tccaaccttg tggagagctt gagcgatgaa ttctaccttg atgagaaacg cgaactcttt 2100 gaaattgtga aatactag 2118 <210> 22 <211> 2121 <212> DNA <213> Artificial sequence <220> <223> Maize codon-optimized BT1633 coding sequence <400> 22 atgaagctta agaatcaaaa tatgcaccag tccctcagct ccaatgccac tgttgataag 60 agctttacgg attctttgga acacaataca aatatggaac tccagaattc caatcacgag 120 gactgcctga agatgagcga atacgaatcg atagaacctt ttgtttcagc ttcaactatt 180 cagaccggga tcgggattgc tggaaaaatc ctgggtactt tggggtgcc attcgctggg 240 cagattgctt cgctgtactc attcattctt ggcgagctct ggcctaaagg taaatcacaa 300 tgggaaattt ttatggagca tgttgaagaa ctcatcaacc agaagatttc aacgtacgcc 360 cggaaagg cactggcaga cctcaaaggg ctcgggggatg ctcttgctgt gtatcacgag 420 480 caatatatcg ccctcgagct tatgtttgtc cagaagctgc cttcatttgc cgtttcaggc 540 gaagaggtgc cactcctgcc aatatacgcg caggctgcaa acctccatct tctcctcctc 600 cgcgacgcgt ctatcttcgg caaggaatgg gggctctcgg aatccgaaat ttcaacattc 660 tataatcgcc aggtggaaag gacccgggac tactcagatc actgtgtcaa atggtacaac 720 acagggttga ataggttgcg ggggaccaat gccaaatctt gggtccggta taaccagttc 780 agaaaggata tgacgcttat ggtccttgat ttggtggctc ttttcccatc ttatgacacc 840 ctggtttacc ccatcaagac cacttcgcag cttactaggg aagtgtatac agacgctatt 900 ggcaccgtcc accctaatca ggcatttgcc tccacgactt ggtacaataa caatgctccg 960 agcttctcag cgatcgaggc agccgtcatt cggtctccgc atctgttgga ctttttggag 1020 aaagtcacaa tatactcctt gttgagccgc tggtcgaaca cgcagtatat gaacatgtgg 1080 ggcgggcaca agctcgaatt cagaaccatt ggtgggaccc ttaacacatc tacacaggga 1140 tctaccaata cctctataaa ccccgttacg cttccgttca cctcccgcga cgtctaccgc 1200 actgagtcgt tggctggttt gaatttgttc ctcacgcaac ccgtgaacgg tgtccctcgg 1260 gtcgattttc attggaaatt cgttacgcat cctatagctt ccgacaactt ctactaccct 1320 ggatacgctg gtatcgggac gcaactgcag gattcagaaa atgaattgcc gccagaaacc 1380 acgggccagc cgaactacga atcttactca catcgcctgt cgcatattgg cctcatttct 1440 gcctctcatg tcaaagcgct ggtttacagc tggacacaca ggtctgctga tcggacgaat 1500 actatagagc caaactctat tactcaaatc cctttggtta aggcctttaa cctgccgtcg 1560 ggggcagccg tggtcagagg gcctgggttc actgggggag atatactcag gaggaccaac 1620 actgggacct tcgcggatat gcgggtgaat atcacaggtc cactctcgca acgctaccgc 1680 gtgagaatcc ggtatgcttc gacgacggat ttgcagtttt ttacgaacat taatggtaca 1740 accataaata tgggaaattt tccaaagacc gtcaataact cgagctcgga ggggtataga 1800 actgtctcct tctcaacacc tttttccttc tccaatgctc agagcatttt tcgccttgga 1860 atacaggcct tctccggcgt gcacgagatt catgtggaca gaatcgagtt tgtcccggcc 1920 gaagttacgt ttgaagcaga atatgatttg gaacgggctc aaaaggcggt caatgccctt 1980 tttacatcta ctaaccctaa agatatgaaa acatacgtga ctgagtcaca gatcgaccag 2040 gtgttcaatc ttgtcgagtg tctttcagat gaagtttgcc ttgacgagaa aagagagttg 2100 ttcaagaaag ttaaatatta g 2121 <210> 23 <211> 2157 <212> DNA <213> Artificial Sequence <220> <223> Mutant BT0204 Coding Sequence <400> 23 atgaagctca agaaccccga taagcaccag agcttcagca gcaatgccaa agtcgacaaa 60 attgccaccg atagccttaa gaatgagacg gatatcgaac tcaagaacat gaataacgaa 120 gattacatcc ggatgtcgga gcatgagagc atagatccgt ttgtctctgc atctacaatt 180 cagacggggaa ttggtatcgc tggaaaaatc ttgggcaccc ttggagtgcc cttcgctggg 240 cagatcgctt cgctttactc gttcatattg ggagaactgt ggccaaaggg taagtcccaa 300 tgggaaatct tttggaaca tgtcgaagag ttgattgccc aaaagatctc aacatatgct 360 cgcaacaagg cactcacgga tctcaagggt cttggtgacg ctttggcagt ttaccatgaa 420 tctcttgagt cttggattaa aaatcgcaac aacactaggg ctcggtcggt cgtcaagtcc 480 cagtacatca gcttggagct gatgtttgtc cagaaactcc cgtcgtttgc tgtctcggga 540 gaagaggttc ctctgttgcc catatatgca caggctgcta acctgcacct cttcttttg 600 cgcgacgcat ccatctttgg gaaagaatgg gggctgtctt cttctgagat cagcacgttt 660 tataaccggc aagccgaaag gacatccgac tactcggatc actgtgtcaa atggtattcc 720 acgggtctga ataacctcag gggcaaaaat gcggaaagct gggtgaggta taatcaattc 780 agaaaagata tgattcttat ggtcttggat cttgtggcgc tgtttccttc ctatgacaca 840 catatgtatc cgatcaagac taccgcacaa ctgactaggg aggtgtacac taacgcgata 900 ggcacggtcc acccgcaccc ctccttcgcg tccacaactt ggtataacaa taatgcccct 960 tcgttctcag ccatagaagc cgccgttatt cgctcgccac acttgctgga ctttctggaa 1020 caagtcacaa tctatagcct gctgtcacgc tggtcgaaca cgcaatatat gaacatgtgg 1080 ggagggcacc ggctggagtt caggaccatt ggtggagctc tgaacactag cacgcaaggt 1140 tcaaccaaca ctagcatcaa tcctgtcaca ctcccgttta catcccggga cgtgtaccgc 1200 acagagtcct tggctgggct caacctcttc cttacgcaac ctgtcaatgg cgttccaaga 1260 gtggattttc actggaagtt cgttacccac ccaatcgcct ccgataattt ttactatcct 1320 ggctatgctg gaatcggcac tcaactccag gattctgaaa ctgagctccc acctgaaacc 1380 accgggcaac ctaactatga gtcttactca catcggttga gccatattgg acttatatcg 1440 gcatctcacg ttaaagcact ggtctatagc tggacccata gatcggctga tcggacaaac 1500 acaatcgaac ccaactcgat aactcaaata ccacttgtga aagcgtttaa cttgcctagc 1560 ggtgcagctg ttgtgagagg accgggtttc actgggggag acatccttag acggacaaac 1620 accgggactt tcggagatat acgggtcaac attaatcccc ccttcgccca gagatacagg 1680 gttcggatca gatacgcctc gacaacagat gtccagttcc ataccagcat caacggaaaa 1740 gcaatcaatc aggggaattt ttccgccacc atgaaccgcg gtgaggatct ggattacaaa 1800 acattcagaa ctgtcgggtt tacaactcct ttttccttct cggacgttca gtcgacgttc 1860 acgataggtg cttggaattt ctcttcaggg aatgaggtgt atatagatcg catagaattc 1920 gtgcctgtcg aggtgaccta tgaggcggag catgactttg aaaaagccca agaggaggtt 1980 accgccctgt tcacatctac aaacccgggt gggctgaaga ccaacgtcac cgagtatcac 2040 atagatcagg tctcgaattt ggtcgagtct ctgtccaatg aattctattt ggacgagaaa 2100 cgcgaactgt ttgaaattgt gaagtacgcc aagcagcttc atctcggtag aaatatg 2157 <210> 24 <211> 1875 <212> DNA <213> Artificial Sequence <220> <223> Mutant BT0235 Coding Sequence <400> 24 atgagaaacg cttcaaaaga agtgaaaatt ctgcgcactc ggcaatatga gaaagacagc 60 gcgatggtgt acgcgatgga ggatcaacct ctctcattcg gtggtgtggt ggagatctct 120 ggcaaaatcg ggctgggtgt ggtgaaaacg gttatatctt caataacccg gagagggagg 180 gatgacgaga tagccgggag aatcttgtca gacgtgtacg gtgtgctttg gtcaaacaga 240 aaaggctatt ggaacgaaat gattgaagct gtcgaaacac tgataagaca tgacatcaac 300 gaaaacgtca agaataatac gttggctgtg ctgacagaca ttcggaatgc tctccttctt 360 taccagcagg cgaccgaagc ctggcaaaac aatagaactg acccgcagct tcaggaaagg 420 atcaggaacc aattcattgc cacgaacacc ttcattgaat ttgctatgcc ttccttcatc 480 gttccgcact acgaggtgat tttgctcccg atattcgctc aagtcgcaaa ctttcatctt 540 cttcttttga gagacattgc catatttgga cttgaatggc ggatgtcgaa ggcagagatc 600 gacgactact acttcgcaaa taccgggctt acagggctca cgtctaagta cacgtcgcat 660 tgcgtcaagt ggtactgcga aggactgtgc atagctacca atgtcgacct cggtcagtac 720 ccagagtttt accaactcga caaatggaac gctatgaatg atttcagaag agaaatgacc 780 tttatggttt tggatattat cgctctgtgg cctacatatg accccataag ataccctctg 840 ggcatcaaaa ccgaattgac tcgggaggtc tttacacctc tccttgggat taatccgaac 900 agctcatggt tgatccatac catggaagag atagaagcta aactcacatt ccttagcccg 960 tttcttagct ggatttcgtt tgagcaactc gtcaagcaag gggatggcat ctccacattt 1020 acagactggg gatcatttac cttgtccaat accatgctcc cgctttccta catcctgggc 1080 ggagctggtt caggcacggg cgagtccacg aacatcccca ttaagtctga aaactatgac 1140 gtttacaagg ttctggttgg cactgattat tcacaccctt caaatgtgcc cataagaaag 1200 cttgaatatt attgcaccaa tggaacaatc gaaaacgtca tcacggcagg cactggtacg 1260 acgaacgctc tgtttgagct gcctaacaac ggttgtattg actactccca ccgggtctcg 1320 agactgtcgt gttccaatgt cgaagtctac gaatgggagg gtggaccgaa gtatgccttg 1380 aaaaacattg catatggatg gacccatatt tcagtcgact caaaaaacac tctgtccgcc 1440 aatgtcatta cgcagatacc cgcacgcaag ggttactctt cttcggaatc aaacccgtcc 1500 atagctggac cgtacttcac aggtggcgat cttatcgcat tgccgccaaa cggcgctcaa 1560 ctccaaatgc gggtcactcc tccagtttca tcatgtacaa caaactactg tgtcaggttg 1620 agatatgctt catctgggaa tactaacatt tacgtcgaga gggtcctgcc gagcggggat 1680 acgtacggag agacccacga cgttcccgcc acttattatg gaggctcact gtcatacagc 1740 tccttcgcct acgtggtgaa cttgacggcc atgttcgagg gggtcaacgt tgagataaag 1800 atcaaaaaca ttggatcatc acaaatcatc ttggacaagc tcgaattcct ccctatcaaa 1860 gagtctctca aagaa 1875 <210> 25 <211> 2145 <212> DNA <213> Artificial sequence <220> <223> Mutant BT0645 coding sequence <400> 25 atgaagctca agaaccaaga caagcaccag tcgtacagct cgaacgagaa agttgacaaa 60 atcagcacga acaaaacgga catagaactt aaaaacatgg ataatgagga ctatatcagg 120 gtctcagaac atgaatccat caacccattt gttagcgctt caaccattca aaccggtatt 180 gggatcgcgg ggaagatact ggggacgttg ggcgtgccgt tcgccggtca gatagcttct 240 ctttactctt tcatacttgg tgagctttgg cccaagggca agtcacagtg ggaaattttt 300 atggagcatg tcgaggaaat cattaatcaa aagatctcaa cctatgcccg gaacaaggca 360 ctgaccgatc tcaagggctt gggcgacgca ctcgcagtct atcatgagtc cttggagagc 420 tgggttgaga acagaaacaa cacacgggct cggtccgtgg tcaaaggtca atatatcgcc 480 cttgagctga tgttcgtgca aaaacttcca tcgtttgcag tgtctggcga agaagtccct 540 cttttgccca tatacgtgca agcagccaat cttcacttgt tgcttctcag agatgcctct 600 atttttggga aggaatgggg gttgtcccca tccgagatca gcacgtttta taacagacaa 660 gtcgacagaa ctcgggacta ctcggatcac tgcgtgaagt ggtacaacac tgggctcaac 720 aatttgcggg gtacaaatgc ggagtcttgg gttcggtata accagtttcg gaaagatatg 780 acactcatgg tgttggatct tattgccctc ttcccgtcgt acgatactat tgtgtatccg 840 atcaaaacga cttctcaact caccagagaa gtctatacag acgctattgg tactgttcac 900 cctcatgcga gctttgcgtc aacgacgtgg tacaataata acgcaccgtc cttttctgcc 960 attgaagctg cggttattcg ctcacctcac ctgttggact ttctcgagaa ggtgaccata 1020 tactcccttc tgagcagatg gtctaacacg fotatatga atatgtgggg gggacaccgc 1080 ctggaatcta ggcccattgg cggggcactt aatatatcta ctcaagggtc aacgaacaca 1140 tctataaacc ccgttaccct tcaatttacc tcgcgcgatg tttatcgcac tgaatcatgg 1200 gctggtctta atctctttct cacgcaacca gtcaacggag tccctagggt tgatttccac 1260 tggaagtacc ctactcttcc aatagcttct gataactttt actacctggg gtacgccggg 1320 gttgggaccc agctccaaga ctccgaaaat gaattgccac cagagacgac cggtcagccc 1380 aactacgaaa gctattctca ccggctttca catattggtt tgatttctgc gtcgcacgtt 1440 aaggcgttgg tttattcatg gacccactca tcggcaaacc gcaccaacac tatagaagcc 1500 aactcgatta cccagatccc gcttgtgaaa gccttcaacc ttccatcggg tgcaacggtg 1560 gttagggggc ctggatttac gggcggtgat atacttcgcc gcaccaacac aggtactttt 1620 ggtgacatcc gcgttacaat aaacccgccg tttgctcagc gctacagggt ccggatcagg 1680 tatgcatcaa ccactgactt gcaattccac acctccatca atgggcgcgc catcaaccag 1740 ggcaatttct ctgccacgat gaatagggaa gataacctca attacagaac gttccggacg 1800 gcaggattca caaccccttt ctcattctcg gacacgcaaa gcacatttac tatcggcgcg 1860 tggtcgttta gctccggcaa tgaagtctat atcgatcgca tagagttcgt tccggtcgag 1920 gttgcacatg aggaaaatta cgactttgag aaggtgcagg aggaggttac ggcattgttc 1980 acccccacca atcctagggg attgaagaca aacgtcacag attacgacat cgaccaagtc 2040 cttaatctgg tcgagtcgtt gtccgacgag ttttacgtcg acgagaagcg ggagctcctt 2100 gaactcgtga aatacgcaaa gcagttgaac atagatagga acatg 2145 <210> 26 <211> 2148 <212> DNA <213> Artificial Sequence <220> <223> Soybean codon-optimized mBT645-2 coding sequence. <400> 26 atgaagctta agaaccagga taagcatcag tcttactctt caaacgagaa ggttgataag 60 atctcaacta acaagacaga tatcgaactt aagaacatgg ataacgagga ttacttgaga 120 gtttcagagc acgaaagcat taacccattt gtgtctgctt caaccattca aactggaatt 180 ggtattgcag gaaagatttt gggaaccctt ggtgttccat ttgctggtca gatcgcatct 240 ttgtactcat tcattttggg agagctttgg cctaagggaa agtctcaatg ggaaattttc 300 atggagcatg tggaggaaat tattaatcag aagatctcta catatgctag aaacaaggca 360 ttgaccgatc ttaagggatt gggagatgct cttgcagttt accacgagtc tttggaatca 420 tgggtggaga ataggaacaa tacaagagct aggtctgttg tgaagggaca atatattgca 480 cttgagttga tgtttgttca gaagcttcca tcattcgctg tttctggaga ggaagtgcca 540 cttttgccta tctatgtgca agctgcaaac cttcatcttt tgcttttgag agatgcaagc 600 atttttggaa aggaatgggg tttgtctcct tcagagattt caacattcta taataggcag 660 gttgatagaa ccagggatta ttctgatcac tgtgtgaagt ggtacaacac tggacttaac 720 aatttgagag gtacaaatgc tgaatcttgg gttagataca accaattcag aaaggatatg 780 acacttatgg tgcttgattt gattgcattg ttcccatctt acgataccat cgtttaccct 840 attaagacta catcacagct tacaagggag gtttataccg atgctattgg aactgtgcat 900 cctcacgctt cttttgcatc aaccacttgg tacaacaata acgctccatc tttctcagca 960 attgaagctg cagttattag atcacctcat cttttggatt ttcttgagaa agtgactatc 1020 tattctcttt tgtcaaggtg gtctaacaca cagtacatga acatgtgggg aggtcacaga 1080 cttgaatcta ggccaattgg aggtgctttg aacatctcaa ctcaaggatc tacaaatacc 1140 tccatcaacc ctgttacctt gcagtttact tctagagatg tgtataggac cgagtcatgg 1200 gctggactta atttgtttct tactcagcca gtgaacggtg ttcctagagt ggatttccat 1260 tggaagtatc caacacttcc tattgcttca gataacttct attacttggg ttacgcagga 1320 gttggtaccc aacttcagga ttctgagaac gagcttccac cagaaacaac cggacagcca 1380 aactatgagt cttactcaca tagactttca cacattggtt tgatttctgc ttcacatgtt 1440 aaggcacttg tgtactcttg gacccactct tcagctaata ggactaacac aatcgaagca 1500 aactcaatca ctcagatccc acttgttaag gcttttaact tgccttctgg tgcaaccgtt 1560 gtgagaggac ctggattcac tggaggagat attttgagaa ggaccaatac tggaacattt 1620 ggagatatca gggttactat taacccacct ttcgctcaaa gatatagggt gagaattagg 1680 tatgcttcta ctacagatct tcaattccat acttctatta acggaagagc tatcaatcag 1740 ggtaacttct ctgcaactat gaacagggag gataatttga actacagaac ttttagaact 1800 gctggattca ccactccatt ttctttctca gatactcaat ctacctttac tattggagca 1860 tggtcattct cttctggtaa cgaggtttac atcgatagaa tcgaatttgt tcctgtggag 1920 gttgctcacg aggaaaacta cgattttgag aaggttcaag aggaagtgac agcacttttc 1980 acaccaacta atcctagggg tttgaagact aacgtgacag attacgatat tgatcaggtt 2040 ttgaatcttg tggaatctct ttcagatgag ttctatcttg atgagaagag agaacttttg 2100 gagattgtga agtacgctaa gcaattgaat attgagagga acatgtga 2148 <210> 27 <211> 2052 <212> DNA <213> Artificial sequence <220> <223> Soybean codon-optimized mBT645-3 coding sequence <400> 27 atggataacg aggattactt gagagtttca gagcacgaaa gcattaaccc atttgtgtct 60 gcttcaacca ttcaaactgg aattggtatt gcaggaaaga ttttgggaac ccttggtgtt 120 ccatttgctg gtcagatcgc atctttgtac tcattcattt tgggagagct ttggcctaag 180 ggaaagtctc aatgggaaat tttcatggag catgtggagg aaattattaa tcagaagatc 240 tctacatatg ctagaaacaa ggcattgacc gatcttaagg gattgggaga tgctcttgca 300 gtttaccacg agtctttgga atcatgggtg gagaatagga acaatacaag agctaggtct 360 gttgtgaagg gacaatatat tgcacttgag ttgatgtttg ttcagaagct tccatcattc 420 gctgtttctg gagaggaagt gccacttttg cctatctatg tgcaagctgc aaaccttcat 480 cttttgcttt tgagagatgc aagcattttt ggaaaggaat ggggtttgtc tccttcagag 540 atttcaacat tctataatag gcaggttgat agaaccaggg attattctga tcactgtgtg 600 aagtggtaca acactggact taacaatttg agaggtacaa atgctgaatc ttgggttaga 660 tacaaccaat tcagaaagga tatgacactt atggtgcttg atttgattgc attgttccca 720 tcttacgata ccatcgttta ccctattaag actacatcac agcttacaag ggaggtttat 780 accgatgcta ttggaactgt gcatcctcac gcttcttttg catcaaccac ttggtacaac 840 aataacgctc catctttctc agcaattgaa gctgcagtta ttagatcacc tcatcttttg 900 gattttcttg agaaagtgac tatctattct cttttgtcaa ggtggtctaa cacacagtac 960 atgaacatgt ggggaggtca cagacttgaa tctaggccaa ttggaggtgc tttgaacatc 1020 tcaactcaag gatctacaaa tacctccatc aaccctgtta ccttgcagtt tacttctaga 1080 gatgtgtata ggaccgagtc atgggctgga cttaatttgt ttcttactca gccagtgaac 1140 ggtgttccta gagtggattt ccattggaag tatccaacac ttcctattgc ttcagataac 1200 ttctattact tgggttacgc aggagttggt acccaacttc aggattctga gaacgagctt 1260 ccaccagaaa caaccggaca gccaaactat gagtcttact cacatagact ttcacacatt 1320 ggtttgattt ctgcttcaca tgttaaggca cttgtgtact cttggaccca ctcttcagct 1380 aataggacta acacaatcga agcaaactca atcactcaga tcccacttgt taaggcttt 1440 aacttgcctt ctggtgcaac cgttgtgaga ggacctggat tcactggagg agatattttg 1500 agaaggacca atactggaac atttggagat atcagggtta ctattaaccc acctttcgct 1560 caaagatata gggtgagaat taggtatgct tctactacag atcttcaatt catacttct 1620 attaacggaa gagctatcaa tcagggtaac ttctctgcaa ctatgaacag ggaggataat 1680 ttgaactaca gaacttttag aactgctgga ttcaccactc cattttcttt ctcagatact 1740 caatctacct ttactattgg agcatggtca ttctcttctg gtaacgaggt ttacatcgat 1800 agaatcgaat ttgttcctgt ggaggttgct cacgaggaaa actacgattt tgagaaggtt 1860 caagaggaag tgacagcact tttcacacca actaatccta ggggtttgaa gactaacgtg 1920 acagattacg atattgatca ggttttgaat cttgtggaat ctctttcaga tgagttctat 1980 cttgatgaga agagagaact tttggagatt gtgaagtacg ctaagcaatt gaatattgag 2040 aggaacatgt ga 2052 <210> 28 <211> 1848 <212> DNA <213> Artificial Sequence <220> <223> Mutant BT0727 Coding Sequence <400> 28 atgctcagaa cgaggcaata caagaagggc ccggagatgg tctatacggg cagggaacag 60 acccttccgt tcgaggaagt ggtcaagata tccgggaaga tagggatcgg tgtggttaaa 120 actgtgataa cctcaatcat tagatgtggc cgggataacg agattgcggg ccgcatcctc 180 tcagacgtgt actcggtcct gtggagcacg cctaaagggt actgggcaga aatgatagaa 240 gccgtggaaa ctctgatcca gcatgagatc tccgagaaca tcaggaacaa cgctttcgcc 300 gtcctgactg acgtgagaaa cgcacttctt ctttaccaac aggcggcgga ggaatggcaa 360 tccaacagaa ccgaccctca actgcaggag agagtgagaa atcagtttat tgcaacgaac 420 acacttatcg aattcgcaat gccctcgttt accgtccctc attacgaggt gattcttctc 480 cctatctttg cgcaagcggc gaacctccat ttgctcctcc ttagagatgt ggagatattt 540 gggctcgagt ggggcatgag caaggcgga attgacgact actatttgc aaattccggc 600 660. ctcaccggcc tgacacaaaa gtacacaaat cactccgtta aatggtacag agaggggctc tgcatcgcaa ctaatataga cctcggacag tttccagagt tttaccagct ggacaaatgg aacgccatga atgattttag gaggaatg actttcatgg ttttggacat cattgcgctg tggcccacgt atgatcctat aaggtatcca ctcggcatca aaacagagtt gacaagagag gtctttacgc ctcttctcgg aatcaatccg aactcttcgt ggctgatcca tacaatggaa gaatcgaag cgaaattgac ttttctgtcg ccgttcttgt cgtggatttc cttcgagcaa ctggtcaagc aaggggatgg cattgcaaca ttcaccgatt ggggtaactt cacactgtca aataccatgc tgcctctttc atatattctt ggaggggcag gttcggggac aggagactca 1080 actataatac cgatgcagtc agaaaactac gatgtgtaca aggttcatgt ggggactgat tactcccatc cgtccaatgt gccgatccgc aaactcgaat actactgtac caacgggaca atggaaaaag tgattactgt ggggacagga aggactaacg ctctttttga gcttccgaat 1260 aatggttgtg ttgattactc tcatcgcatc tcaagattgt catgtagcaa cgttgaagtc 1320 tatgaatggg agggcggccc gaggtatgcg cttaaaaaca ttgcctacgg ctggacgcac 1380 atcagcgtgg atagcaagaa tactttgagc gccaacgcca ttacgcaaat tcccgcacgg 1440 aagggctatg catcttccgg tagcaatctc tccatagcgg ggccctactt tactggaggt 1500 gacctcatcg ttctcccacc caatggcgcc caacttcaaa tacgggttac gccaccggtg 1560 tcaagcaagt ctaagaagta ctgtgttagg ttccggtatg ccagctccgg aaacacgaac 1620 atttatttcg aacgggtcct gtcttcaggt gatacgtatt cagaaaccca cgatgtcccg 1680 gcgacctatc cgggtggcgc actttcttat tcgagctttg cctatgttgt gaatttgacg 1740 gcgatttttg aggggttcaa cgttgagatc aaaatcaaaa acataggttc gtcccaaatc 1800 atactcgaca agatagagtt ccttccgctc aaagaatcgc tgaaagaa 1848 <210> 29 <211> 2277 <212> DNA <213> Artificial Sequence <220> <223> Synthetic polynucleotide sequence encoding mutant BT1047 <400> 29 atgaatctct gtttctatct caacattaaa aacgctctct catatacaat attttggaag 60 tgtttgttcg agcaagactt tataaggaag ttgaagctca taattaatgg agttattaat 120 atgaaaccaa aaaatcagaa taagtgtcaa tcgctttact ctaatgggac cttcgatatg 180 gactctaagg cctcactcaa gaacgacaaa aatatggaac tccagtccat tactcacgaa 240 gattgcctgc ggatgtctga gcatgaaagc atagaaccgc ttgttagcgc gtccgtgata 300 caaaacggca taggtatagc tggaaagata ttgggtaccc tcggggttcc atttgctggg 360[[ID=!]] cagattgcgt cgctgtactc gttcattctg ggtgagctct ggcccaaggg caagtcgcaa 420 tgggagatat tcatggagca tgttgaggaa ttgatagacc aaaagatttc gatctatgct!80 aggaacaagg ccctgactga gcttaaaggc cttggggatg ccctcgcagt ttaccacgaa 5!0 tcactggagt catggataga aaataggaac aacacacgcg cgcgctcagt ggtcaaatcg 600 caatatatca cactcgaact gatgttcgtc caaggtttgc cttcgttcgc cgtctccggg 660 It should be noted that there seems to be some incorrect or unclear content in the original text at positions like "!80" and "5!0" which may need to be verified and corrected in the source material for a more accurate translation.gaagaagtcc ttttgcttcc gatctatgca caagcggcga atctgcatct gctgctcctt 720 cgggatgcgt ctatttttgg cgaggagtgg ggtctttctg cttccgagat ttctacattt 780 tataatcgcc aagttgaacg cgtgaatgac tacacagact actgtgtgaa gttctacaac 840 acgggtttga attcctccag aggtacggat gcgaaaagct gggcatcata caatcaattt 900 aggaaagata tgaccttgat ggttctggat ttggtggccc ttttcccttc gtatgacact 960 catgtttatc cgatcaagac taattctcaa ctgactcgcg acgtgtatac cgatgcgatt 1020 gggacagtcc accctaatcc atcattcgcc tcaacgacgt ggtacaacaa caatgcccct 1080 gccttctctg cgatagaggc agcagtcata agaagcccac atctcttgga cttcctggag 1140 gaggttacga tttactcagc cctcagcaga tggtctaata ctcagtacat gaacatttgg 1200 tccggtcact ctctgaaatt tcgcactatc ggaggagggc tgaatacgtc aacacagggc 1260 tccactaatt ctacgatttc acctgttaca ttccagtttc ccgcccggga tgtttaccgg 1320 acagaatcat tggcagggct gaatatattt cttacgcaac cagtcaacgg agttccgtca 1380 gtttcgttc attggatact gcctggcatc gaagttggta atagcatcac atataatcct 1440 gggtacgtgg gagtgggcac ccagctgcaa gattcggaaa ctgactgcc gcccgagacc 1500 acggagcgcc ccaactatga aagctactcc caccgctgt cccatagg attgataaca 1560 gcgtcgcatg tccggcatt gttttattcc tggacgcacc gtcagccga acgcacaaac 1620 accatagagc cgaacaggat aactcagata ccactcgtta aggctctcaa tctgtactcc 1680 ggaacaacgg ttgttaaggg accaggggttc accgggggag atattctcg gcgcacgaat 1740 accggcattt tcggagat taggttaac attactgcgc ccctgagcca aaggtacaga 1800 gtgcgggtga ggtatgccag cacgactgac cttgagtttt acacctcagt gaacggcacc 1860 acaataaca tgggaattt tagcaaacg atggatagcg ggaacaattt ggattctctcg 1920 agcttcaaga caactggctt ttcgacgcca ttcagctct cgaacgcgca gagcacgttc 1980 acgttgggta cgatggacttt ttctaccaa gaagtttata tcgatagaat tgaatttcttt 2040 cccgttgaag tgacctatga agaggagtgc gacttgaga aggctcagga ggccgtgact 2100 gccctcttta cacccaagaa tcctaagggg ttgcgcatga atgtcacgga ctatcacatc 2160 gatcaagcgt ccaacctggt tgagggtctt tctgacgaat catacctcga tgagaaaagg 2220 gagcttttcg aaaaggttga atacgtaaag cagcttaata tagagcggaa catatag 2277 <210> 30 <211> 2205 <212> DNA <213> Artificial Sequence <220> <223> Synthetic polynucleotide sequence encoding mutant BT1280 <400> 30 atgaagctca agaatcaaga taagcatcag tcgttttcaa gcaatgccaa agttgacaag 60 ataagcactg attccttgaa gaatgaaacc gacatcgagc ttcaaaatat aaaccacgaa 120 gattgcctga aaatgtctga gtacgaaaac gtggaacctt ttgtgtcggc atcaacaata 180 cagacaggta taggcatagc tggaaaaatt ctgggtactc tgggcgttcc gttcgcgggt 240 caagtggcct ctttgtacag ctttattttg ggcgagctct ggcccaaagg taagaaccaa 300 tgggagattt ttatggaaca cgtcgaggag ataataaacc agaagatatc gacctatgca 360 cgcaataagg ctctcacaga ccttaaaggc ctcggtgatg cacttgctgt ctaccacgac 420 agccttgagt cttgggtcgg caacaggaat aacacgcggg ctaggtccgt tgtgaagagc 480 cagtatatcg cgcttgagct gatgtttgtc cagaaacttc catcttttgc tgtttctggc 540 gaagaggtcc ctctgttgcc gatatatgct caagctgcaa acctgcatct tttgttgttg 600 agggacgcgt caatcttcgg taaggagtgg ggtctgtcta gctcagagat cagcacgttt 660 tacaaccgcc aagttgaaag agctggggat tactcagatc attgtgtcaa atggtattca 720 accggactta ataaccttag gggtacgaat gctgagtctt gggttagata taatcaattc 780 cgcagggata tgaccttgat ggttctcgac cttgtggctc ttttcccatc atatgatacc 840 caaatgtacc caatcaaaac cacagcccag cttaccagag aggtgtacac agacgcgatt 900 gggacggtgc acccgcaccc ctcgtttacg tccacaacat ggtataataa taatgccccg 960 tcattttcag ccattgaagc ggcggtggtc cggaacccac acttgctcga cttcctggaa 1020 caggtgacca tatattcact gctgtctcgc tggagcaaca cgcaatatat gaacatgtgg 1080 ggcgggcata agcttgaatt tcgcacaatc ggaggtacgc ttaatatttc tacacaggga 1140 tctaccaata catccatcaa ccctgttacc cttccgttta cttctagaga cgtttatagg 1200 accgaaagcc tcgctggttt gaatctcttc ctcacacagc ccgtgaacgg ggttccgcgc 1260 gtcgattttc attggaaatt tgttacacat ccgattgcat cggataattt ttattaccca 1320 gggtatgctg gtataggaac acagctccaa gattctgaaa atgaactccc tcccgaagca 1380 acagggcaac caaattatga atcctattct cacagacttt cgcacatcgg cctgatatcg 1440 gcatcacacg tcaaggctct ggtctactct tggacccatc gcagcgcaga taggacaaac 1500 acaatagagc cgaactcaat aactcagatt ccgttggtta aagccttcaa cctgtcctcc 1560 ggtgcggctg tcgtcagggg accggggttc accggagggg atatattgcg caggaagaat 1620 actgggacct ttggggacat cagggtcaac ataaatccgc ccttcgctca gagatacagg 1680 gttagaatca gatacgccag caccaccgac ttgcaattcc acacgagcat caatggcaag 1740 gcaattaatc aggggaactt ttcagccacg atgaaccggg gagaagatct ggactacaag 1800 actttcagga ccgtgggctt tacaaccccg ttctcatttt ccaacgggaa ggctattaac 1860 cagggtaatt tttcagctac catgaatcgg ggcgaggacc tggattataa aactttccgc 1920 actgtgggtt tcacaacacc cttttctttc cttgacgtcc agtcaacctt cacgatcggt 1980 gcatggaact tctcctccgg gaatgaggtt tatattgacc gcatagagtt tgttcctgtt 2040 gaagtcactt acgaggcaga atatgacttt gagaaggccc aagagaaagt tacggccttg 2100 ttcacaagca ctaatcctag gggccttaag accgatgtca aggattatca tatagaccag 2160 gcctctaacc ttgctgaatc tctttccgat gtccttttta gataa 2205 <210> 31 <211> 1787 <212> DNA <213> Artificial sequence <220> <223> Synthetic polynucleotide sequence encoding mutant BT1555 <400> 31 atggacctgt cacccgatgc gcggattgag gattcgcttt gcgttgcaga aggcaacaac 60<0, atcgacccat tcgtgtcagc ctcaacagtc cagactggta tatccatcgc tgggaggata 120 ctgggagtct tgggtgtgcc ctttgccggc caacttgcca gcttttactc atttcttgtg 180 ggtgaattgt ggccatccgg gagggacccc tgggagatat tcatggagca tgtcgaacaa 240 atagtgcggc aacaaattac ggactcagtc cgcgatacag ccatcgctag gctcgaaggg 300 ttgggtcggg ggtatcggtc atatcagcaa gctctggaga cttggcttga taacaggaat 360 gatgcccgct cacgctcaat cattagggag aggtacatag ccctggagct tgacatcacc 420 actgctatac cgctgttcag catcaggaat caagaggtgc ctcttcttat ggtttacgca 480 caggccgcaa atctccacct cctgcttttg agggatgcat ccatcttcgg gaaggaatgg 540 gggctgtctg cgtcggagat ctcgactttc tataatagac aggtcgaacg gacccgggat 600 tattccgacc actgtgttaa gtggtataac acgggcctga acaatctccg gggtacaaac 660 gccaaatctt gggttcgcta taatcaattc cggaaggata tgaccctgat ggtgcttgac 720 ctggttgcac tcttcccttc ttatgatacc ttggtgtacc caattaagac tacctctcag 780 ttgactcggg aggtctatac tgacgcaatc ggtacggttc atccgaacca agccttcgcc 840 tcgacaacat ggtacaacaa caacgcgccc tctttttcaa ccatcgaggc ggcggttgtg 900 cgcaaccctc acctccttga cttcctcgag caagtcacaa tttactcctt gctgtcgagg 960 tggagcaaca cccaatacat gaatatgtgg ggcggccaca agttggaatt tcgcacaata 1020 ggcgggacac tgaatacatc tacgcaagga tcaaccaata cttcaataaa ccccgttacg 1080 ttgccattca cttccagaga cgtttatcgg accgagagct tggccggcct taatctcttt 1140 cttacgcaac ctgttaatgg tgttccaaga gttgactttc attggaaatt cgtgacccac 1200 cccattgcta gcgataactt ttattatcca gggtacgcgg gaatagggac tcagcttcag 1260 gactctgaaa atgaattgcc tcccgaaacg accgggcaac cgaactatga atcatactca 1320 cacagactct cgcatattgg acttatatcg gcctcccag ttaaagccct ggtgtattcc 1380 tggacccata ggagcgcaga caggactaat actatagagc cgaacagcat cactcaaaatc 1440 ccgctggtta aagcctttaa tttgccatcc ggagctgccg tggtcagagg cccgggtttt 1500 accggtggcg acatcctcca gcgcacaaat acaggtacct tcggagacat tagagttaac 1560 atcaaccctc cctttgcaca aagatatagg gtgaggatac gctatgcgtc cactactaat 1620 gttgagttcc ataccagcat taatggcaag gcgattaacc agggtaattt ttctgccacc 1680 atgaacagag gtgaagatct tgattacaag acatttagga ccgttggttt caccacgccc 1740 ttctcgttga gcgatgttca gtcgactttc acaataggtg cgtggaa 1787 <210> 32 <211> 2040 <212> DNA <213> Artificial sequence <220> <223> Synthetic polynucleotide sequence encoding mutant BT1559 <400> 32 atgaatctgt caacagatgc aagaattgag gactcgctgt gtatagcaga aggtaataac 60 atcgatccct ttgtctccgc atctactgtg caaactggga taaatatagc gggaaggatc 120 cttggagtct tgggcgtgcc gttcgcaggc caaattgcat cattctattc cttcctggtt 180 ggcgagctgt ggccaagagg gagggatccg tgggaaattt ttcttgagca cgttgagcag 240 ctgattcggc aacaagtgac tgaaaataca cgggatactg cgctggcgcg gctgcagggg 300 ttgggaaact catttcgggc ataccagcag tcactggaag attggcttga aaatcgggac 360 gacgctcgga cccgctcagt gctctatacg caatacattg ccctcgagct ggatttcttg 420 aacgccatgc cactgttcgc aatacgcaac caagaggtcc ctctgctcat ggtgtacgca 480 caagctgcaa atcttcatct tttgctcttg cgggatgctt cactgtttgg atccgaattt 540 ggtctgacat cccaagagat acaaaggtac tatgaacggc aggtcgaaaa gacccgggaa 600 tattccgatt attgtgcacg gtggtataac acggggctca acaacctccg gggtaccaac 660 gcagagtcat ggctgcggta caaccagttt cggagagacc tcaccctcgg tgtcctcgat 720 ttggtggcat tgtttccatc ttacgataca agagtttatc ccatgaatac gagcgcgcag 780 ttgacccgcg aaatttatac agatccgata ggacgcacga acgccccttc cggatttgca 840 tccactaatt ggtttaataa taatgctccc tcgttctccg ccatagaagc tgccgtgatc 900 cggtcaccac atctgctcga ctttctcgaa caagtcacta tttatagcct tttgtccaga 960 tggtcgaaca cgcaatatat gaacatgtgg ggcggccata agctcgaatt ccggacgatt 1020 ggtgggactt tgaatacgtc tactcagggg tccacaaata cgtctattaa ccctgtgacg 1080 ctgccgttca catcacggga tatctatcgc accgagagcc tcgccgggct caaccttttc 1140 ctgactcaac cggtgaacgg cgtgcctaga gtggacttcc actggaagtt cgttacccac 1200 ccaatcgctt cggacaactt ttattacccg gggtatgcgg gtatcgggac ccaacttcaa 1260 gactcagaga acgagcttcc cccagaaaca accggtcagc cgaactatga gtcctattcc 1320 catcggttgt cacacatcgg ccttataagc gcgtctcacg tcaaagcttt ggtctattcg 1380 tggacccatc gctccgcaga taggactaac accatccact ctgattcgat aactcaaatc 1440 ccattggtca aagctcatac gttgcagagc ggcactacgg ttgtcaaggg tcccggtttc 1500 actggcggcg atatcctgcg ccggacttcc ggagggccct ttgcgttttc gaacgttaat 1560 ctcgattgga acctctcaca aaggtatcgc gccaggatcc gctacgcgtc aacaacgaac 1620 ctcagaatgt acgtgactat cgctggggag cggatttttg ccggccagtt caataagacg 1680 atgaacactg gcgatcctct gaccttccaa tcgttttcat atgccactat cgataccgct 1740 tttacctttc ctactaaagc ttcgagcctc acggtgggtg cagacacctt ctccagcggt 1800 aacgaagtct atgtggatcg gttcgaactt ataccagtta ctgcaaccct cgaagctgtg 1860 accgacttgg agcgggcaca gaaagcggtg cacgagctct tcacctcaac taaccccgga 1920 ggacttaaga cagacgtgaa ggactaccat atagatcaag tgtctaactt ggcggaatct 1980 ctttcggatg aattctattt ggacgagaag cgggagctgt ttgagattgc gaagtattag 2040 <210> 33 <211> 2040 <212> DNA <213> Artificial Sequence <220> <223> Synthetic polynucleotide sequence encoding mutant BT1563 <400> 33 atgaaccttt ccacggacgc gagaatagaa gacagcttgt gcatagccga gggaaacaat 60 atcgacccct tcgtttccgc gagcactgtg cagaccggta taaacatcgc cggtcgcatc 120 ctcggagtcc tcggggtgcc gtttgctggt cagatagcca gcttttattc gttcctcgtg 180 ggtgagctgt ggcccagagg tagggatcct tgggaaattt ttctcgagca cgtggagcaa 240 ttgattcggc aacaggtgac cgagaacacg cgcgacaccg cacttgcgcg gttgcaaggg 300 ctcggcaatt cgtttagggc gtaccagcag tcacttgaag attggctgga gaaccgcgat 360 gatgcgagaa ctcggtcggt tctctacacc caatacatag cactcgaact tgatttcttg 420 aatgctatgc cgctttttgc cattcggaac caagaggtcc ctcttttgat ggtgtacgca 480 caagcagcca acctccactt gctgctcctt cgcgacgcat ctttgttcgg gtcagaattt 540 ggtctgacat cacaggagat acaacgctac tatgaacggc aggtcgaaaa aacccgggag 600 tactcggact actgtgcgcg ctggtataac actgggctca acaacctcag ggggacaaat 660 gctgaatcgt ggctgagata taatcagttc cggagggaca tgacattgat ggttttggat 720 ctggttgcat tgtttccgag ctacgacaca cgggtgtacc ccatgaacac ctccgcccag 780 cttactagag aaatttacac ggatcccatc ggtcgcacta acgcaccctc cggattcgca 840 tcaactaact ggtttaataa caatgctccc tcattttcgg ctatcgaggc agcggtcgtg 900 agaaacccac atctcctcga ttttcttgag caggtgacaa tctactcgct cctttcgagg 960 tggtcaaaca cacaatatat gaatatgtgg ggaggacaca agctggagtt ccggacaatt 1020 ggaggcacac ttaatacttc gactcagggc tccaccaaca cgtccatcaa cccagtcact 1080 ttgcctttta ccagccgcga tgtttacagg acagaatcgc tcgccggctt gaacctcttt 1140 ttgactcagc cggtcaatgg ggtgcctaga gttgatttcc actggaagtt tgttacgcac 1200 ccgatcgcta gcgacaactt ctactaccct ggctacgccg ggataggcac gcagctccaa 1260 gactctgaaa acgagctgcc ccctgaagca actggccaac cgaattatga aagctacagc 1320 cacaggttgt cccatatagg tcttatctct gcatcccacg ttaaggcgct cgtttattcc 1380 tggacgcatc gcagcgccga caggactaac acgatcgagc cgaactcgat aactcagatt 1440 cccttggtca aggccttcaa tctgtcgagc ggcgcggcgg ttgtcagagg tcccggattt 1500 acgggtggcg atatcttgcg gaggactaac acaggaacgt tcggggacat ccgcgtgaat 1560 attaacccgc cattcgcaca acgctatcgc gtgaggatac ggtacgcctc aacgacagac 1620 cttcaatttc acactagcat aaacggtaag gcaatcaacc aagggaactt ctcagctacc 1680 atgaaccgcg gcgaggattt ggattacaag acgtttcgca cagtgggttt cactacaccg 1740 ttctcattta gcgatgtgca atccacgttt actataggtg catggaactt ctctagcgga 1800 aacgaggttt acatcgacag aattgaattt gtgcccgttg aagtgaccta cgaggctgag 1860 tatgatttcg agaaagcgca agaaaaagtc acggccctct ttacatccac aaatccgcgc 1920 ggccttaaga cagatgtgaa ggactatcac atcgaccaag tgagcaacct tgtcgagtcg 1980 atcagcgatg agttctacct ggacgaaaag cgcgagttgt tcgaaatcgc caaatattag 2040 <210> 34 <211> 2118 <212> DNA <213> Artificial sequence <220> <223> Synthetic polynucleotide sequence encoding mutant BT1571 <400> 34 atgacttcaa acaggaagaa cgagaacgag ataattaacg cactgtcgat accagcggtc 60 tctaaccatt ccgcacagat ggatctttcg cttgatgcgc ggattgaaga ctccctgtgc 120 attgctgagg gcaacaacat aaatccattg gtcagcgcct caacggtgca gactgggatc 180 aacattgctg ggcgcatact cggtgtcctc ggagttccgt tcgcaggaca actcgcttca 240 ttctactctt ttctcgtcgg tgaactctgg ccttctggta gggatccttg ggaaatattt 300 ttggagcacg tggagcaact gatacggcag caggttacag aaaatacaag gaatacagca 360 atcgcacgcc tggaggggct gggacgcgga tacaggtctt atcaacaggc actcgaaaca 420 tggttggata acagaaacga cgcacgctcg agatcgataa tacttgagag atacgttgct 480 ctcgagcttg atatcacgac cgccatcccc ttgtttcgca tccggaacga agaggtcccg 540 ttgctcatgg tctatgccca ggctgccaac ctccatcttt tgctcttgcg cgacgcatca 600 ctgttcggtt cagaatgggg tatggcgtct agcgatgtta atcaatatta tcaggaacag 660 atccggtata ctgaggagta ctctaatcat tgtgttcagt ggtacaatac tggactcaat 720 aacctcaggg gtaccaatgc cgagtcgtgg ctgaggtaca atcagttccg cagggacttg 780 acgctgggcg ttcttgatct cgttgcgctc ttcccttctt acgatacacg cacctaccct 840 ataaatacta gcgctcaact cactagggaa atctatacgg atccaatcgg gcgcaccaat 900 gccccatctg gtttcgcctc aacgaattgg ttcaacaata atgccccatc tttttccgct 960 atcgaatcag cagtggtccg gaacccccat ctcttggact ttcttgaaca ggttaccatt 1020 tactccttgc tttctagatg gtcgaacacc caatatatga acatgtgggg tggacaccgg 1080 cttgaattta ggacgatcgg cggtgttctt aatacttcta cacaagggtc aaccaacact 1140 tctattaatc ccgttactct tccctttacg tcgcgggatg tctatcggac ggaaagcctc 1200 gctgggctga atctgtttct cactcaacct gtcaacgggg ttccgagggt tgatttccat 1260 tggaaatttg ctactctccc gatagcatcg gataatttct attacttggg gtatgctgga 1320 gtcggcactc aacttcaaga ctcagaaaat gaacttcccc ccgaaacaac tggtcagccc 1380 aattatgaat cgtactcaca ccggctttcc catataggcc tcatctctgc atcccatgtg 1440 aaggcgctgg tgtactcctg gacgcacagg agcgcagata ggaccaatac gatagaaccg 1500 aactctatca cgcagattcc actggtcaag gcattcaatt tgagctctgg ggcggctgtt 1560 gtcagagggc ccggatttac cggcggggac atcctgcgca gaactaatac gggaaccttt 1620 ggagacataa gagtgaatat caatcctccc tttgcccagc ggtatcgcgt gcgcattcgg 1680 tatgcgtcaa ccaccgatct gcaattccac accagcatca atggcaaggc aattaaccaa 1740 gggaacttct cagctacaat gaataggggc gaagatctcg actacaagac gttcggacg 1800 gttgggttta cgactccgtt ttccttctct gatgtccaat ctacgttcac catcggggcg 1860 tggaactttt cctcaggcaa cgaagtttat atagacagaa tcgagtttgt ccctgtggag 1920 gtgacatacg aagctgagta tgatttcgaa aaggcgcagg agaaagtcac tgctcttttt 1980 acctcgacca atccccgcgg gttgaagacg gatgtgaaag actaccatat agatcaggtg 2040 tccaacttgg tggagtcttt gtcagacgaa ttctatatcg atgagaagag agaactgttc 2100 gaactcgtca aatattag 2118 <210> 35 <211> 2121 <212> DNA <213> Artificial sequence <220> <223> Synthetic polynucleotide sequence encoding mutant BT1633 <400> 35 atgaagctta agaaccaaaa catgcaccag tctttgagct ctaacgctac agttgataaa 60 tcctttactg attccctcga acataatacg aacatggagc ttcaaaattc aaatcacgaa 120 gattgcctga agatgtccga atatgaatca atagagccct ttgtctcggc atcaaccata 180 cagactggca taggaattgc tggtaaaatt ttgggcacat tgggtgttcc tttcgccggc 240 caaatagcgt cgctttactc ttttatattg ggtgagcttt ggcctaaggg caagagccag 300 tgggagatct tcatggaaca tgttgaagaa ctgattaacc agaagatctc cacgtacgct 360 aggaataaag cattggcaga tcttaagggc cttggagatg cactcgcggt ttaccacgaa 420 tctttggaat cctggatcga aaataggaat aacacacggg ctaggtcagt cgtgaagaat 480 cagtatattg cactggagct catgtttgtt cagaaactgc cctccttcgc agtctccggt 540 gaggaggtcc cattgttgcc gatctatgca caagcggcca acttgcatct cctgctgctc 600 cgggatgcca gcatttttgg taaggaatgg ggattgtccg agtctgaaat ttccaccttc 660 tacaacagac aagttgaacg gacacgggat tattcggatc attgcgtcaa gtggtacaac 720 acgggcttga atagattgcg cggtactaat gccaagtcgt gggtccgcta caaccagttt 780 aggaaagaca tgaccttgat ggtcctcgac ttggtcgcat tgtttccttc ttacgataca 840 cttgtttacc ctattaaaac aactagccaa ctcacacggg aagtgtatac agatgctatc 900 ggtacagtgc acccgaatca ggcctttgct tccactacgt ggtataacaa caatgctcca 960 tcgttttccg caatagaagc tgcggttatc agatcacccc atctccttga ttttcttgaa 1020 aaggttacaa tatattcact cctctcaaga tggagcaaca cccagtatat gaacatgtgg 1080 ggcggccaca aacttgagtt tcggaccatt ggtgggacat tgaacacatc gacccagggg 1140 tctacgaata catcaattaa tcccgttacg cttccgttca cgtcaaggga tgtttacagg 1200 actgaatccc tggcgggcct caacctgttc ctgactcagc cagttaatgg ggtcccgagg 1260 gttgactttc attggaaatt tgtcacccat ccgatagcct ccgataactt ctactaccca 1320 ggctacgcgg gtatcggaac acagcttcag gatagcgaaa atgagctgcc gccagagaca 1380 accggacagc cgaattacga atcctatagc cacagactgt cacacatagg actcatttca 1440 gcttcgcacg ttaaggcact ggtgtatagc tggacacatc ggagcgcgga tcgcactaac 1500 acgatagagc cgaattcgat cacacaaata ccattggtta aagccttcaa tcttccgtcg 1560 ggcgctgcgg tggttcgcgg acccggtttt acaggtggtg atattcttcg cagaaccaac 1620 acaggcacct tcgccgatat gcgcgtgaat attaccgggc ccctgtcaca aaggtaccgc 1680 gttcgcatta ggtatgctag cacgaccgat ctgcaattct ttaccaatat taacggcacg 1740 acgataaaca tgggcaattt cccgaagaca gtgaacaatt cgtcttctga aggctaccgc 1800 acggtttcct tttcaacacc tttttctttc agcaacgcac aatccatctt cagattggga 1860 atccaggcat tctctggagt gcatgagata cacgtggata gaatcgagtt tgtccctgcg 1920 gaagttactt tcgaagctga gtacgatctg gagagagcgc agaaggccgt gaatgcgctg 1980 tttacgagca caaacccgaa ggacatgaaa acttatgtta ctgagtctca aattgatcaa 2040 gtcttcaatc tggtcgagtg tatttctgac gaggtttgct tggatgaaaa aagagagatt 2100 ttcaagaagg tgaaatatta g 2121 <210> 36 <211> 719 <212> PRT <213> Artificial Sequence <220> <223> Assembled BT204 <400> 36 Met Lys Leu Lys Asn Pro Asp Lys His Gln Ser Phe Ser Ser Asn Ala 1 5 10 15 Lys Val Asp Lys Ile Ala Thr Asp Ser Leu Lys Asn Glu Thr Asp Ile 20 25 30 Glu Leu Lys Asn Met Asn Asn Glu Asp Tyr Leu Arg Met Ser Glu His 35 40 45 Glu Ser Ile Asp Pro Phe Val Ser Ala Ser Thr Ile Gln Thr Gly Ile 50 55 60 Gly Ile Ala Gly Lys Ile Leu Gly Thr Leu Gly Val Pro Phe Ala Gly 65 70 75 80 Gln Ile Ala Ser Leu Tyr Ser Phe Ile Leu Gly Glu Leu Trp Pro Lys 85 90 95 Gly Lys Ser Gln Trp Glu Ile Phe Met Glu His Val Glu Glu Leu Ile 100 105 110 Ala Gln Lys Ile Ser Thr Tyr Ala Arg Asn Lys Ala Leu Thr Asp Leu 115 120 125 Lys Gly Leu Gly Asp Ala Leu Ala Val Tyr His Glu Ser Leu Glu Ser 130 135 140 Trp Ile Lys Asn Arg Asn Asn Thr Arg Ala Arg Ser Val Val Lys Ser 145 150 155 160 Gln Tyr Ile Ser Leu Glu Leu Met Phe Val Gln Lys Leu Pro Ser Phe 165 170 175 Ala Val Ser Gly Glu Glu Val Pro Leu Leu Pro Ile Tyr Ala Gln Ala 180 185 190 Ala Asn Leu His Leu Leu Leu Leu Arg Asp Ala Ser Ile Phe Gly Lys 195 200 205 Glu Trp Gly Leu Ser Ser Ser Glu Ile Ser Thr Phe Tyr Asn Arg Gln 210 215 220 Ala Glu Arg Thr Ser Asp Tyr Ser Asp His Cys Val Lys Trp Tyr Ser 225 230 235 240 Thr Gly Leu Asn Asn Leu Arg Gly Lys Asn Ala Glu Ser Trp Val Arg 245 250 255 Tyr Asn Gln Phe Arg Lys Asp Met Ile Leu Met Val Leu Asp Leu Val 260 265 270 Ala Leu Phe Pro Ser Tyr Asp Thr His Met Tyr Pro Ile Lys Thr Thr 275 280 285 Ala Gln Leu Thr Arg Glu Val Tyr Thr Asn Ala Ile Gly Thr Val His 290 295 300 Pro His Pro Ser Phe Ala Ser Thr Thr Trp Tyr Asn Asn Asn Ala Pro 305 310 315 320 Ser Phe Ser Ala Ile Glu Ala Ala Val Ile Arg Ser Pro His Leu Leu 325 330 335 Asp Phe Leu Glu Gln Val Thr Ile Tyr Ser Leu Leu Ser Arg Trp Ser 340 345 350 Asn Thr Gln Tyr Met Asn Met Trp Gly Gly His Arg Leu Glu Phe Arg 355 360 365 Thr Ile Gly Gly Ala Leu Asn Thr Ser Thr Gln Gly Ser Thr Asn Thr 370 375 380 Ser Ile Asn Pro Val Thr Leu Pro Phe Thr Ser Arg Asp Val Tyr Arg 385 390 395 400 Thr Glu Ser Leu Ala Gly Leu Asn Leu Phe Leu Thr Gln Pro Val Asn 405 410 415 Gly Val Pro Arg Val Asp Phe His Trp Lys Phe Val Thr His Pro Ile 420 425 430 Ala Ser Asp Asn Phe Tyr Tyr Pro Gly Tyr Ala Gly Ile Gly Thr Gln 435 440 445 Leu Gln Asp Ser Glu Thr Glu Leu Pro Pro Glu Thr Thr Gly Gln Pro 450 455 460 Asn Tyr Glu Ser Tyr Ser His Arg Leu Ser His Ile Gly Leu Ile Ser 465 470 475 480 Ala Ser His Val Lys Ala Leu Val Tyr Ser Trp Thr His Arg Ser Ala 485 490 495 Asp Arg Thr Asn Thr Ile Glu Pro Asn Ser Ile Thr Gln Ile Pro Leu 500 505 510 Val Lys Ala Phe Asn Leu Pro Ser Gly Ala Ala Val Val Arg Gly Pro 515 520 525 Gly Phe Thr Gly Gly Asp Ile Leu Arg Arg Thr Asn Thr Gly Thr Phe 530 535 540 ...

Claims

1. A nucleic acid molecule consisting of a nucleotide sequence encoding a Cry protein that is toxic to lepidopteran pests, wherein the nucleotide sequence: (a) consists of SEQ ID NO: 3; or (b) encodes a Cry protein consisting of the amino acid sequence of SEQ ID NO: 38; or (c) is an assembled nucleotide sequence of (a) or (b); or (d) is a synthetic sequence of (a), (b) or (c), which has been codon-optimized for expression in transgenic organisms.

2. The nucleic acid molecule of claim 1, wherein the nucleotide sequence consists of SEQ ID NO:

3.

3. The nucleic acid molecule as described in claim 1, wherein the Cry protein consists of the amino acid sequence of SEQ ID NO:

38.

4. The nucleic acid molecule of claim 1, wherein the synthetic sequence consists of SEQ ID NO:

14.

5. A chimeric gene comprising a heterologous promoter, and the nucleic acid molecule according to any one of claims 1 to 4 operably linked to the heterologous promoter. The chimeric gene of claim 5 , wherein the heterologous promoter is a plant-expressible promoter.

7. The chimeric gene of claim 6, wherein the plant expressible promoter is selected from the group consisting of: Ubiquitin, tuberose flavivirus, maize TrpA, OsMADS 6, maize H3 histone, bacteriophage T3 gene 9 5'UTR, maize sucrose synthase 1, maize alcohol dehydrogenase 1, maize light-harvesting complex, maize heat shock protein, maize mtl, pea small subunit RuBP carboxylase, rice actin, rice cyclophilin, Ti plasmid mannopine synthase, Ti plasmid nopaline synthase, petunia chalcone isomerase, legume glycine-rich protein 1, potato glycoprotein, lectin, CaMV 35S, and S-E9 small subunit RuBP carboxylase promoter.

8. The chimeric gene of claim 5, wherein the lepidopteran pest is Ostrinia furnacalis.

9. The chimeric gene of claim 5, wherein the transgenic organism is a bacterium.

10. A Cry protein, which is toxic to lepidopteran pests, wherein the Cry protein consists of the following amino acid sequence: (a) an amino acid sequence consisting of SEQ ID NO: 38; or (b) an amino acid sequence encoded by a nucleotide sequence or an assembled nucleotide sequence consisting of SEQ ID NO: 3 or 14.

11. The Cry protein as described in claim 10, wherein the amino acid sequence consists of SEQ ID NO:

38.

12. The Cry protein as described in claim 10, wherein the amino acid sequence is encoded by a nucleotide sequence, and the nucleotide sequence consists of SEQ ID NO: 3 or 14.

13. The Cry protein of any one of claims 10-12, wherein the Lepidoptera pest is selected from the group consisting of European corn borer, soybean looper, Spodoptera exigua, tobacco budworm, southern armyworm, Cowes armyworm and corn rootworm.

14. An isolated Bacillus thuringiensis strain, which produces the Cry protein of claim 11.

15. An insecticidal composition comprising the Cry protein according to claim 10 and an agriculturally acceptable carrier.

16. The composition of claim 15, wherein the agriculturally acceptable carrier is selected from the group consisting of dusts, pellets, granules, sprays, emulsions, colloids and solutions.

17. The composition of claim 15, wherein the composition comprises transgenic bacterial cells that produce the Cry protein.

18. A recombinant vector comprising the nucleic acid molecule according to claim 1 or the chimeric gene according to claim 5.

19. A transgenic bacterial cell, comprising the recombinant vector according to claim 18.

20. The transgenic bacterial cell of claim 19, wherein the bacterial cell is in the genus Bacillus, Clostridium, Xenorhabdus, Photorhabdus, Pasteurella, Escherichia, Pseudomonas, Erwinia, Serratia, Klebsiella, Salmonella, Pasteurella, Xanthomonas, Streptomyces, Rhizobium, Rhodopseudomonas, Methylophilus, Agrobacterium, Acetobacter, Lactobacillus, Arthrobacter, Azotobacter, Leuconostoc, or Alcaligenes.

21. The transgenic bacterial cell of claim 20, wherein the bacterial cell is a Bacillus thuringiensis cell.

22. A method for producing a Cry protein toxic to lepidopteran pests, the method comprising: The transgenic bacterial cell of claim 19 is cultured under conditions whereby the transgenic bacterial cell produces the Cry protein.

23. The method of claim 22, wherein the lepidopteran pest is selected from the group consisting of European corn borer, soybean looper, mulberry bean armyworm, tobacco budworm, southern armyworm, coweed armyworm, corn rootworm, or any combination thereof.

24. The method of claim 22, wherein the nucleic acid molecule or the chimeric gene consists of SEQ ID NO: 3 or 14.

25. The method of claim 22, wherein the Cry protein consists of the amino acid sequence of SEQ ID NO:

38.

26. A method for producing an insect-resistant transgenic plant, the method comprising: Introducing the chimeric gene of claim 5 into a plant, wherein the Cry protein is expressed in the plant, thereby producing an insect-resistant transgenic plant.

27. The method of claim 26, wherein the step of introducing is accomplished by: a) transforming the plant; or b) crossing a first plant comprising the chimeric gene with a second, different plant.

28. The method of claim 26, wherein the plant is a maize plant.

29. A method for controlling lepidopteran pests, the method comprising delivering an insecticidal composition to the lepidopteran pests or their environment, the insecticidal composition comprising an effective amount of the Cry protein of claim 10.

30. The method of claim 29, wherein the lepidopteran pest is selected from the group consisting of European corn borer, soybean looper, mulberry bean armyworm, tobacco budworm, southern armyworm, coweed armyworm, corn rootworm, or any combination thereof.